Endocrine Abstracts

Contents

• 21th European Congress of Endocrinology 2019
• • Prize Lectures and Biographical Notes
  • The European Journal of Endocrinology Prize Lecture
  • • New approaches in the differential diagnosis of Diabetes insipidus

      ea0063eje1
    • EJE Award 2019 - Biography

      ea0063eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Translational research in pituitary disease

      ea0063gh1
    • ESE Geoffrey Harris Prize 2019 - Biography

      ea0063gh1biog
  • European Hormone Medal Lecture
  • • Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis

      ea0063ehm1
    • European Hormone Medal 2019 - Biography

      ea0063ehm1biog
  • Clinical Endocrinology Trust Lecture
  • • How can patients' perception of outcome be improved after controlling pituitary disease?

      ea0063cet1
    • Clinical Endocrinology Trust Award 2019 - Biography

      ea0063cet1biog
• Plenary Lectures
• • Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
  • • Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease

      ea0063pl1
  • Genetic epidemiology of puberty timing and reproductive lifespan (Endorsed by the European Journal of Endocrinology)
  • • Genetic epidemiology of puberty timing and reproductive lifespan

      ea0063pl2
  • Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
  • • Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes

      ea0063pl3
  • Exercise Training in the Management of Type 2 Diabetes
  • • Exercise Training in the Management of Type 2 Diabetes

      ea0063pl4
  • Paracrine regulation of the adrenal cortex
  • • Paracrine regulation of the adrenal cortex

      ea0063pl5
  • Graves orbitopathy
  • • Graves Orbitopathy

      ea0063pl6
  • Control of Integrative Physiology by the Melanocortin Circuitry
  • • Control of Integrative Physiology by the Melanocortin Circuitry

      ea0063pl7
• Symposia
• • Thyroid in cancer
  • • What is the value of molecular markers in nodules?

      ea0063s1.1
    • Iodine refractoriness in thyroid cells

      ea0063s1.2
    • New paradigms in the treatment of low risk thyroid cancer

      ea0063s1.3
  • Trends in puberty
  • • Exploring the Epigenetic landscape of puberty

      ea0063s2.1
    • Endocrine disrupters in puberty

      ea0063s2.2
    • The genetic basis of pubertal timing

      ea0063s2.3
  • Circadian clocks: from pathophysiology to chronomedicine
  • • Circadian control of glucocorticoid function

      ea0063s3.1
    • Fixing the broken clock in adrenal disorders

      ea0063s3.2
    • Understanding the molecular basis of seasonal changes in behavior

      ea0063s3.3
  • Immunology and endocrinology (Endorsed by Endocrine Connections)
  • • Basic: immunotherapy and endocrine disease

      ea0063s4.1
    • Clinical: Immunotherapy and endocrine disease

      ea0063s4.2
    • Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders

      ea0063s4.3
  • Microbiota as new treatment for diabetes and metabolic disease
  • • Human gut microbiome: hopes, threats and promises

      ea0063s5.1
    • Fecal transplantation: Myth or reality

      ea0063s5.2
    • Targeted Microbiome Intervention for handling insulin resistance

      ea0063s5.3
  • A better life with thyroid hormone (Endorsed by the European Journal of Endocrinology)
  • • Prediction of the thyroid axis set-point

      ea0063s6.1
    • Subclinical hypothyroidism in children

      ea0063s6.2
    • Subclinical hypothyroidism in the elderly

      ea0063s6.3
  • Endocrine disrupting chemicals (Endorsed by Endocrine Connections)
  • • Mixtures measured in human, disrupt thyroid hormone signaling and behavior in Xenopus laevis

      ea0063s7.1
    • Actions of endocrine disrupting chemicals on pancreatic beta cells and risk of diabetes mellitus

      ea0063s7.2
    • Prenatal obesogen exposure leads to a transgenerational thrifty phenotype in mice

      ea0063s7.3
  • Genderdysphoria - delayed puberty
  • • Psychoendocrinology of gender dysphoria

      ea0063s8.1
    • Management of puberty in transgender adolescents

      ea0063s8.2
    • Gender reassignment surgery in dysphoria

      ea0063s8.3
  • Controversies in adrenal disease
  • • Metanephrines: Plasma or Urine

      ea0063s9.1
    • The dos and don'ts of genetic testing in phaeochromocytoma

      ea0063s9.2
    • Is there a role for subtotal adrenalectomy

      ea0063s9.3
  • Cancer drug-induced osteoporosis (Endorsed by Endocrine Connections)
  • • Mechanisms of skeletal metastasis

      ea0063s10.1
    • Aromatase inhibitors and bone

      ea0063s10.2
    • TSH suppressive therapy and bone

      ea0063s10.3
  • EDCs & reproduction
  • • Impact of pesticide postnatal exposure on oocyte quality and clinical outcomes of patient undergoing IVf programme

      ea0063s11.1
    • Environmental endocrine disruptors and testicular germ cell cancer

      ea0063s11.2
    • Mitigating against endocrine disruption in pregnancy

      ea0063s11.3
  • Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
  • • The view of the surgeon: When, how much and when to refrain from surgery?

      ea0063s12.1
    • New potential treatment alternatives in patients with papillary craniopharyngioma

      ea0063s12.2
    • How to manage the long-term consequences of hypothalamic damages

      ea0063s12.3
  • Central control of metabolism: Brain rules all
  • • Sensors of survival: Pleiotropic function and the regulation of hunger circuits

      ea0063s13.1
    • Role of mitochondria/cell bioenergetics in CNS regulation of energy balance

      ea0063s13.2
    • Genetics of appetite regulation: Can an old dog teach us new tricks?

      ea0063s13.3
  • Innovations in NETs
  • • Innovative imaging of benign insulinomas - the end of sampling

      ea0063s14.1
    • A role for radionuclide therapy for high-grade NETs

      ea0063s14.2
    • Fishing for NETs

      ea0063s14.3
  • European Young Endocrine Scientists (EYES)
  • • European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease

      ea0063s15.1
    • Investigating glucocorticoid excess as mediators of bone marrow adiposity expansion during caloric restriction

      ea0063s15.2
    • Best young abstract submission

      ea0063s15.3
    • The role and cross-talk between incretin hormones and occurrence of non-alcoholic steatohepatitis

      ea0063s15.4
    • Lysophosphatidic acid in pathogenesis of HNF1B-MODY syndrome

      ea0063s15.5
    • Closing remarks and invitation to the EYES social

      ea0063s15.6
  • Thyroid in pregnancy
  • • Thyroid autoimmunity and (in)fertility

      ea0063s16.1
    • Thyroid disease and pregnancy outcomes

      ea0063s16.2
    • Mild maternal thyroid dysfunction during pregnancy and offspring neurodevelopment

      ea0063s16.3
  • Where do pituitary tumours come from?
  • • Specification of pituitary cell fates

      ea0063s17.1
    • Pertubations in novel signalling pathways

      ea0063s17.2
    • 'From Lab to Clinic - Can we translate into effective therapeutics'

      ea0063s17.3
  • Congenital hypogonadotropic hypogonadism: New insights into GnRH Regulation
  • • The transcription factor Gli3 plays a pivotal role in controlling the development of the terminal nerve and GnRH-1 neuronal migration

      ea0063s18.1
    • Flipping the GnRH switch with microRNAs

      ea0063s18.2
    • Congenital hypogonadotropic hypogonadism: clinical perspectives

      ea0063s18.3
  • Adrenal insufficiency
  • • New insights into autoimmune adrenal insuffisiency

      ea0063s19.1
    • Long-term results of modified release glucocorticoids in adrenal insufficiency - are they really better?

      ea0063s19.2
    • Optimising care delivery in congenital adrenal hyperplasia

      ea0063s19.3
  • News on nutrition: when to eat what
  • • Precision nutrition for managing obesity - does it work?

      ea0063s20.1
    • Is limiting the timing of food intake a viable nutritional approach?

      ea0063s20.2
    • PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health

      ea0063s20.3
  • Rare bone disorders
  • • Animal models of bone fragility

      ea0063s21.1
    • New perspectives on the treatment of skeletal dysplasia

      ea0063s21.2
    • Osteogenesis imperfecta throughout life

      ea0063s21.3
  • The pituitary as metabolic sensor (Endorsed by Endocrine Connections)
  • • Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis

      ea0063s22.1
    • How treatments with endocrine & metabolic drugs influence pituitary cell function?

      ea0063s22.2
    • Bidirectional interrelationship between growth hormone and metabolism

      ea0063s22.3
  • PCOS: can we personalise treatment?
  • • Gut and brain axis

      ea0063s23.1
    • Implicating androgen excess in metabolic disease in PCOS

      ea0063s23.2
    • Treatment options in cardiometabolic pcos phenotype

      ea0063s23.3
  • What's new in the Adrenal Cortex? (Endorsed by the European Journal of Endocrinology)
  • • Adrenocortical tumors: new genes, new understanding, new therapy

      ea0063s24.1
    • Primary hyperaldosteronism: does our treatment work?

      ea0063s24.2
    • Autonomous cortisol secretion has cardiovascular consequences

      ea0063s24.3
  • Late Breaking Session
  • • Liver Stress kinases - crossroad between obesity and liver cancer (Source paper: Nature 2019)

      ea0063s25.1
    • Levothyroxine in preconception women with thyroid peroxidase antibodies

      ea0063s25.2
    • Maternal smoking and high BMI disrupt thyroid gland development

      ea0063s25.3
  • Impact of thyroid disease on...
  • • Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders

      ea0063s26.1
    • Bone

      ea0063s26.2
    • Thyroid hormones in the cardiac physiopathology

      ea0063s26.3
  • What's new in reproductive endocrinology?
  • • Dissecting androgens in Polycystic Ovary Syndrome (PCOS)

      ea0063s27.1
    • Large scale genetic studies in male infertility

      ea0063s27.2
    • Menopause and cardiovascular risk

      ea0063s27.3
  • Vitamin D - non-skeletal effects in RCT
  • • Vitamin D for healthy ageing

      ea0063s28.1
    • Vitamin D and type 1 diabetes

      ea0063s28.2
    • How and when to measure vitamin D?

      ea0063s28.3
  • Endocrine controversies in sport
  • • Female hyperandrogenism and elite sport

      ea0063s29.1
    • Performance enhancing drugs in young males

      ea0063s29.2
    • Omics to fight doping

      ea0063s29.3
  • Personalised medicine in diabetes and obesity (Endorsed by the European Journal of Endocrinology)
  • • Mechanisms for Cardiovascular Complications of Diabetes - Implications for Personalized Therapy

      ea0063s30.1
    • New avenues for novel drugs to treat obesity

      ea0063s30.2
    • Curing diabetes with alternatives: bariatric surgery

      ea0063s30.3
  • Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - Endocrinology of Aging
  • • Obesity gives you cancer: the bigger picture!

      ea0063ss1.1
    • Sleep deficiency: A pathway to obesity

      ea0063ss1.2
    • Obesity is an economic burden and we know why

      ea0063ss1.3
• New Scientific Approaches
• • (1)
  • • Steroidomics

      ea0063nsa1
    • Single cell spatial reconstruction of endocrine organs

      ea0063nsa2
    • Intelligent image based in situ single cell isolation

      ea0063nsa3
    • How can AI create value for the endocrinologist? Challenges and opportunities for AI-enabled solutions

      ea0063nsa4
    • Genome-wide effects of vitamin D on chromatin

      ea0063nsa5
    • Diving into the brain: deep brain imaging techniques in conscious animals.

      ea0063nsa6
• Debates
• • Food addiction in humans: to be or not to be?
  • • PRO: Food addiction in humans: to be or not to be?

      ea0063d1.1
    • CON: Food addiction in humans: to be or not to be?

      ea0063d1.2
  • Surgical treatment of phaeochromocytoma - query pre-treatment
  • • PRO: Surgical treatment of phaeochromocytoma - query pre-treatment?

      ea0063d2.1
    • CON: Surgical treatment of phaeochromocytoma - query pre-treatment?

      ea0063d2.2
  • T4 is not enough
  • • 'Yes, T4 is not enough'

      ea0063d3.1
    • 'No, T4 is enough'

      ea0063d3.2
  • Pituitary pathology: Do we care?
  • • Yes, we care about pituitary pathology!

      ea0063d4.1
    • No, we don't care about pituitary pathology

      ea0063d4.2
  • MicroRNAs as hormones?
  • • PRO: MicroRNAs and extracellular vesicles as hormones?

      ea0063d5.1
    • CON: MicroRNAs and extracellular vesicles as hormones?

      ea0063d5.2
  • Should we treat young osteoporotic patients?
  • • Yes, we should treat young osteoporotic patients

      ea0063d6.1
    • 'No, we shouldn't treat young osteoporotic patients'

      ea0063d6.2
• Meet the Expert Sessions
• • (1)
  • • The road from flash glucose monitoring to hybrid closed loop systems: keys to success.

      ea0063mte1
    • Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?

      ea0063mte2
    • The management of primary aldosteronism

      ea0063mte3
    • Management of a life-long disease in CAH

      ea0063mte4
    • Risk classification of thyroid nodules by ultrasound and indications for FNA

      ea0063mte5
    • Primary Hyperparathyroidism: Surgical vs. Medical Therapy

      ea0063mte6
    • Non functional Pituitary Tumours - not always easy

      ea0063mte7
    • Comorbidities in Turner Syndrome

      ea0063mte8
    • Co-morbidities in Klinefelter syndrome

      ea0063mte9
    • NCAH and Female Reproduction

      ea0063mte10
    • 'Shifting treatment paradigms in osteoporosis'.

      ea0063mte11
    • Fracture Risk Prediction in Benign and Tumoral Bone: New Insights

      ea0063mte12
    • Flushing, blushing and sweating

      ea0063mte13
    • How multidisciplinay care and tailor-made transition save lives of young adults with Prader-Willi syndrome

      ea0063mte14
    • To what degree does hypopituitarism exist after TBI?

      ea0063mte15
    • Is it all in your head or just in the lab?

      ea0063mte16
    • The metabolic effects of SGLT2 inhibitors - Does the increase in ketone bodies protect the heart?

      ea0063eyijc1
• Meet the Basic Scientist Session
• • (1)
  • • New tracers for PET in humans: Hopes, aims and current evidence

      ea0063mtbs1
    • Genetically tailored pig models in translational endocrine and metabolic research

      ea0063mtbs2
    • The gravitostat - possible relation to hormones

      ea0063mtbs3
• Nurse Sessions
• • (1)
  • • Overview of immunotherapy: Indications and adverse effects

      ea0063ns1.1
    • Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring

      ea0063ns1.2
    • The role of the endocrine nurse in managing patients with immunotherapy-induced endocrinopathies

      ea0063ns1.3
    • Nursing approach to the holistic care of patients with intellectual disability

      ea0063mtne1
    • Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards

      ea0063npd1
    • Testosterone replacement: 'The best practice'.

      ea0063npd2
    • Hypoparathyroidism: Aetiology, diagnosis and challenges in management

      ea0063npd2.1
    • How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)

      ea0063npd3
    • MY DIABBY - Improving skills and competence in diabetes education

      ea0063npd4
    • How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)

      ea0063npd5
• Uems Session
• • (1)
  • • The role of UEMS in Europe and the distinct and independent but allied pathway with ESE

      ea0063uems1.1
    • Update on European Exam in Endocrinology

      ea0063uems1.2
    • The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells

      ea0063uems1.3
• Oral Communications
• • Calcium and Bone
  • • Genetic testing for hereditary hyperparathyroidism in a large UK cohort

      ea0063oc1.1
    • Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism

      ea0063oc1.2
    • Menin and EZH2 activities modulate the expression of the long non-coding RNA HAR1B in parathyroid tumors

      ea0063oc1.3
    • Risk of sepsis, respiratory infections, and kidney or other genitourinary (GU) infections in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

      ea0063oc1.4
    • Renal function in 711 patients with hypoparathyroidism during more than 4 years of therapy

      ea0063oc1.5
  • Diabetes 1
  • • Every fifth patient with type 1 diabetes suffers from an additional endocrinological autoimmune disease - a finnish nationwide study

      ea0063oc2.1
    • Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission

      ea0063oc2.2
    • Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes

      ea0063oc2.3
    • Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice

      ea0063oc2.4
    • 5[beta]-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo

      ea0063oc2.5
  • Cushing's and acromegaly
  • • Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study

      ea0063oc3.1
    • Outcomes after primary treatment for Nelson's syndrome: a study from 13 UK centres

      ea0063oc3.2
    • Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale

      ea0063oc3.3
    • Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial

      ea0063oc3.4
    • T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly

      ea0063oc3.5
  • Thyroid 1
  • • Subclinical hypothyroidism troughout pregnancy in TPOAb positive pregnant women

      ea0063oc4.1
    • Thyroid dysfunction and mortality in cardiovascular hospitalized patients - a 12 year follow-up observational study

      ea0063oc4.2
    • Prognostic impact of microscopic extrathyroidal extension (mETE) on recurrence-free survival in patients with papillary thyroid carcinoma (PTC)

      ea0063oc4.3
    • Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France

      ea0063oc4.4
    • A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project

      ea0063oc4.5
  • Adrenal 1
  • • Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma

      ea0063oc5.1
    • Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved

      ea0063oc5.2
    • SF3B1 as novel target for the treatment of multiple endocrine-related cancers

      ea0063oc5.3
    • The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy

      ea0063oc5.4
    • Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients

      ea0063oc5.5
  • Obesity
  • • Impaired glucose homeostasis in leptin-deficient ob/ob mice is corrected by AZP-3404, a 9-amino acid peptide analog derived from insulin-like growth factor-binding protein 2, a key mediator of leptin action

      ea0063oc6.1
    • Deep Transcranial Magnetic Stimulation modulates body temperature in obesity

      ea0063oc6.2
    • Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance

      ea0063oc6.3
    • Fat mass impact of sirolimus after clinical islet transplantation, a case control study

      ea0063oc6.4
    • Lipolysis defect in white adipose tissue and rapid weight regaining

      ea0063oc6.5
  • Endocrine Connections 1
  • • Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women

      ea0063oc7.1
    • Thyroid hormones are new key regulators of glucocorticoid metabolism

      ea0063oc7.2
    • Higher dose of burosumab is needed for treatment of children with sever forms of X-linked hypophosphatemia

      ea0063oc7.3
    • Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA

      ea0063oc7.4
    • Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome: French prospective study in a cohort of 25 patients

      ea0063oc7.5
  • Reproduction 1
  • • Dissecting the roles of KNDy-derived kisspeptins in the control of reproduction: Generation and characterization of the Tac2-specific Kiss1 KO (TaK-KO) mouse

      ea0063oc8.1
    • AMH is a predictive factor for successful sperm retrieval in non-mosaic Klinefelter syndrome patients

      ea0063oc8.2
    • Endocrine Disruptors transgenerationally alters pubertal timing through epigenetic reprogramming of the hypothalamus

      ea0063oc8.3
    • Conditional ablation of AMP-Activated Protein Kinase (AMPK) in GnRH neurons reveals specific roles in reproductive and metabolic homeostasis

      ea0063oc8.4
    • The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: responder analysis results from a randomized, placebo-controlled, double-blind, dose-ranging study

      ea0063oc8.5
  • Thyroid 2
  • • 3D mapping and in silico predictions of the DEHAL1 enzyme as a tool to discriminate pathogenic mutations from non-functional variants in hypothyroidism

      ea0063oc9.1
    • Direct evidence for disulfides in the mechanism of deiodinase 1

      ea0063oc9.2
    • Novel driver mutations in thyroid cancer recurrence

      ea0063oc9.3
    • Resistance to thyroid hormone alpha associated with early-onset severe NASH

      ea0063oc9.4
    • Deciphering the origin of the sexually dimorphic thyrotropin secretion in mouse models

      ea0063oc9.5
  • Adrenal 2
  • • Steroid metabolomics: a rapid computational approach for accurate differentiation of inborn disorders of steroidogenesis

      ea0063oc10.1
    • Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism

      ea0063oc10.2
    • Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (glucocorticoid receptor) and PDE11A4 (phosphodiesterase 11) in 389 patients

      ea0063oc10.3
    • Cullin 3 is a partner of armadillo repeat containing 5 (ARMC5), the product of the gene responsible for primary bilateral macronodular adrenal hyperplasia

      ea0063oc10.4
    • Cyclin dependent kinase 4 as promising drug target in adrenocortical carcinoma

      ea0063oc10.5
  • Diabetes 2
  • • Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study

      ea0063oc11.1
    • Molecular mechanisms regulating hepatic sex hormone-binding globulin production: clinical implications in human diseases

      ea0063oc11.2
    • Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes

      ea0063oc11.3
    • MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease

      ea0063oc11.4
    • Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study

      ea0063oc11.5
  • Endocrine Connections 2
  • • Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover

      ea0063oc12.1
    • Epigenetic programming of transgenerational hypertension in preterm birth mice

      ea0063oc12.2
    • Neuronostatin and GPR107 system: a novel therapeutic circuit in prostate cancer

      ea0063oc12.3
    • Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France

      ea0063oc12.4
    • Sexual desire in transgender persons in relation with gender affirming hormone treatment: Results from ENIGI, a large multicenter prospective cohort study in transgender people

      ea0063oc12.5
  • Anterior and Posterior pituitary 2
  • • Arginine-stimulated copeptin measurements - a new test for diabetes insipidus

      ea0063oc13.1
    • Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion - a randomized, double-blind, placebo-controlled trial

      ea0063oc13.2
    • Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype

      ea0063oc13.3
    • Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study

      ea0063oc13.4
    • Pan-genomic classification of pituitary adenomas

      ea0063oc13.5
  • Sex Hormones
  • • Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial

      ea0063oc14.1
    • The effect of testosterone therapy on serum oestradiol levels in transgender men

      ea0063oc14.2
    • First identification of bone morphogenic protein receptor variants as a cause of primary ovarian insufficiency

      ea0063oc14.3
    • Thyroid diseases in danish women with polycystic ovary syndrome

      ea0063oc14.4
    • The pattern of cancer occurrence in Turner syndrome

      ea0063oc14.5
• Guided Posters
• • Adrenal and Neuroendocrine - Tumour
  • • 68Ga-exendin-4 PET/CT detects insulinomas in patients with hypoglycemia in multiple endocrine neoplasia type 1

      ea0063gp1
    • Lanreotide therapy vs wait-and-see in patients with pancreatic neuroendocrine tumors

      ea0063gp2
    • ProGRP is an effective marker for disease monitoring in lung carcinoids with non-informative chromogranin A: Lessons from clinical practice

      ea0063gp3
    • Two cases of pseudopheochromocytoma due to Obstructive sleep apnea: which mechanisms?

      ea0063gp4
    • Pheochromocytoma's of MENX rats belong to the pseudo-hypoxia cluster

      ea0063gp5
    • Cellular modelling of SDH-associated pathomechanism of pheochromocytomas and paragangliomas

      ea0063gp6
    • Parafibromin is regulated by ubiquitin specific protease 37 (USP37) and the c-terminus of USP37 interacts with the beta-catenin binding region of CDC73 in hyperparathyroidism-jaw tumor syndrome

      ea0063gp7
    • Pheochromocytoma: Positive predictive values of mildly-elevated urinary fractionated metanephrines in a large cohort of community-dwelling patients

      ea0063gp8
    • IGF-1 splice variants' expression in adrenal gland neoplasms- Possible role in adrenal tumorigenesis

      ea0063gp9
    • Brown fat proliferation- A rare complication of Phaeochromocytoma

      ea0063gp10
    • Corticotropinoma as the underlying cause of intermittent Cushing's syndrome in a patient previously diagnosed with primary pigmented adrenocortical disease (PPNAD) - a case report

      ea0063gp11
    • Functional mixed oncocytic adrenocortical neoplasm presenting as an asymptomatic adrenal mass

      ea0063gp12
    • KCTD20, a new gene in cortisol-secreting adrenocortical tumors related to inactivating mutations of the Carney Complex gene (PRKAR1A)

      ea0063gp13
    • Endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) as a novel therapeutic approach in highly-selected pancreatic functioning and non-functioning neuroendocrine neoplasms (pNENs) patients: Preliminary report

      ea0063gp14
  • Calcium and Bone 1
  • • Recombinant human parathyroid hormone 1-84 for the treatment of adults with chronic hypoparathyroidism: Six-year safety and efficacy results of the RACE study

      ea0063gp15
    • The effect of parathyroidectomy on glucose homeostasis and incretin hormone release in patients with primary hyperparathyroidism: a pilot study

      ea0063gp16
    • Utility of a second technecium99mMIBI-SPECT imaging before re-operating in patients with persistent sporadic primary hyperparathyroidism: results of a retrospective multicentric study

      ea0063gp17
    • Calcium to Phosphorus (Ca/P) ratio as an accurate index for the diagnosis of primary hyperparathyroidism (PHPT) and hypoparathyroidism (HypoPT)

      ea0063gp18
    • 18F-Fluorocholine PET/CT in patients with primary Hyperparathyroidism and negative or inconclusive 99mTc-MIBI parathyroid scan: clinico-pathological correlations

      ea0063gp19
    • Clinical, biochemical and radiological profile of normocalcaemic hyperparathyroidism: a multicentric cross-sectional evaluation

      ea0063gp20
    • The long-term outcomes of chronic post-surgical hypoparathyroidism

      ea0063gp21
    • OFELIA - Prevalence of osteoporosis in fragility fracture patients

      ea0063gp22
    • Study of hsa-miR-30e miRNA as a biomarker in identifying multiple gland disease in sporadic primary hyperparathyroidism: Is it time for individualized molecular-based surgery?

      ea0063gp23
    • The impact of impaired calcium-phosphorus metabolism on the renin-angiotensin-aldosterone system in patients with primary hyperparathyroidism

      ea0063gp24
    • Impact of chronic hypoparathyroidism on health-related quality of life, symptoms, employment, and relationships: findings from a 13-country patient survey

      ea0063gp25
  • Diabetes and Cardiovascular Disease
  • • Association of MR-proANP with cardiovascular risk factors in middle aged patients with diabetes mellitus type 2 and non-diabetic controls

      ea0063gp26
    • Serum insulin levels are associated with vulnerable plaque components in the carotid artery

      ea0063gp27
    • The synergistic impact of apolipoprotein B/ A-1 and lipoprotein (a) on coronary artery calcification

      ea0063gp28
    • Systematic screening of masked hypertension in normotensive type 2 diabetic patients

      ea0063gp29
    • Cardiovascular risk factors in patients with type 2 diabetes and non-alcoholic fat liver disease

      ea0063gp30
    • Abstract unavailable

      ea0063gp31
    • Breastfeeding is inversely associated with subclinical atherosclerosis in postmenopausal women

      ea0063gp32
    • Application of 3D skin culture model as a tool to study the role of immune mechanisms in chronic diabetic foot ulcers pathogenesis

      ea0063gp33
    • Stroke in diabetic patients and cardiovascular risk factors control

      ea0063gp34
    • Cardiovascular biomarkers and calculated risks - an association study

      ea0063gp35
    • Family education, quality of life and glycosylated haemoglobin control among Nigerian diabetics: a quasi-experimental study

      ea0063gp36
  • Metabolic Syndrome and Hypoglycaemia
  • • Abstract unavailable

      ea0063gp37
    • Beta cell senescence: effect of glucotoxicity and glucolipotoxicity

      ea0063gp38
    • Generalized lipodystrophy associated with delayed neuro-somatic development and multiple dysmorphisms in a neonate with a compound heterozygous missense mutation in the SYNE2 gene

      ea0063gp39
    • Long-term administration of Empagliflozin may promote hepatic and renal lipid accumulation, and inflammation in the APOE knockout model

      ea0063gp40
    • Applying the Bradford Hill criteria to evaluate the association between hypoglycaemia and cardiovascular events/mortality (CVEM) [Data from meta-analysis (MA), Randomized Controlled Trials (RCTs), and observational outcome studies (OBS)]

      ea0063gp41
    • Magnitude of effects of testosterone replacement therapy on testosterone normalization, parameters of metabolic syndrome and vascular function and morphology in obese hypogonadal patients with type 2 diabetes - the SETH2 study

      ea0063gp42
    • The elevated chemerin plasma concentrations in men diagnosed with metabolic syndrome are correlated with markers of low-grade state inflammation but not with SHBG serum levels and accompanying hypoandrogenemia.

      ea0063gp43
    • Effects of anti-inflammatory treatment on fibroblast growth factor-21 in obesity and metabolic syndrome

      ea0063gp44
    • Hypoglycemia and dementia risk in older patients with type 2 diabetes: a propensity-score matched analysis of a population-based cohort study

      ea0063gp45
    • Characteristics and management of Type 1 diabetes mellitus patients with diabetic ketoacidosis

      ea0063gp46
    • Awareness, treatment rates and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable and definite familial hypercholesterolemia

      ea0063gp47
  • Acromegaly and GH
  • • Prolonged diagnostic delay in acromegaly is associated with long-term morbidity and excess mortality: data from a nationwide study

      ea0063gp48
    • Pharmacokinetics of somapacitan in individuals with renal impairment: an open-label, parallel group, phase 1 study

      ea0063gp49
    • Sleep disorders and cognitive dysfunction in acromegaly

      ea0063gp50
    • Prognostic value of short-acting pasireotide test for response prediction to pasireotide LAR in patients with acromegaly resistant to first-generation analogs. Can a short-acting pasireotide test predict the response of long-acting pasireotide treatment in patients with acromegaly resistant to first generation somatostatin analogs?

      ea0063gp51
    • Final height in childhood onset hypopituitarism

      ea0063gp52
    • Efficacy and safety of once-weekly somapacitan in adult growth hormone deficiency (AGHD) confirmed in a 53-week REAL-1 trial extension

      ea0063gp53
    • Pharmacokinetics in patients with prolactinomas

      ea0063gp54
    • Acromegaly do not increase the risk of vertebral fractures: a retrospective and prospective study on 50 patients

      ea0063gp55
    • Sclerostin and fracture risk assessment in acromegaly

      ea0063gp56
    • Biochemical control was sustained with long-acting pasireotide in patients with uncontrolled acromegaly over continued treatment with first-generation somatostatin analogues (SSAs): Results from the extension of phase 3b, open-label study

      ea0063gp57
    • ACROSTUDY - safety and efficacy in a cohort of 110 Naive patients with acromegaly treated with pegvisomant

      ea0063gp58
    • Effects of pegvisomant and pasireotide LAR on incidence of vertebral fractures in patients with acromegaly resistant to treatment with first-line somatostatin analogs

      ea0063gp59
    • Metabolic outcome in adolescents with growth hormone deficiency during transition phase

      ea0063gp60
  • Reproductive Axis
  • • Novel phenotype of isolated diminished ovarian reserve and new CSB-PGBD3 (ERCC6) mutations revealed by targeted next generation sequencing in a cohort of caucasian infertile women

      ea0063gp61
    • Hypothalamic miR-30 regulates puberty onset via repression of the puberty-suppressing factor, Mkrn3

      ea0063gp62
    • A KISS1R gene variant in a pedigree with maternally inherited precocious puberty

      ea0063gp63
    • Untargeted lipidomics profiling by high-performance liquid chromatography/time-of-flight mass spectrometry in polycystic ovary syndrome: candidate biomarkers and association to disease traits

      ea0063gp64
    • Testosterone replacement therapy outcomes in subjects with Klinefelter syndrome: preliminary results from a meta-analysis study

      ea0063gp65
    • Diet patterns in patients with PCOS

      ea0063gp66
    • MRI-based proton-density fat fraction measurements reveal alterations of abdominal fat, bone and muscle composition in lean women with PCOS

      ea0063gp67
    • DHT, rather than free testosterone, influences symptoms of aging in eugonadal men

      ea0063gp68
    • Male patients with hypogonadism have an impaired lipoprotein function

      ea0063gp69
  • Thyroid Autoimmune Disorders
  • • Serum levels of the soluble receptor for advanced glycation end products (AGEs) are reduced and AGEs increased in hashimoto's thyroiditis (HT)

      ea0063gp70
    • The randomised probiotic trial of indigo study (investigation of novel biomarkers and definition of role of the microbiome in Graves' orbitopathy)

      ea0063gp71
    • Microarray profile of CD19+B cells from Graves' disease patients reveals potential molecular mechanisms associated with the proliferation of B cell signaling

      ea0063gp72
    • Clinical experiences in autoimmune polyglandular diseases

      ea0063gp73
    • The change of pulmonary artery pressure and serum vascular endothelial growth factor in Graves' disease before and after treatment

      ea0063gp74
    • Grave's orbitopathy: clinical, paraclinical and therapeutic features

      ea0063gp75
    • Cardiovascular risk factors, autoimmunity and insulin resistance in Graves disease

      ea0063gp76
    • Lipid profile, insulin resistance and cytokines evaluation in autoimmune thyroiditis patients

      ea0063gp77
    • Autoimmune thyroiditis, Graves' disease and adiponectin, resistin and plasminogen activator inhibitor-1 levels

      ea0063gp78
    • The neutrophil-to-lymphocyte ratio as a novel marker in patients with thyroid-associated orbitopathy - a prelimininary study

      ea0063gp79
    • Effect of nine months of vitamin D supplementation on muscle performance in Graves' disease: a double-blinded, randomized clinical trial

      ea0063gp80
    • Retrospective analysis of the efficacy of three different dose regimens of rituximab in patients with active moderate-severe graves' orbitopathy

      ea0063gp81
  • Thyroid Nodules and Cancer
  • • Coexistence of the BRAF V600E and TERT promoter mutations and their impact on response to therapy and final outcome of papillary thyroid cancer

      ea0063gp82
    • Prognostic significance of TERT promoter and BRAF mutations in cytologically suspicious or malignant thyroid nodules: a monocentric case series at a tertiary-level endocrinology unit

      ea0063gp83
    • Polygenic susceptibility to papillary thyroid cancer: detection of the main genetic signature in Italian patients

      ea0063gp84
    • Follistain-like 1 (Fstl1) may reduce metastastic activity of anaplastic thyroid cancer by increasging thyroid transcription factor 1 (TTF1) and epithelial gene markers

      ea0063gp85
    • Benefits and limitations of TKIs in patients with medullary thyroid cancer: a systematic review and meta-analysis

      ea0063gp86
    • Intronic RAS and PI3KCA mutations identified by Next Generation Sequencing in thyroid nodules with indeterminate cytology may associate with follicular thyroid cancer

      ea0063gp87
    • An analysis of false-positive uptake on radioiodine whole-body scintigraphy

      ea0063gp88
    • Prospective sonographic assessment of 214 consecutive nodules as per the ATA 2015 guidelines. Real world data

      ea0063gp89
    • Treatment modalities in DTC patients with neck disease persistence. Second surgical intervention is more beneficial than only radioiodine (RAI) treatment

      ea0063gp90
    • Detection of EIF1AX>, CHEK2 and PPM1D gene variants in thyroid carcinomas

      ea0063gp91
    • Diagnostic performance evaluation of a computer-assisted imaging analysis system for ultrasound risk stratification of thyroid nodules

      ea0063gp92
    • Tirads classification and final diagnosis of thyroid nodules classified as bethesda-3 after fine-needle aspiration

      ea0063gp93
  • Adrenal and Neuroendocrine - Basic
  • • Somatic transmembrane domain mutations of a cell adhesion molecule, CADM1, cause primary aldosteronism by preventing gap junction communication between adrenocortical cells

      ea0063gp94
    • The role of filamin A (FLNA) in the regulation of IGF2/IGF1R pathway in adrenocortical carcinomas

      ea0063gp95
    • An unusual association of P450 oxidoreductase Deficiency and Argininosuccinatelyase Deficiency

      ea0063gp96
    • Structural changes in the zona glomerulosa of normal aging adrenals

      ea0063gp97
    • Methylation status and gene expression of steroidogenic enzymes in benign adrenocortical tumors

      ea0063gp98
    • Implementation of two preclinical ACC models for a comparative drug screen and initial mechanistic investigations

      ea0063gp99
    • Characterization of cell death induced by mitotane in adrenocortical carcinoma cells

      ea0063gp100
    • Infiltrating CD68+/CD163+ macrophages regulate Gonadotroph-tumour invasion through collagen remodelling

      ea0063gp101
    • Development of a simple experiment to distinguish ARMC5 missense mutants from rare ARMC5 polymorphisms in PBMAH patients using a quantitative western blot approach

      ea0063gp102
    • Abstract unavailable

      ea0063gp103
    • Identification of genes mediating dysregulated cell growth in aldosterone-producing adenomas

      ea0063gp104
    • Reappraisal of the human adrenal cortex and fate

      ea0063gp105
    • Gene expression changes in visceral adipose tissue of Cushing syndrome.

      ea0063gp106
    • Abstract unavailable

      ea0063gp107
  • Calcium and Bone 2
  • • Exploring the mechanism of TGF-[beta]1 signaling in counteracting BMP activities during the osteogenesis of mesenchymal stem cells

      ea0063gp108
    • Sex steroids as determinants of Wnt-Signalling markers in men

      ea0063gp109
    • Denosumab in post-liver transplantation osteoporosis: preliminary data on the effects on bone mineral density and turnover markers

      ea0063gp110
    • Hip structure analyses in acromegaly: Decrease of cortical bone thickness after treatment

      ea0063gp111
    • Body composition determines muscle strength in osteoporotic patients with vertebral fractures

      ea0063gp112
    • Vertebral fracture in outpatients with type 2 diabetes mellitus

      ea0063gp113
    • Qualitative and quantitative parameters of diabetic osteopathy in type 1 diabetes mellitus

      ea0063gp114
    • Different impact of marrow and visceral adipose tissue on bone phenotype

      ea0063gp115
    • FGF-23 beyond the kidney: a new bone mass regulator in the general population

      ea0063gp116
    • Bone health and final height in craniopharyngioma patients.

      ea0063gp117
    • Gene variants of osteoprotegerin, estrogen-, calcitonin- and vitamin D-receptor genes and serum markers of bone metabolism in patients with Gaucher disease type 1

      ea0063gp118
  • Diabetes: Late Complications
  • • Glycemic variability and mortality in patients hospitalized to general surgery wards

      ea0063gp119
    • High prolactin levels within the normal range are associated with improved metabolic profile and lower carotid intima media thickness in premenopausal women

      ea0063gp120
    • The A allele of the rs4636297 (G/A) polymorphism in the microRNA-126 is associated with protection for diabetic retinopathy

      ea0063gp121
    • Vitamin D supplementation and dynamics of LDF skin microcirculation in patients with diabetes mellitus and diabetic polyneuropathy

      ea0063gp122
    • Four out of five patients with type 2 diabetes mellitus have hearing loss

      ea0063gp123
    • Unrecognized high risk for diabetic foot ulcer among hospitalized patients

      ea0063gp124
    • Vitamin D3 deficiency is associated with more severe insulin resistance and metabolic profile in patients with type 2 diabetes

      ea0063gp125
    • Depression and associated risk factors in older adults with diabetes: the 2010-2011 Korean national health and nutrition examination survey

      ea0063gp126
    • Genetic polymorphisms in patients with type 2 diabetes mellitus and coronary heart disease

      ea0063gp127
    • Clinical and metabolic characteristics of a population of diabetic patients previously educated having fasted all month of Ramadan

      ea0063gp128
    • Efficiency of application of silicate sorbents in surgical treatment of patients with neuro-ischemic form of diabetic foot ulcer

      ea0063gp129
  • Obesity
  • • Glucagon activity in human adipose precursors

      ea0063gp130
    • A Study of the Effect of Laparoscopic Mini Gastric Bypass Versus Sleeve Gastrectomy On Obese Type 2 Diabetic Patients

      ea0063gp131
    • Variants in genes of the leptin / melanocortin pathway are involved in 3% of cases of early-onset severe obesity

      ea0063gp132
    • Effect of IL1-receptor antagonist on renin-angiotensin-aldosterone system and hemodynamics in obese individuals

      ea0063gp133
    • Higher habitual intakes of dietary carbohydrates are associated with leptin gene expression in visceral and subcutaneous adipose tissues among non-diabetic people

      ea0063gp134
    • Obesity is associated with a downregulation of UCP2 and miR-133a-3p but not NLRP3 in subcutaneous adipose tissue

      ea0063gp135
    • Administration of a growth hormone bolus down-regulates gene-expression of the g0/g1 switch gene 2 (g0s2) in subcutaneous adipose tissue in healthy, obese men: a randomized, placebo-controlled, cross-over study

      ea0063gp136
    • Empagliflozin as well as Anakinra reduce symptomatic hypoglycemia in patients after Roux-Y-gastric bypass by lowered insulin secretion

      ea0063gp137
    • Androgen metabolism during weight loss in men with obesity

      ea0063gp138
    • Prediction of clinically significant weight loss with Gelesis100 in the GLOW study as early as 8 weeks post-treatment

      ea0063gp139
    • The efficacy of complex kinesiotherapy in weight loss and muscle function improving in obesity patients

      ea0063gp140
    • Dietary inflammatory index is differently associated with ectopic fat depots in overweight and obese adults

      ea0063gp141
  • Interdisciplinary Endocrinology 1
  • • Impact of age and metabolic profile on the definition of 12 circulating steroid reference intervals measured by LC-MS/MS in an Italian healthy adult male cohort

      ea0063gp142
    • Impact of age, menstrual phase, menopausal status and metabolic profile on the definition of 12 circulating steroid reference intervals measured by LC-MS/MS in an Italian healthy adult female cohort

      ea0063gp143
    • Bilateral femoral head necrosis with low dose oral corticosteroid therapy for pan-hypopituitarism

      ea0063gp144
    • Final (FH) and target height (TH) in male and female patients with congenital hypogonadotropic hypogonadism (CHH)/Kallmann syndrome (KS): a monocentric study of 216 patients

      ea0063gp145
    • Turner syndrome: mental health and social skills from childhood to emerging adulthood

      ea0063gp146
    • Risk of nephrolithiasis and nephrocalcinosis in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

      ea0063gp147
    • Risk of myocardial infarction (MI), stroke, and other cardiovascular (CV) conditions in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

      ea0063gp148
    • Risk of chronic kidney disease (CKD) and CKD progression in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

      ea0063gp149
    • Increased prevalence of overweight and obesity and its clinical predictors in children affected by x-linked hypophosphatemia

      ea0063gp150
    • MEN4: is there a link with autoimmunity?

      ea0063gp151
    • UMD-MEN1 database: analysis of clinical and genetic data from 1,676 patients by the TENGEN network

      ea0063gp152
  • Cushing's
  • • Evaluation of the corticotrophin-releasing-hormone test and the high dose dexamethasone suppression test in ACTH dependent Cushing's syndrome: a 25-year prospective cohort study

      ea0063gp153
    • Pathway enrichment analysis in functioning and silent corticotroph pituitary adenomas reveals mechanisms to explain their distinct clinical behaviour

      ea0063gp154
    • Endocrine immune-related adverse events following immune checkpoint inhibitors in patients with advanced melanoma: single-center retrospective analysis

      ea0063gp155
    • Correlation between responsiveness to CRH stimulation test in Cushing's disease patients and USP8 mutational status

      ea0063gp156
    • DNA Methylation and fMRI responses in patients with Cushing's syndrome in remission - suggestions of a functional link between hypercortisolism and neurocognitive dysfunction

      ea0063gp157
    • Cortisol and cortisone assays in hair by mass spectrometry for the diagnosis of Cushing's syndrome

      ea0063gp158
    • Skeletal muscle fatty infiltration in the thigh, as assessed by MRI T2-weighted and 3-point Dixon sequences, is associated with poor performance on muscle function testing in patients with Cushing's syndrome in remission

      ea0063gp159
    • Brain 18F-fluorodeoxyglucose PET/CT in localization of MRI-negative ACTH-producing pituitary adenomas

      ea0063gp160
    • Ubiquitin-specific protease 8 (USP8) potentiates glucocorticoid receptor activity in corticotroph tumour cells

      ea0063gp161
    • Pharmacokinetics of osilodrostat following single and multiple doses of osilodrostat in healthy subjects and patients with Cushing's disease

      ea0063gp162
    • Effects of a single dose of pasireotide on glucose metabolism in patients with Cushing's disease and predictors of diabetes mellitus developement during treatment

      ea0063gp163
    • Assessment of bone marrow fat by single-voxel vertebral magnetic resonance spectroscopy in cushing's syndrome with or without vertebral fractures

      ea0063gp164
  • Obesity (1)
  • • Role of invasive and non-invasive diagnostic tests in differential diagnosis of ACTH-dependent Cushing's syndrome

      ea0063gp165
    • Results from the phase 3 multicenter SONICS study of levoketoconazole: subgroup analysis of Cushing's syndrome patients with diabetes mellitus

      ea0063gp166
    • Epigenetic regulation by miRNAs in corticotroph tumors

      ea0063gp167
    • Evaluation of utility of salivary cortisol levels after suppression with 1 mg Dexamethasone in screening of Cushing's syndrome

      ea0063gp168
    • The role of copeptin and cortisol in critically ill patients

      ea0063gp169
    • Microstructural white matter changes using diffusion tensor imaging in patients with Cushing's disease

      ea0063gp170
    • A new generation somatostatin-dopamine chimeric analogue exerts potent antitumoral actions on primary pituitary neuroendocrine tumor cells

      ea0063gp171
    • Pituitary surgery as first-line therapy for microprolactinomas

      ea0063gp172
    • Excellent tumor response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma

      ea0063gp173
    • Sleep disorders after craniopharyngioma surgery

      ea0063gp174
    • Normal IGF-bioactivity and low free IGF-I in patients with Prader-Willi syndrome with high total serum IGF-I: immunoreactive IGF-I concentrations poorly reflect IGF bio-activity and bio-availability

      ea0063gp175
  • Benign Thyroid Disorders
  • • Do different initial doses of L-T4 within the range of 10-15 mcg/kg/die influence neurodevelopment during the first two years of life in children with congenital hypothyroidism?

      ea0063gp176
    • Abstract unavailable

      ea0063gp177
    • Cystic fibrosis as a novel cause of thyroxine (l-t4) malabsorption and increased requirement

      ea0063gp178
    • Long-term cardiometabolic effects of maternal sub-optimal gestational thyroid function and relative treatment in the Controlled Antenatal Thyroid Screening (CATS) study II

      ea0063gp179
    • Urinary concentration of iodotyrosines correlates with the severity of iodine deficiency in dehal1 knockout mice

      ea0063gp180
    • Effect of anti-streptavidin interference when diagnosing thyroid disease using immunoassay analyses

      ea0063gp181
    • Can hepcidin be a useful marker in the diagnosis and monitoring of de Quervain thyroiditis?

      ea0063gp182
    • High-dose intravenous levothyroxine treatment as a successful, safe and clinically effective therapy option in severe hypothyroidism: a retrospective study

      ea0063gp183
    • Effect of restoration of thyroid function on body composition, insulin resistance and visfatin concentrations in women with hypo- and hyperthyroidism

      ea0063gp184
    • Thyroid-related adverse events in patients treated with Nivolumab and Pembrolizumab

      ea0063gp185
    • Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus

      ea0063gp186
  • Adrenal and Neuroendocrine - Clinical
  • • Primary adrenal insufficiency in children: results from a large nationwide cohort

      ea0063gp187
    • Increased risk of infections in Addison's disease and congenital adrenal hyperplasia patients: a longitudinal study based on a United Kingdom primary care database

      ea0063gp188
    • Plasma renin concentration is associated with cardiac function and morphology in primary adrenal insufficiency

      ea0063gp189
    • Management and outcome of pregnancies in women with adrenal insufficiency: experience from a retrospective European study

      ea0063gp190
    • Pneumocystis pneumonia as a major complication of medical treatment for severe Cushing's syndrome linked either to ectopic ACTH secretion or to Cushing's disease

      ea0063gp191
    • Diagnostic accuracy of captopril challenge test and saline infusion test in patients at high risk for primary aldosteronism

      ea0063gp192
    • Comparison of whole-genome expression analysis in patients with secondary adrenal insufficiency treated with conventional treatment versus modified-release hydrocortisone

      ea0063gp193
    • New perioperative imaging techniques, immunohistochemistry and genetic analysis to investigate the suitability of laparoscopic partial adrenalectomy in primary aldosteronism

      ea0063gp194
    • Evaluation of clinical and biochemical cure and adrenal CYP11B2 and CYP11B1 immunostaining in primary aldosteronism operated after adrenal venous sampling

      ea0063gp195
    • Sexual function in adrenal insufficiency: data from the DREAM trial

      ea0063gp196
    • Optimizing mineralocorticoid replacement therapy in patients with congenital adrenal hyperplasia and Addison's disease

      ea0063gp197
    • Analysis of circulating microRNAs in primary aldosteronism

      ea0063gp198
    • LC-MS/MS measurement for urinary aldosterone improves primary aldosteronism screening

      ea0063gp199
  • Diabetes: Pharmacotherapy
  • • A liver selective knockdown of Dpp4 by therapeutic siRNA affects lipid metabolism but fails to improve glucose control in diabetic mice

      ea0063gp200
    • Blood intact incretin levels are related to beta-cell function and glycemia in patients with type 2 diabetes

      ea0063gp201
    • The growth hormone effect blocked with pegvisomant did not alter the free fat acid plasma concentration in pre-diebetic or type 2 diabetic patients treated with empagliflozin

      ea0063gp202
    • Effects of cardiovascular function of SGLT-2 inhibitos versus DPP-4 inhibitors in type 2 diabetes with coronary artery disease

      ea0063gp203
    • Fasting insulin levels correlate with the incidence of hypoglycemic events in patients with Type 2 Diabetes treated with sulfonylureas: a retrospective cross-sectional study

      ea0063gp204
    • Metabolic changes in men undergoing androgen deprivation therapy for prostate cancer

      ea0063gp205
    • Antioxidant and hypoglycemic effects of gossitan

      ea0063gp206
    • Treatment with sitagliptin in patients with type 1 diabetes and type LADA diabetes

      ea0063gp207
    • Effects of glucagon-like peptide 1 receptor agonist on short-chain fatty acids, carbohydrate and lipid metabolism in patients with type 2 diabetes

      ea0063gp208
    • Efficacy and tolerability of dulaglutide in patients with type 2 diabetes: Experience on a secondary Hospital

      ea0063gp209
    • Empagliflozin inhibits apoptosis of pancreatic beta-cells through amelioration of ER-stress.

      ea0063gp210
    • New insights on strain-specific impacts of probiotics on insulin resistance

      ea0063gp211
  • Gestational and Type 1 Diabetes
  • • Prevalence of gestational diabetes during 14 pregnancies of acromegalic women

      ea0063gp212
    • The impact of the intrauterine hyperglycaemia on the expression of genes related to cardio-metabolic diseases in human umbilical vein endothelial cells: results from a randomised, controlled study of different glycaemic targets during gestational diabetes treatment

      ea0063gp213
    • Association between sleep disturbances and fear of hypoglycemia in adults with type 1 diabetes, data from VARDIA Study

      ea0063gp214
    • Brain volume and variability of glycemia in patients with type 1 diabetes mellitus

      ea0063gp215
    • Specific pattern of insulin delivery during pregnancy in tightly controlled type 1 diabetic patients treated with insulin pump; unchanged total daily insulin dose per kilogram with consecutive basal/prandial insulin ratio adjustment

      ea0063gp216
    • The rs2304256 A allele in the TYK2 gene is associated with protection for type 1 diabetes mellitus in a Brazilian population

      ea0063gp217
    • Effect of HbA1c and hyperglycemia on hemostasis in patients with type 1 diabetes

      ea0063gp218
    • Impact of type 1 diabetes mellitus and its complications on markers of nitric oxide metabolism

      ea0063gp219
    • Definition of a third-trimester HbA1c cut-off point for an increased risk of Large-for-Gestational-Age in mothers with Gestational Diabetes

      ea0063gp220
    • Insulin requirements during lactation in women with diabetes mellitus type 1 in comparison with pre-pregnancy levels - a retrospective study

      ea0063gp221
    • The impact of gestational weight gain on subclinical atherosclerosis, placental circulation and neonatal complications

      ea0063gp222
  • Adrenal and Neuroendocrine - Clinical (1)
  • • Small molecule allosteric agonist of relaxin receptor ML290 demonstrates antifibrotic properties in liver fibrosis

      ea0063gp223
    • Caffeine upregulates hepatic SHBG production by increasing adiponectin in white adipose tissue

      ea0063gp224
    • Activation of the ATM/Akt/CREB/eNOS expression signaling axis by aphidicolin increases nitric oxide production to attenuate endothelial cell death

      ea0063gp225
    • Evaluation of the CCK-2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma - final Results of the phase 0 'Lumed' Study

      ea0063gp226
    • Multikinase inhibitors for the treatment of progressive, metastatic parathyroid cancer

      ea0063gp227
    • Serine-threonine PAK1 as a novel common node for estrogen- and prolactin-dependent pathways in breast cancer

      ea0063gp228
    • Melatonin prevented beta cell senescence against glucolipotoxicity

      ea0063gp229
    • Low-dose pollutant mixture triggers metabolic disturbances in ovariectomized mice and comparison with the effects of 17[beta]-estradiol (E2) treatment

      ea0063gp230
    • In vitro effects of bisphenol A and its analogs on human melanocortin 4 receptor

      ea0063gp231
    • Can phthalates impair liver function?

      ea0063gp232
  • Anterior and Posterior Pituitary
  • • Evaluation of postoperative copeptin concentration as a predictive factor of diabetes insipidus after pituitary surgery. preliminary results

      ea0063gp233
    • Is the molecular study of pituitary transcription factors useful in the identification of Pituitary Neuroendocrine Tumor subtypes according to the new WHO 2017 criteria?

      ea0063gp234
    • The effect of previous optic chiasm compression on the post-illumination pupil response in pituitary patients

      ea0063gp235
    • Characteristics and natural history of a large cohort of non-functioning pituitary incidentalomas: a two-centers study

      ea0063gp236
    • Diagnostic accuracy of copeptin in the diagnosis of diabetes insipidus after pituitary surgery

      ea0063gp237
    • Immune checkpoint inhibitors therapy-induced hypophysitis is frequently associated with previous thyroid disorders: results from ImmuCare study

      ea0063gp238
    • Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature

      ea0063gp239
    • Adrenal axis deterioration in the families/sporadic patients with PROP1 mutation, over 30 years of single center longitudinal observation

      ea0063gp240
    • Inflammatory response to osmotic stimulus in healthy volunteers

      ea0063gp241
    • Copeptin levels in SIADH - a marker of malignant disease?

      ea0063gp242
    • Histological classification of pituitary neuroendocrine tumors: genomic insights on cell lineage

      ea0063gp243
    • Tomosyn negatively regulates arginine vasopressin secretion in embryonic stem cell-derived neurons

      ea0063gp244
  • Disturbances of Reproduction
  • • MRI detection of aortic anomalies in 204 adult patients with Turner syndrome: a longitudinal study

      ea0063gp245
    • Is monosomia related to poorer cardiometabolic state in Turner syndrome?

      ea0063gp246
    • The efficacy of long-term metformin treatment in overweight and obese women with PCOS: A 10-year database study

      ea0063gp247
    • Gut microbiota-dependent cardiometabolic risk and oral contraceptive use in polycystic ovary syndrome: A prospective study

      ea0063gp248
    • Maternal 3rd trimester cortisol status was associated with offspring sex and PCOS status. Odense Child Cohort

      ea0063gp249
    • Diagnostic potential of a 'mouse azoospermia' gene panel in human azoospermia: identification of novel genetic causes of meiotic arrest

      ea0063gp250
    • Free Testosterone (FT) is inversely related to frailty in Human Immunodeficiency Virus (HIV)-Infected Men

      ea0063gp251
    • Prolactin and prostate: an observational case-control study in men with prolactinoma under cabergoline treatment

      ea0063gp252
    • Genetic architecture of greek patients with isolated GnRH deficiency

      ea0063gp253
  • Thyroid Nodules and Cancer 2
  • • Recurrent laryngeal nerve liberation technique for phonation recovery

      ea0063gp254
    • Are clinicopathological features of isthmic thyroid nodules different from nodules located in thyroid lobes?

      ea0063gp255
    • Impact of age at the diagnosis of radioiodine resistance in differentiated thyroid cancer patients

      ea0063gp256
    • Effects of hospital volume on clinical outcomes after thyroidectomy - a Swiss nation-wide study

      ea0063gp257
    • Predictors of malignancy in thyroid FNA classified as high-risk indeterminate lesions (TIR3B): combining ultrasonographic and cytology features

      ea0063gp258
    • Sentinel lymph node biopsy using methylene blue dye in clinically N0 papillary and medullary thyroid carcinomas for decision on one-time lateral neck dissection

      ea0063gp259
    • Factors influencing nodular goiter - An analysis of the growth rates in long-term follow-up patients

      ea0063gp260
    • Evaluating effects of thyrotrophin receptor antibody positivity on cytology and histopathology in patients with graves disease

      ea0063gp261
    • Classification of thyroid nodules by ultrasound in clinical practice: the added value of the judgment of the skilled endocrinologist

      ea0063gp262
    • Predictive factors of short and long-term vandetanib response in locally advanced or metastatic medullary thyroid cancer: a single center experience

      ea0063gp263
    • Assessment of different ti-rads systems using computer-aided detection technology

      ea0063gp264
• Poster Presentations
• • Adrenal and Neuroendocrine Tumours 1
  • • A novel heterozygous mutation in exon 3 of VHL gene leading to Von Hippel-Lindau disease in a Turkish family

      ea0063p1
    • Long evolution of Connshing syndrome?

      ea0063p2
    • Effect of Glucocorticoid receptor antagonist administration in a Cushing's syndrome model rat

      ea0063p3
    • Ectopic adrenocorticotropic hormone (ACTH-ectopic) syndrome and osteoporosis: Rare cases and difficult treatment

      ea0063p4
    • Paraganglioma of the urinary bladder wall: 2 cases with 2 different presentations

      ea0063p5
    • Adrenal insufficiency secondary to bilateral adrenal diffuse large B-cell lymphoma: a case report

      ea0063p6
    • A rare association of Adrenocortical carcinoma with haematological and breast malignancy in a young female

      ea0063p7
    • Metabolic and cardiovascular profile of 143 adrenal incidentalomas

      ea0063p8
    • HNRNP Q suppresses polyglutamine huntingtin aggregationby post-transcriptional regulation of Vaccinia-related kinase 2

      ea0063p9
    • Study of body composition and phase angle in relation to nutritional parameters in patients with neuroendocrine tumors

      ea0063p10
    • A case series of two patients with intrapericardial paragangliomas

      ea0063p11
    • Combined autophagy and mTOR inhibition reduces cells proliferation and induces apoptosis in a lung carcinoid in-vitro model

      ea0063p12
    • Pheochromocytoma - 3 sides of the same story

      ea0063p13
    • Analysis of the 22-years experience of surgical treatment of adrenal tumor in single specialized endocrinological center

      ea0063p14
    • Immunohistochemical characteristics of adrenal tumors in patients with primary aldosteronism

      ea0063p15
    • Cortex protecting surgery in MEN 2A

      ea0063p16
    • Unilateral non-haemorrhagic adrenal infarction (NHAI) as a cause of abdominal pain during pregnancy

      ea0063p17
    • Evaluating the applicability of urinary miR-483-5p as a non-invasive marker in adrenocortical cancer patients

      ea0063p18
    • Allgrove syndrome (Triple A syndrome): A case report

      ea0063p19
    • A case series of metastatic pheochromocytomas and paragangliomas: patients characteristics, therapeutic approach and follow-up

      ea0063p20
    • Retroperitoneal paraganglioma: clinical case

      ea0063p21
    • The frequency of confirmed primary hyperaldosteronism in patients with high aldosteron renin ratio

      ea0063p22
    • Evaluation of angiotensin II in primary aldosteronism and other forms of hypertension - a preliminary study

      ea0063p23
    • Management of adjuvant mitotane therapy for adrenocortical carcinoma: a survey in Italy

      ea0063p24
    • Management of mitotane for advanced adrenocortical carcinoma: a survey in Italy

      ea0063p25
    • How do sex and BMI affect glucocorticoid treatment in adrenal insufficiency?

      ea0063p26
    • Abstract unavailable

      ea0063p27
    • Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency

      ea0063p28
    • Pheocromocytoma, newly diagnosed during pregnancy in a subject with neurofibromatosis type 1: A case report and review of literature

      ea0063p29
    • Becoming of patients with primary aldosteronism according to their treatment

      ea0063p30
    • Predictors of bilateral and unilateral primary aldosteronism: a retrospective observational study

      ea0063p31
    • 18-oxocortisol synthesis in aldosterone-producing adrenocortical adenoma and significance of KCNJ5 mutation status

      ea0063p32
    • Complete remission of a highly aggressive, metastasized, SDHB-related paraganglioma after chemotherapy with CVD and peptide-receptor radiotherapy

      ea0063p33
    • Aldosterone measurement in the Diagnosis of primary aldosteronism - comparison between two automated immunoassays and two liquid chromatography tandem mass-spectrometry methods

      ea0063p34
    • Embolization of the adrenal artery to control severe adrenal hemorrhage

      ea0063p35
    • Vitamin D deficiency is a predictor marker of tumor aggressiveness in sporadic and MEN1-related well-differentiated, low-grade GEP-NET

      ea0063p36
    • Role of KCNJ5 mutations in mediating cell growth in aldosterone-producing adenomas

      ea0063p37
    • Influence of Tumor Microenviroment in response modulation to treatment in human BP-NENs

      ea0063p38
    • A novel CYP11B1 mutation presenting as a classical congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency

      ea0063p39
    • Available 3D cultures methods: study on a Pancreatic Neuroendocrine Neoplasm cell line

      ea0063p40
    • Prevalence and prognosis of bone metastases in pancreatic and small intestinal neuroendocrine tumours

      ea0063p41
    • Endocrine hypertension?

      ea0063p42
    • Ninety-four serum steroids measured by gas chromatography tandem mass spectrometry (GC-MS/MS) in patients with Cushing's syndrome

      ea0063p43
    • Comparative study between autoimmune metaplastic atrophic gastritis (AMAG) and type 1 gastric neuroendocrine tumors (G-NETs) in Hospital Clinico San Carlos (HCSC), Madrid

      ea0063p44
    • Pheochromocytoma and disorders of carbohydrate metabolism

      ea0063p45
    • Heart and vessels after a pheochromocytoma: which outcomes?

      ea0063p46
    • First presentation of Addison's disease as hyperkalaemia: a rare case report

      ea0063p47
    • Pharmacokinetic Interaction Study of the Effects of Multiple-dose Gastric Acid Reducers Omeprazole (OMP) and Famotidine (FAM on the Pharmacokinetics (PK) of Single-dose Telotristat Etiprate (TE) in Healthy Subjects

      ea0063p48
    • Endocrine hypertension: before and after treatment of the endocrinopathy

      ea0063p49
    • A seminoma with entrapped nerve ganglion masquerading as a paraganglioma

      ea0063p50
    • Magnetic resonance imaging in the initial diagnosis of pancreatic insulinoma: primary data analysis

      ea0063p51
    • Exome analysis of pituitary adenoma tissue derived cell cultures

      ea0063p52
    • A rare association of neuroendocrine tumor with adenocarcinoma of ampulla of vater: difficulties for diagnosis and effects of multi therapeutic approach

      ea0063p53
    • Continuous glucose monitoring during the prolonged fast test for the diagnosis of hypoglycemic diseases: primary data analysis

      ea0063p54
    • Clinical case of a repeated life-threatening upper gastrointestinal bleeding due to previously unknown primary hyperparathyroidism

      ea0063p55
    • A difficult diagnosis: pheochromocytoma or methamphetamine abuse?

      ea0063p56
    • Association of the BclI glucocorticoid receptor polymorphism with body composition and metabolic parameters in female patients with adrenal incidentalomas

      ea0063p57
    • A case of Von Hippel-Lindau disease with bilateral pheochromocytoma and ectopic hypersecretion of intact parathyroid hormone

      ea0063p58
    • Adrenal pheocromocytoma during childhood - a case report

      ea0063p59
    • Adrenal morphology in a large cohort of adult subjects with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

      ea0063p60
  • Calcium and Bone 1
  • • Vitamin D status and linear growth in a sample of Egyptian adolescents

      ea0063p61
    • The effectiveness of colecalciferol and selective vitamin D receptor agonists treatment on secondary hyperparathyroidism in chronic kidney diseases patients

      ea0063p62
    • Osteoporosis in developing-nations: need for centralized-data-collection & treatment-guidance centers to study epidemiology

      ea0063p63
    • Prevalence and the main risk factors for vitamin D deficiency in pregnant women living in a locality of Algiers

      ea0063p64
    • Effects of dexamethasone for calcium channels and mucin-related genes regulation on A549 cell line

      ea0063p65
    • Regulatory effect of dexamethasone on tracheal calcium processing proteins and mucosal secretion

      ea0063p66
    • The effect of steroid hormone on the expression of the calcium-processing proteins in the immature rat brain

      ea0063p67
    • Distribution of and steroid hormone effects on calbindin-D9k in the immature rat brain

      ea0063p68
    • Pledoary for using Trabecular Bone Score as a method for osteoporosis diagnosis, not only for the risk

      ea0063p69
    • Relationship between leptin level, body mass index and parathyroid hormone in chronic hemodialysis patients

      ea0063p70
    • Challenging clinical case of primary hyperparathyroidism caused by atypical adenoma

      ea0063p71
    • Severe hypocalcemia: when the skin expresses itself

      ea0063p72
    • Ultrasound detection of parathyroid hyperplasia in patients with chronic kidney disease treated by dialysis

      ea0063p73
    • Multiple fragility fractures in young female patients caused by FGF23-induced hypophoshatemic osteomalacia

      ea0063p74
    • Clinical significance of parathyroid incidentalomas during thyroidectomy: a South Indian experience

      ea0063p75
    • Value of ultrasonography guided fine-needle-aspiration in the diagnosis of an intrathyroidal parathyroid adenoma associated with thyroid pathology

      ea0063p76
    • The effect of parathyroidectomy on the BMD in postmenopausal women with mild primary hyperparathyroidism: the results of comparative retrospective dynamic study

      ea0063p77
    • Obstructive urolithiasis as first sign of primary hyperparathyroidism caused by a large parathyroid hyperplasia

      ea0063p78
    • Parathyroid adenoma in pregnancy: a case report

      ea0063p79
    • Effects of bariatric surgery on bone health

      ea0063p80
    • A rare case of hypoparathyroidism due to MELAS syndrome

      ea0063p81
    • A case report of tumor-induced osteomalacia

      ea0063p82
    • Pregnancy-related osteoporosis: a series of cases

      ea0063p83
    • Bone mineral density, prevalence of fractures, antiosteoporotic drugs effectiveness and Ca/Vit D supplementations intake in elder patients with osteoporosis: a cross-sectional study on Moscow population

      ea0063p84
    • Brown tumor of the palate as first manifestation of a primary hyperparathyroidism

      ea0063p85
    • Difference in trabecular bone score according to spine-femur bone mineral density discordances in healthy postmenopausal women

      ea0063p86
    • Heterogenous clinical presentation of primary hyperparathyroidism in Romania

      ea0063p87
    • A case of primary hyperparathyroidism due to a giant parathyroid adenoma extending into the mediastinum

      ea0063p88
    • Diagnostic and treatment delay in primary hyperparathyroidism (phpt): a pending issue

      ea0063p89
    • Epidemiology of hypoparathyroidism in Korea

      ea0063p90
    • Effectiveness of intramuscular Ergocalciferol treatment in a patient with o steomalaciadueto severe vitamin D deficiencyafterbariatric surgery

      ea0063p91
    • A rare case of hypercalcemia associated with dysgerminoma with elevation of 1,25(OH)2 Vitamin D

      ea0063p92
    • Analysis of non-invasive DXA-derived bone structure parameters in patients with acromegaly with regards to vitamin D levels

      ea0063p93
    • Osteitis Fibrosa Cystica - A Forgotten Clinical And Radiological Feature Of Primary Hyperparathyroidism

      ea0063p94
    • Clinical use of Cinacalcet in patients with complex primary hyperparathyroidism

      ea0063p95
    • A rare case of Graves' disease in a patient with type 1B pseudohypoparathyroidism and associated TSH resistance

      ea0063p96
    • Primary hyperparathyroidism: clinical manifistation in Russian population

      ea0063p97
    • The effect of vitamin D supplementation on sarcopenia indices: a systematic review and meta-analysis of randomized controlled trials

      ea0063p98
    • The factors affecting balance function in patients with osteoporotic vertebral fractures

      ea0063p99
    • Evaluation of trabecular bone score in men with type 1 diabetes

      ea0063p100
    • Association between body mass index and the risk of falls: a nationwide population-based study

      ea0063p101
    • Various clinical features of Digeorge syndrome

      ea0063p102
    • About a case of familial hypocalciuric hypercalcemia (FHH) type 3 with neurological involvement

      ea0063p103
    • Verified data on parathyroid hyperplasia incidence not related to primary hyperparathyroidism in persons exposed to ionizing radiation

      ea0063p104
    • Parathyroid carcinoma: identity with diagnostic difficulties and therapeutic strategies

      ea0063p105
    • Case Report of a large family with hyperparathyroidism- jaw tumor syndrome (HPT-JT) and a deletion of the third exon of CDC73

      ea0063p106
    • Pseudohypoparathyroidism- a tale of hypo- and hypercalcemia with a genetic solution

      ea0063p107
    • Generalized skeletal hyperostosis mimicking acromegaly

      ea0063p108
    • Evaluation of bone quality in acromegaly and thyrotoxicosis using trabecular bone score

      ea0063p109
    • Primary hyperparathyroidism and vitamin D

      ea0063p110
    • The coincidence of primary hyperparathyroidism and primary hyperaldosteronism is not infrequent: a retrospective case analysis

      ea0063p111
    • Bilateral hip fractures and osteoporosis in a 40-year old man - identification of a novel TMEM38 mutation causing osteogenesis imperfecta

      ea0063p112
    • Hypomagnesemia induced disturbance of consciousness in alcoholic cirrhosis

      ea0063p113
    • Is any body composition parameter a risk factor for symptomatic hypocalcemia after thyroidectomy?

      ea0063p114
    • Severe diffuse tissue calcifications in a patient with pseudohypoparathyroidism type 1 A due to a novel large deletion of GNAS gene

      ea0063p115
    • Successful removal of parathyroid cancer metastasis from VI thoracic vertebra

      ea0063p116
    • Primary Hyperparathyroidism: about 34 observations

      ea0063p117
    • The clinical spectrum and endocrine profile of pseudohypoparathyroidism: ACTH resistance should not be ignored

      ea0063p118
    • Biochemical and clinical features of a family with a novel mutation of CYP24A1

      ea0063p119
    • A case of primary hyperparathyroidism in a patient with Lobstein's disease

      ea0063p120
  • Diabetes, Obesity and Metabolism 1
  • • Lifestyle modification strategies to prevent diabetes in individuals who participated in a medical health check

      ea0063p121
    • Effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus

      ea0063p122
    • Effects of lemon and cumin on premature atherosclerosis in obese patients

      ea0063p123
    • Management of acute charcot arthropathy

      ea0063p124
    • Non-Governmental Organizations (NGO's) & Diabetes - advocacy for support services in resource-poor nations

      ea0063p125
    • Microvascular and macrovascular complications in a cohort of patients with type 2 diabetes mellitus

      ea0063p126
    • Calbindin-D9k ablation cause endoplasmic reticulum stress induced [beta] cell death

      ea0063p127
    • Serum 25-hydroxycholecalciferol and the A allele of rs2228570 of the vitamin D receptor locus reduce the risk of type 2 diabetes mellitus in Jordan

      ea0063p128
    • Long term functional prognosis is worse in patients with chronic hyperglycemia

      ea0063p129
    • Role of blood catecholamine in cases with dysmetablolic iron overload syndrome (DIOS) in patients of Metabolic Syndrome

      ea0063p130
    • Incidence of obesity, overweight and hypertension in children and adolescents in Ahvaz southwest of Iran

      ea0063p131
    • Association of serum lipid profile and insulin resistance in polycystic ovary syndrome (PCOs) women in Ahvaz, Iran

      ea0063p132
    • A1c level in people with newly diagnosed type 2 diabetes during screening

      ea0063p133
    • Metabolic syndrome is associated with peripheral endothelial dysfunction amongst men

      ea0063p134
    • The frequency of Cushing's disease, ACTH independent Cushing's syndrome, and autonomous cortisol secretion among turkish patients with obesity

      ea0063p135
    • Higher level of astrocyte elevated gene 1 expression in peripheral blood monocytes in adults with newly diagnosed type 2

      ea0063p136
    • The EMPA-REG OUTCOME, a real cardiovascular benefit or a play on words?

      ea0063p137
    • Diabetic nephropathy and arterial stiffness in patients with type 1 diabetes mellitus

      ea0063p138
    • Evaluation of perior-operational safety and efficiency of the laparoscopic gastroplication procedure compared to laparoscopic handle gasstroektomia in patients with overweight and metabolic syndrome

      ea0063p139
    • Predictors of incident hypertension in healthy, non-diabetic postmenopausal women with normal renal function

      ea0063p140
    • The role of sodium glucose co-transporter inhibitors in patients with acromegaly and diabetes: is there an additive effect beyond glucose control? A clinical hypothesis

      ea0063p141
    • Irisin level in type 2 diabetic patients and its relation to glycemic control and diabetic complications

      ea0063p142
    • Clinical importance of determination of glytoxic methylglyoxal in nafld and type 2 type

      ea0063p143
    • The psychometric adaptation of the Russian version of the Diabetes Eating Problem Survey-Revised (DEPS-R)

      ea0063p144
    • Retinol binding protein 4-marker insulin resistance in patients with diabetes mellitus 2 types and NAFLD

      ea0063p145
    • Metabolic profile and diabetes in prison

      ea0063p146
    • The treatment of fertile age women with obesity

      ea0063p147
    • Prevalence and risk factors of hepatic steatosis among patients with chronic hepatitis B

      ea0063p148
    • Negative regulation of AMPK-related kinase MPK38/MELK activity by protein phosphatase 5 (PP5)

      ea0063p149
    • Effects of diabetes mellitus and autoimmune thyroiditis on features of rheumatoid arthritis

      ea0063p150
    • 'Killing two birds with one stone' treating porphyria patient with diabetes with SGLT2 inhibitors - a case report

      ea0063p151
    • Effect of glucocorticoid on agouti-related protein deficient mice

      ea0063p152
    • Insulin content and activity of inflammatory markers in patients with nonalcoholic fatial liver disease and diabetes of the second type

      ea0063p153
    • The role of bile acids in the pathogenesis of NAFLD

      ea0063p154
    • Improvement of human pancreatic islet quality after co-culture with human adipose-derived stem cells

      ea0063p155
    • The association between lipoprotein (a) and metabolic syndrome

      ea0063p156
    • Relationship study between blood groups, rhesus factor and the risk of diabetes type 2 in a population of the Sidi Othmane district, Casablanca

      ea0063p157
    • Case-control study on the obesity prevalence in a population of diabetic's consultant at the health department of Sidi-Othmane district, Casablanca: Morocco

      ea0063p158
    • Vitamin D: cardiovascular risk marking? About 290 patients

      ea0063p159
    • Complementary-alternative medicine & diabetes treatment adherence

      ea0063p160
    • Diabetes and QOL: strategies we need to work on

      ea0063p161
    • The relationship between glycated hemoglobin, postload blood glucose levels and non-hdl cholesterol among 75 gram oral glucose tolerance test applied women

      ea0063p162
    • Diabetes-, sex-, and BMI specific associations of genetic variants in PRRG1 with cardiovascular surrogates in a large cohort at CV risk

      ea0063p163
    • CGI-58 gene expression is decreased in the subcutaneous adipose tissue of patients with obesity

      ea0063p164
    • Results at 2 years of bariatric surgery in patients with type 2 diabetes mellitus

      ea0063p165
    • Assessment of the functional activity of neutrophilic granulocytes in patients with metabolic syndrome

      ea0063p166
    • Hygienic-dietetic habits in a group of patients with morbid obesity waiting for bariatric surgery and in a group already intervened

      ea0063p167
    • Challenges in managing patients with type 1 diabetes and hypersensitivity reaction to insulin

      ea0063p168
    • Relationship between liver fibrosis and diabetes-related complications in type 2 diabetic patients

      ea0063p169
    • Study on compositions of lipids in tissues of rats with alimentary obesity

      ea0063p170
    • Dopamine Receptor and Dopamine Transporter in Obesity: A Meta-analysis

      ea0063p171
    • Cerebral glucose metabolism and Cerebral blood flow in Hypothyroidism and Hyperthyroidism: An activation likelihood estimation Meta-analysis

      ea0063p172
    • Biomarkers of myocardial fibrosis at coronary heart disease in the presence and absence of diabetes mellitus type 2

      ea0063p173
    • Prevalence of vitamin D deficiency in a population of patients with prediabetes and type 2 diabetes mellitus

      ea0063p174
    • Genealogical analysis in diabetes mellitus risk assessment

      ea0063p175
    • The waist-to-hip ratio is a better obesity index than body mass index and waist circumference for screening for nonalcoholic fatty liver disease in postmenopausal women

      ea0063p176
    • The severity of different components of metabolic syndrome in hypertensive patients depending on IRS-1 gene polymorphism

      ea0063p177
    • The association of fibroblast growth factor 23 with other factorsof mineral and bone disorder in chronic kidney disease

      ea0063p178
    • Delivery in the diabetic women

      ea0063p179
    • Peripheral arterial disease in Asian Type 2 diabetes mellitus under 65 years old and its risk factors

      ea0063p180
    • Gestational diabetes mellitus and continuous glucose monitoring: glycemic patterns and pregnancy outcomes

      ea0063p181
    • Evaluation of leptin levels in diabetic and nondiabetic patients with increased BMI

      ea0063p182
    • Adiponectin concentrations in type 2 diabetes mellitus patients compared with healthy controls

      ea0063p183
    • Diagnosis of type 1 DM in a patient with Hydroxymethylglutaric aciduria: Case report

      ea0063p184
    • Novel clusters of adult-onset Diabetes: Casuistic from an Endocrinology Department

      ea0063p185
    • Relationship between cortisoluria and the presence of metabolic syndrome among HIV-infected patients

      ea0063p186
    • Complication of bariatric surgery as a reason of unsuccessful hypothyroidism and hypoparathyrosis treatment

      ea0063p187
    • Assessment of asymptomatic coronary aretry disease using myocardial perfusion scan in diabetic patients

      ea0063p188
    • HbA1c as a marker of glycemic control in patients with thalessemia HbH disease

      ea0063p189
    • HbA1C as a marker of retrograde glycemic control in diabetes patient with co-existed beta thalassemia: Case report

      ea0063p190
    • Clinical determinants of mean platelet volume in patients with abdominal obesity from different age groups

      ea0063p191
    • Large phenotypic variability of diabetes due to ABCC8 gene mutation illustrated by the paradigm of a family

      ea0063p192
    • Find prevalence of type 2 diabetes mellitus (DM) in age, BMI, symptoms and comorbidities (hypertension, dyslipidimia) in Indian scenario

      ea0063p193
    • Clinical case of insulin autoimmune syndrome

      ea0063p194
    • Evaluation of distance learning activities for healthcare professionals in diabetes management in Albania

      ea0063p195
    • Type 1 diabetic patients with more than five years of disease have increased global methylation levels

      ea0063p196
    • Results of application intensive weight management program in overweight (obese) patients with type 2 diabetes in real clinical practice

      ea0063p197
    • Structural changes of bone tissue in patients with type 1 diabetes mellitus

      ea0063p198
    • Early morphofunctional changes in the myocardium in young people with type 1 diabetes can be detected by magnetic resonance imaging

      ea0063p199
    • PCSK9 inhibitors effects after 2 years in real life

      ea0063p200
    • Acquired generalized lipodystrophy: a new cause of Anti-PD-1 immune-related diabetes

      ea0063p201
    • Necrotizing external otitis: a severe form of otitis in diabetic patients

      ea0063p202
    • Does osteocalcin have a role in Turkish gestational diabetes mellitus and its subgroups

      ea0063p203
    • False memory is very common by elderly diabetics and could be a big problem in patients education and diabetes outcome

      ea0063p204
    • GLP-1 secretion after oral glucose load is greater as eGFR is lower

      ea0063p205
    • Lessons from studying the characteristics of type 1 diabetes mellitus patients in a tertiary hospital in Singapore

      ea0063p206
    • An assessment of physician reasons for prescribing insulin lispro 200 units/ml in a prefilled pen in Germany

      ea0063p207
    • Lipoprotein apheresis during pregnancy in severe familial hypercholesterolemia - How and when should we switch treatment in the era of PCSK9 monoclonal antibodies?

      ea0063p208
    • Insulin sensitivity and counter regulatory responses following hypoglycemia in healthy and type 1 diabetes patients

      ea0063p209
    • Cardiovascular complications in metabolic syndrome in the Chernobyl NPP accident clean-up workers of in a late period upon exposure to ionizing radiation

      ea0063p210
    • Pattern of C-peptide response to oral glucose tolerance test: interest and reference values

      ea0063p211
    • Microalbuminuria and its relation to other factors of cardiovascular risk in type 2 diabetic patients

      ea0063p212
    • Pecularites of psychoemotional state at diabetes mellitus

      ea0063p213
    • Peroxisome proliferator activated receptor gamma mutation responsible for partial lipodystrophy with end stage renal disease: pharmacokinetics of metreleptine during hemodialysis: Clinical case report

      ea0063p214
    • Lipodistrophy, a rare disease: 'If you don't think about it, you doesn't diagnose it'

      ea0063p215
    • Please Don't Sugarcoat it: An avoidable case of Euglycaemic DKA in the setting of a SGLT-2 Inhibitor

      ea0063p216
    • Metabolic health is strongly predicted by free Testosterone and SHBG levels in non-obese postmenopausal women

      ea0063p217
    • The presence of polymorphic variant A1298C of the MTHFR (methylenetetrahydrofolate reductase) gene is associated with lower body mass index in girls with anorexia nervosa

      ea0063p218
    • The inverted U-shaped curvilinear effect of fat mass on bone mineral density in Korean adolescent teenagers

      ea0063p219
    • The effect of dapagliflozin add on to triple combination therapy in Type 2 diabetes

      ea0063p220
    • The correlation between overweight and beta-cell function in a healthy young population: a cross-sectional study in Korea

      ea0063p221
    • Vitamin B12 deficiency prevalence and associated biomarkers in type 2 Diabetes (T2DM) treated with metformin: biochemical assessment in a series of 106 patients

      ea0063p222
    • The association between serum cystatin C and carotid artery intima-media thickness in Korean type 2 diabetic patients

      ea0063p223
    • Prevalence of psychiatric comorbidities in diabetic patients who are candidates for therapy with SGLT2 inhibitors: clinical and metabolic characteristics

      ea0063p224
  • Pituitary and Neuroendocrinology 1
  • • Efficacy and safety of multimodal therapy in the management of aggresive prolactinoma

      ea0063p225
    • Metabolic fingerprint of acromegaly and its potential usefulness in clinical practice

      ea0063p226
    • NCKX3 knockout mice showed abnormal motor function and social behavior

      ea0063p227
    • Long terms effects of cranial irradiation for nasopharyngeal carcinoma on hypothalamic-pituitary function - a 5-years longitudinal study

      ea0063p228
    • A rare case of recurrent granulomatous hypophysitis treated with a trial of oral glucocorticoids

      ea0063p229
    • The role of interleukin-1 in the dynamics of exercise-induced copeptin

      ea0063p230
    • Growth hormone deficiency, which etiologies?

      ea0063p231
    • Mammosomatotropic adenoma and acromegaly: about 3 cases

      ea0063p232
    • Silent somatotropic adenoma: about a case

      ea0063p233
    • Posterior pituitary spindle-cell oncocytoma: case presentation and literature review

      ea0063p234
    • No central adrenal insufficiency found in adults with prader-willi syndrome tested by multiple dose metyrapone test

      ea0063p235
    • Serum aryl hydrocarbon receptor-interacting protein (AIP) levels are independent of serum GH levels both at baseline and in dynamic tests of GH stimulation and suppression

      ea0063p236
    • Some risk factors of re-growth of non-functional pituitary adenomas in patients with growth hormone deficiency

      ea0063p237
    • The frequency of growth retardation among children and adolescents from orphanages in Tashkent city

      ea0063p238
    • Supraselar tumor as cause of amaurosis - the unusual suspects-case series

      ea0063p239
    • Pituitary stalk interruption syndrome: an uncommon presentation

      ea0063p240
    • Long-term results of bilateral adrenalectomy in a patient with cyclic Cushing's syndrome

      ea0063p241
    • Pituitary tumors diagnosed in octogenarians - clinical implications

      ea0063p242
    • Papillary thyroid carcinoma in acromegalic patient diagnosed with McCune Albright syndrome (MAS)

      ea0063p243
    • Effects of octreotide on hallmarks of autophagy and on parameters related to cell viability and metabolic activity in rat pituitary tumor cells

      ea0063p244
    • Effects of body mass index and estimated glomerular filtration rate on pituitary function in patients with non-functioning pituitary tumor

      ea0063p245
    • Salivary carcinoma of the pituitary gland: an exceptional localization never described

      ea0063p246
    • MRI follow-up is not useful in patients with GH-secreting pituitary adenomas primarily treated and responsive to long-acting somatostatin analogs (SMSa)

      ea0063p247
    • Study of relationship between levels of kisspeptin and neurokinin B and markers of calcium-phosphate metabolism and water-electrolyte balance in patients with neuroendocrine disorders

      ea0063p248
    • Spontaneous pregnancy obtained in persistent Cushing Disease treated with Cabergoline: Report of two cases

      ea0063p249
    • Genetic study of AHR exonic part and GNAS intronic part mutations in some of Iraqi acromegalic patients

      ea0063p250
    • Primary infundibulohypophysitis in a young man with DI and Hypogonadism

      ea0063p251
    • A case of 'micromegaly': need for revision of oral glucose tolerance test (OGTT) cut-offs with modern growth hormone assays in acromegaly

      ea0063p252
    • What patients with acromegaly have to say about their diagnostic pathway: A qualitative study

      ea0063p253
    • IgG4-releated hypophysitis: A case report

      ea0063p254
    • Trunk fat increase is prevented both in patients undergoing long-lasting continuous r-hGH therapy and in those who discontinued r-hGH compared to untreated patients: results from baseline data of the MAGHD study

      ea0063p255
    • Hyperglycemia and pasireotide lar in acromegaly: a study with continuous glucose monitoring

      ea0063p256
    • Radiation therapy in patients with pituitary somatotropinomas

      ea0063p257
    • Anterior pituitary insufficiency in clinically non-functioning pituitary microadenoma

      ea0063p258
    • Neural network for predicting recurrence of the Cushing's disease within three years after neurosurgical treatment

      ea0063p259
    • Hyperglycemia in patients with acromegaly treated with pasireotide LAR

      ea0063p260
    • Novel insight into ACTH-secreting pituitary tumors biological behavior: somatostatin receptor type 5 (SST5) modulation by ubiquitin specific peptidase 8 (USP8)

      ea0063p261
    • Rare lesions of sellar, parasellar and suprasellar pathologies

      ea0063p262
    • Baseline characteristics of adult patients with growth hormone deficiency (GHD) enrolled in NordiNet® International Outcome Study (IOS): are there variations between countries?

      ea0063p263
    • [beta]-arrestin 2 expression is required for dopamine receptor type 2 (DRD2) inhibitory effects on Akt phosphorylation and cell proliferation in PRL-secreting and non functioning pituitary tumors

      ea0063p264
    • Somatostatin receptor type 2 trafficking through the cytoskeleton: role of scaffolding proteins Filamin A and [beta]-arrestin 2

      ea0063p265
    • Antitumor effects of growth hormone-releasing hormone (GHRH) antagonists in ACTH and GH-secreting pituitary adenoma cell lines

      ea0063p266
    • Somatostatin receptor type 5 modulation by Filamin A in ACTH-secreting pituitary tumors

      ea0063p267
    • The PATRO adults study of Omnitrope® for the treatment of adult patients with growth hormone deficiency: latest safety results

      ea0063p268
    • Diabetes insipidus and diabetes mellitus type 2 diagnosed at the same time in a male with langerhans cell histiocytosis

      ea0063p269
    • Assessment of endocrine function before and after transsphenoidal surgery for Cushing s disease

      ea0063p270
    • Diverticular perforation of colon: a dangerous complication in Cushing's disease

      ea0063p271
    • A retrospective study of 275 cases of pituitary intervention in south great plain region of Hungary

      ea0063p272
    • Differences of efficiency of treatment of isolated growth hormone deficiency and panhypopituitarism in children in real clinical practice

      ea0063p273
    • Functioning gonadotroph adenoma in a 46 years old male

      ea0063p274
    • Acromegaly: ominous cause of hirsutism

      ea0063p275
    • Pituitary apoplexy: clinical features, management and outcomes

      ea0063p276
    • Gross total versus incomplete resection of craniopharyngioma in adults

      ea0063p277
    • When a rare syndrome keeps behaving in rarer manners over and over again!

      ea0063p278
    • Ipilumumab induced hypophysitis

      ea0063p279
    • Acute lethargy, the main symptom of macroprolactinoma

      ea0063p280
    • Pituitary apoplexy: which treatment?

      ea0063p281
    • Cushing disease: Clinical presentation

      ea0063p282
    • The Importance of AGR2 Expression in Pituitary Adenoma Tissue Specimens on Tumor Aggressivity

      ea0063p283
    • The assessment of octreotide suppression test, ihc- and mr-structure, mr-signal of gh-producing pituitary adenoma for determining the prognosis of disease and management.

      ea0063p284
    • Precocious puberty in girls in Qazvin, Iran from 2006-2018

      ea0063p285
    • Spinal Epidural Lipomatosis: A rare complication of Cushing's disease

      ea0063p286
    • Diagnostic tests in Cushing's disease

      ea0063p287
    • Efficacy and safety of dopamine agonists in psychiatric patients treated with antipsychotics and presenting a macroprolactinoma

      ea0063p288
    • Imaging features of children with growth hormone deficiency

      ea0063p289
    • The polyuria-polydipsia syndrome: clinical and etiological profiles

      ea0063p290
    • Syndromic growth retardation: etiological aspects

      ea0063p291
    • GH deficiency and congenital malformation of the hypothalamic-pituitary axis: experience of the Endocrinology-diabetology Department of the Mohammed VI University Hospital Center of Oujda, Morocco

      ea0063p292
    • Long-term effects of GH replacement therapy on thyroid function in children with GH deficiency

      ea0063p293
    • Menstrual dysfunction (MD) with ACTH dependent Cushing syndrome

      ea0063p294
    • Silent, isolated ACTH-deficiency in melanoma patients treated with immune checkpoint inhibitors

      ea0063p295
    • A Case of Granulomatous Hypophysitis Mimicking Pituitary Macroadenoma

      ea0063p296
  • Reproductive Endocrinology 1
  • • The natural course of normal weight women with polycystic ovary syndrome: an insight into metabolic changes of a large Caucasian cohort

      ea0063p297
    • Inhibin-B and FSH are the best predictors of spermatogenesis

      ea0063p298
    • High prevalence of psychopathologies among transgender patients presenting at a large tertiary center: implication for the treating clinicians

      ea0063p299
    • Bardet-Biedl syndrome in two siblings: a rare entity

      ea0063p300
    • After up to 11 years observation, testosterone undecanoat 1000 mg at 3 months did not increased Prostatic Specific Antigen level (January 2019)

      ea0063p301
    • Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume: Study during up to 11 years on hypogonadic patients. (January 2019)

      ea0063p302
    • Evidence for preserved ovarian reserve in transgender men receiving testosterone therapy: Anti-mullerian hormone serum levels decrease modestly after one year of treatment

      ea0063p303
    • Female infertility: etiological factors and management

      ea0063p304
    • Assessement of frequency of depression in women of reproductive age with polycystic ovarian syndrome

      ea0063p305
    • A rare cause of the hypergonadotropic hypogonadism: GAPO sydrome

      ea0063p306
    • Menstrual disorders in patients with different etiology of hyperprolactinemia

      ea0063p307
    • Reproductive phenotype in 265 men with congenital hypogonadotropic hypogonadism and 531 men with acquired hypogonadotropic hypogonadism: a monocentric comparative study

      ea0063p308
    • Ano-genital distance in children born of mothers with polycystic ovary syndrome - Odense Child Cohort

      ea0063p309
    • Diagnosis and management of severe hyperandrogenism in the context of tumoral suspicion: case-series report from a tertiary hospital

      ea0063p310
    • Ovarian reserve and exposure to environmental pollutants (ORExPo study)

      ea0063p311
    • Normosmic hypogonadotropic hypogonadism associated with a novel TACR3 mutation

      ea0063p312
    • A novel rare case of normosmic congenital hypogonadotropic hypogonadism associating a GnRHR and a KISS1R variants

      ea0063p313
    • Azoospermia revealing the uncommon Jacob's syndrome

      ea0063p314
    • Pituitary tumor as a cause of male infertility

      ea0063p315
    • The differences in steroid hormones levels in the peripartum period caused by fetal sex and delivery type

      ea0063p316
    • Characterization of the expression and physiological roles of thyroid-stimulating hormone receptor in the male testis

      ea0063p317
    • Semen quality in uncontrolled acromegalic patients with hypogonadism

      ea0063p318
    • Characteristics, geographical distribution and age at diagnosis of patients with Klinefelter syndrome in Italy: a cohort study from the Klinefelter Italian Group (KING)

      ea0063p319
    • Gonadal Function in Human Immunodeficiency Virus (HIV)-Infected Men: comparison between Isotopic Dilution-Liquid Chromatography-Tandem Mass Spectrometry (ID-LC-MS/MS) and Chemiluminescent Immunoassay (CI)

      ea0063p320
    • Automated free testosterone assay: validation and usual values

      ea0063p321
    • Assessment of biochemical hyperandrogenism in PCOs by liquid chromatography tandem mass spectrometry using a multisteroid kit: focus on testosterone and androstenedione

      ea0063p322
    • Effects of fludioxonil on cardiac differentiation of mouse embryonic stem cells

      ea0063p323
    • Monitoring testosterone gel administration: timing and dosage

      ea0063p324
    • Menstrual cycle characteristics in women with premature ovarian insufficiency

      ea0063p325
    • Endocrine and menstrual disorders in adolescent girls: clinical parallels

      ea0063p326
    • Effects of percutaneous treatment of left varicocele on spermatogenetic and endocrine function of the testis: results from a 12-month follow-up

      ea0063p327
    • Predictive factors of polycystic ovary syndrome in women with morbid obesity

      ea0063p328
    • Randomised Controlled Trials in women with polycystic ovary syndrome do not represent the majority of patients who are in a primary care setting: systematic review and meta-analysis

      ea0063p329
    • The awareness of the side effects of the use of AAS as a factor of the conscious rejection of their use: The price of a beautiful body

      ea0063p330
    • Fenhexamid increased the cell viability and metastasis of breast cancer cells via an estrogen receptor-dependent and PI3K/AKT pathway

      ea0063p331
    • Natural estradiol in combined oral contraceptive has a favorable inflammation and lipid profile compared with preparation containing ethinyl estradiol- a randomized controlled trial

      ea0063p332
    • Modes and actions of inter-individual transfer of estradiol and progesterone among conspecifics in both mice and bats

      ea0063p333
    • Definition of hormonal cut-off values for discriminating polycystic ovary syndrome from non classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

      ea0063p334
    • Lipid parameters during pregnancy

      ea0063p335
    • Dysmenorrhea prevalence and its impact on daily functioning of university nursing students in greece

      ea0063p336
  • Thyroid 1
  • • The serum thyroglobulin level after discontinuation of two weeks of thyroid hormone in patients with differentiated thyroid cancer can be used to determine the therapeutic dose of radioiodine

      ea0063p337
    • Thyroid-associated orbitopathy and quality of life: correlation of GO-QoL with clinical activity score and severity in 101 patients

      ea0063p338
    • The influence of thyroid gland subclinical form on hypercholesterolemia patients in Latvia

      ea0063p339
    • Endocrinopathies post Immune check point inhibitors

      ea0063p340
    • Hashimotos encephalopathy in Graves' disease

      ea0063p341
    • Role of lipid peroxidation in the progression of autoimmune thyroiditis

      ea0063p342
    • Clinical evaluation of TSH-receptor antibody measured by a third generation fully automated electrochemiluminescence immunoassay method in Turkish patients with Graves' disease

      ea0063p343
    • Association between hypothyroidism and venous thromboembolism and the effect of levothyroxine in the adult: a nationwide Cohort study

      ea0063p344
    • Should narrower TSH and free thyroid hormone levels be targeted to reduce the cardiovascular risk of euthyroid subjects?

      ea0063p345
    • Thyroid dysfunction in Egyptian HCV patients: prevalence and possible triggering factors

      ea0063p346
    • Management of refractory hypothyroidism with intramuscular levothyroxine: a clinical case

      ea0063p347
    • Thyroid angiosarcoma: in the light of a case

      ea0063p348
    • Collision tumor: A case report of tall cell variant of papillary thyroid carcinoma and laryngeal squamous cell carcinoma

      ea0063p349
    • Outcomes of surgery and radioiodine treatment for neck recurrence in papillary thyroid cancer

      ea0063p350
    • Anaplastic thyroid carcinoma or radiation-induced sarcoma: About a case

      ea0063p351
    • The relationship between thyroid receptor antibody and anti mullerian hormone in Graves' disease

      ea0063p352
    • Infrared thermography in association with indirect calorimetry: a new methodology for diagnosis and follow-up of subclinical hypothyroidism

      ea0063p353
    • How much the implementation of an expert surgical team can improve the incidence of postoperative hypoparathyroidism

      ea0063p354
    • An ununsual thyroid cause for Pyrexia of unknown origin (PUO)

      ea0063p355
    • Relationship among T- and B-lymphocytes of the peripheral blood and thyroid tissue in patients with Graves' disease

      ea0063p356
    • Association between vitamin D receptor gene polymorphisms and Graves' disease: a systematic review and meta-analysis

      ea0063p357
    • Thyroid dysfunction after Alemtuzumab treatment for multiple sclerosis: diagnostic and therapeutic modalities

      ea0063p358
    • A rare cause of goiter

      ea0063p359
    • Changing practice in the management of differentiated thyroid carcinoma - experience at Brugmann Hospital in Brussels

      ea0063p360
    • Intraoperative Neuromonitoring of the laryngeal nerves in thyroid surgery

      ea0063p361
    • Weekly dose of L-thyroxine as a first line treatment for hypothyroidism in young and middle aged working females

      ea0063p362
    • Analysis of clinical and biological predictors of malignancy in thyroid nodules

      ea0063p363
    • Sensitivity and specificity of ultrasound features in predicting malignant thyroid nodules

      ea0063p364
    • Comparison of G-CSF and non-G-CSF treatment of agranulocytosis in patients with hyperthyroidism: a meta-analysis

      ea0063p365
    • Ocular cavity metastasis from poorly differentiated thyroid carcinoma

      ea0063p366
    • Giant cystic pheochromocytoma: A clinically silent entity

      ea0063p367
    • Glucocorticoid Functional Reserve in Hashimoto Hypothyroidism before and after LT4 replacement

      ea0063p368
    • Impact of thyroid autoimmunity on obstetric and perinatal outcomes in pregnant women with subclinical hypothyroidism

      ea0063p369
    • Abstract unavailable

      ea0063p370
    • Navigating thyroid storm: The role of plasmapheresis in a patient also needing urgent aortic valve replacement surgery

      ea0063p371
    • Prognostic factors for lymph node metastases in patients with papillary thyroid microcarcinoma

      ea0063p372
    • Histological characteristics in thyroid carcinoma: our experience in the last fifteen years

      ea0063p373
    • Impact of total thyroidectomy on quality of life: the prospective ThyrQoL multicenter trial

      ea0063p374
    • Can urinary iodine be used in the diagnosis and follow up of subacute thyroiditis?

      ea0063p375
    • Comparative analysis of Hashimoto's and Riedel's thyroiditis morphology and immunohistochemistry

      ea0063p376
    • Is total thyroidectomy and bilateral central lymph node dissection essential for patients with unilateral cN1a papillary thyroid carcinoma?

      ea0063p377
    • Should the dose of levothyroxine be changed in hypothyroidism patients fasting during Ramadan?

      ea0063p378
    • Iodine status of schoolchildren of Belarus in 2017-2018

      ea0063p379
    • The Effect of Ramadan fasting on thyroid hormone levels in patients on levothyroxine treatment

      ea0063p380
    • Switch from tablet to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia in thyroxine-replaced postmenopausal women under simultaneous calcium supplementation.

      ea0063p381
    • Targeting the pentose phosphate pathway in thyroid cancer cells

      ea0063p382
    • Clinical presentation of patients with Autoimmune Polygranular Syndrome III (APS III)

      ea0063p383
    • Prevalence of celiac disease in autoimmune thyroid diseases, and its associaton with other autoimmune disesases: a single center study in Argentina

      ea0063p384
    • Synchronous papillary carcinomas in thyroglossal duct cyst and micro carcinomas in thyroid gland: report of 3 new cases

      ea0063p385
    • Evaluation of the diagnostic algorithm when a suppressed tsh is found in the laboratory

      ea0063p386
    • A novel TPO mutation by next generation sequencing in congenital hypothyroidism and the functional analysis of thyroid peroxidase activity

      ea0063p387
    • Isotretinoin associated hypothyroidism

      ea0063p388
    • Role of subclinical hypothyroidism in modification of metabolic syndrome key components in the Chernobyl accident survivors within three decades

      ea0063p389
    • Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation

      ea0063p390
    • Frequency of comorbidity in primary care patients with hypothyroidism

      ea0063p391
    • The presence of tall cells, even if

      ea0063p392
    • A rare case of suppurative lymphadenitis after treatment with granulocyte-stimulating factor for carbimazole-induced agranulocytosis

      ea0063p393
    • Gastric acidity determines the more appropriate preparation of oral thyroxine

      ea0063p394
    • An unexpected finding of a bronchogenic cyst mimicking thyroid cyst

      ea0063p395
    • Is detection of braf mutation enough to decide prophylactic central neck dissection (CND)?

      ea0063p396
    • Assessment of attainment of recommended TSH target levels in thyroid cancer patients following in Dubai hospital

      ea0063p397
    • Intellectual outcome in children with subclinical hypothyroidism: effects of two years of levothyroxine treatment

      ea0063p398
    • Cardiac size and function in children with subclinical hypothyroidism

      ea0063p399
    • Bone homeostasis in children with Subclinical hypothyroidism: effects of two-years treatment with levothyoxine

      ea0063p400
    • Jejunum metastasis and perforation from anaplastic thyroid cancer

      ea0063p401
    • FNAB results of 520 patients in a mild-to-moderate iodine deficient city in Turkey

      ea0063p402
    • Thyroid lesions in patients with acromegaly: Experience of diabetology-endocrinology department of Oujda's Mohammed VI university hospital

      ea0063p403
    • Pancytopenia and reversible cardiomyopathy - complications of thyrotoxicosis: case report

      ea0063p404
    • Radiofrequency ablation in the treatment of benign thyroid nodules: a good alternative to surgery

      ea0063p405
    • Exacerbation of thyrotoxicosis following radioiodine therapy in benign thyroid diseases: can it be predicted?

      ea0063p406
  • Adrenal and Neuroendocrine Tumours 2
  • • ACTH-dependent hypercortisolism: always follow your nose

      ea0063p407
    • Metyrapone test in secondary adrenal insufficiency - is ACTH measurement alone sufficient for a proper diagnosis?

      ea0063p408
    • Diagnostic accuracy of the aldosterone to active renin ratio in detecting primary aldosteronism: the graz endocrine causes of hypertension (GECOH) study

      ea0063p409
    • Large adrenal incidentalomas require a dedicated diagnostic procedure

      ea0063p410
    • Necessity of educational programs for healthcare givers in preclinical settings of acute adrenal insufficiency in patients with chronic hypocortisolism

      ea0063p411
    • Challenges in diagnosing and treating a glucagon secreting tumor - case report

      ea0063p412
    • Phenotypic variability within a family with multiple endocrine neoplasia type 1 (MEN1) syndrome

      ea0063p413
    • High levels of chromogranin A in connection with proton pump inhibitors

      ea0063p414
    • A case of pheochromocytoma left untreated for twelve years: Role of the endocrinologist

      ea0063p415
    • High prevalence of autonomous aldosterone secretion in patients with type 2 Diabetes Mellitus and arterial hypertension. The effect of SGLT2 inhibitors on renin-angiotensin-aldosterone system

      ea0063p416
    • Extreme improvement in metabolic status with remarkable weight loss of 64 kg after adrenalectomy due to Cushing syndrome, and development of rheumatoid arthritis eight months later

      ea0063p417
    • Contribution of morphological and functional liver imaging to differentiate liver metastases of adrenocortical carcinoma from those of neuroendocrine tumors in a woman with a final diagnosis of multiple endocrine neoplasia type 1

      ea0063p418
    • Prolonged hypoaldosteronism after unilateral adrenalectomy for primary aldosteronism: a report of two cases

      ea0063p419
    • Premature ovarian failure in a patient with schmidt syndrome

      ea0063p420
    • RET Y791F carriers' medical history - experience from one center

      ea0063p421
    • Association between new anthropometric parameters and new inflammation indicators in non-functioning adrenal incidentalomas

      ea0063p422
    • Comparison of visualization methods in ACTH-ectopic lung tumor: a case report

      ea0063p423
    • Paraneoplastic Cushing's syndrome related to recurrence of a malignant ovarian teratoma

      ea0063p424
    • Insulinoma: a case series of a tertiary care center

      ea0063p425
    • Validation of 24-hour human adrenal steroid rhythms measured by ULTRADIAN interstitial automated microdialysis: Comparison with plasma

      ea0063p426
    • Genetic mutations in bladder paragangliomas - not just SDHB-related disease

      ea0063p427
    • PAI-BEL: the Belgian registry on Primary Adrenal Insufficiency

      ea0063p428
    • Urinary steroid profiling by gas chromatography-mass spectrometry (GC-MS) in Cushing's syndrome

      ea0063p429
    • Efficacy of DHEA in improving Quality of Life in prolonged HPA axis suppression from exogenous steroids

      ea0063p430
    • Residual adrenocortical function in autoimmune addison's disease: interim results of a cross-sectional study

      ea0063p431
    • Case report: giant adrenal myelolipoma in CAH - should all patients be screened by ultrasound for adrenal masses?

      ea0063p432
    • Molecular events in a large series of advanced stage III-IV adrenocortical cancer: looking for new therapeutic options

      ea0063p433
    • A severe ACTH-dependent Cushing syndrome associated to a possible concomitant primary adrenal-dependent hypercortisolism: a challenging case

      ea0063p434
    • One-hour glucose level of the oral glucose tolerance test: the new valuable indicator of insulin resistance in patients with adrenal incidentalomas

      ea0063p435
    • Measuring steroids hormones by liquid chromatography-tandem mass spectrometry in 21-hydroxylase deficiency (21OHD) reveal large interindividual differences in hormone levels amongst patient with the same genetic mutation

      ea0063p436
    • Hypoadrenalism in Advanced HIV

      ea0063p437
    • A case of late recognition of the malignant cause of chronic pancreatitis

      ea0063p438
    • Imaging studies of a parathyroid carcinoma case

      ea0063p439
    • Neuroendocrine neoplasms (NEN) arising in uncommon sites: epidemiological and clinical features

      ea0063p440
    • Microwave ablation of the adrenal gland for treatment of functioning adrenocortical tumours: porcine in vivo study

      ea0063p441
    • Simplified model for diagnosis of secondary adrenal insufficiency using non-fasting cortisol and clinical parameters

      ea0063p442
    • Type 1 gastric neuroendocrine tumor study in Hospital Clinico San Carlos (HCSC), Madrid

      ea0063p443
    • The Arg244His missense mutation in SDHB-1 leads to altered metabolism in Caenorhabditis elegans: a new disease model

      ea0063p444
    • 11C-Metomidate PET/CT Identifies Unilateral Primary Aldosteronism in a Multi-ethnic Cohort

      ea0063p445
    • Prevalence of non-carcinoid syndrome (non-CS) diarrhoea in patients with neuroendocrine tumours (NETs): a systematic literature review (SLR)

      ea0063p446
    • Down-regulation of the Ataxia Telangiectasia Mutated Gene (ATM) is associated with increased metastatic potential and decreased overal survival in patients diagnosed with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

      ea0063p447
    • GEP-NET tumors as the first geno-phenotypic association in MEN1 syndrome - the possibilities for a European MEN1 network

      ea0063p448
    • Prevalence of neuroendocrine tumors in a subgroup of young patients: single center experience

      ea0063p449
    • Prognostic role of angiogenesis-associated factors Tie2 and Angiopoietin 2 in patients with neuroendocrine neoplasms: The NETTARE Unit experience

      ea0063p450
    • Attributes valued by patients, health-care practitioners (HCPs) and caregivers using pre-filled delivery systems: a systematic literature review

      ea0063p451
    • Identification of a molecular signature of hypercortisolism by whole blood methylome analysis

      ea0063p452
    • Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a case-control study from NETTARE Unit

      ea0063p453
    • Selective arterial calcium stimulation test in two cases with occult insulinoma

      ea0063p454
    • Can pancreatic tumor in von Hippel-Lindau syndrome be a prognostic factor?- a case study

      ea0063p455
    • An investigation into the role of parathyroid hormone in the regulation of aldosterone secretion in hypertensive cardiovascular patients

      ea0063p456
    • Plasma levels and regulation by the hypothalamic-pituitary-adrenal axis of Androst-5-ene-3[beta],7[alpha]/[beta],17[beta]-triols in human

      ea0063p457
    • A case of non metastatic pheochromocytoma in a patient with multiple sclerosis

      ea0063p458
    • Bilateral gynecomastia revealing a secreting adrenal adrenoma on a 5-year-old boy

      ea0063p459
    • Steroid hormones and cancer immunity - insights into adrenocortical carcinoma

      ea0063p460
    • Multiple endocrine neoplasia: A case report of a pancreatic neuroendocrine tumor in a long evolving MEN1 patient

      ea0063p461
    • A clinical case of adrenal incidentaloma: inconsistency of a prediction to reality

      ea0063p462
    • InfeCtious disease in patients with Adrenal endocRinOpathies: the ICARO prospective observational study

      ea0063p463
    • EGFR and IGF1R affect Sunitinib activity: novel targets for Broncho-Pulmonary Neuroendocrine Neoplasm treatment

      ea0063p464
    • Measurement of metanephrine in adrenal venous sampling may help subtyping primary aldosteronism

      ea0063p465
    • A case of metastatic pheochromocytoma diagnosed at a young age with hypertensive attack

      ea0063p466
  • Calcium and Bone 2
  • • Discovery of a novel NOTCH2 mutation causing Hajdu Cheney Syndrome in a kindred with remarkable phenotypic diversity

      ea0063p467
    • Discovery of a novel CASR mutation causing Familial Hypocalciuric Hypercalcemia in a Greek family

      ea0063p468
    • A case of apparently sporadic primary hyperparathyroidism carrying a germline mutation of CDC73 gene

      ea0063p469
    • Successful management of tertiary hyperparathyroidism associated with hypophosphataemic rickets in an adult

      ea0063p470
    • Parathyroid hormone (PTH) levels are not associated with cancer in patients with primary hyperparathyroidism

      ea0063p471
    • Osteoporosis induced after sleeve gastrectomy in a patient affected of mild asymptomatic primary hyperparathyroidism

      ea0063p472
    • High prevalence of severe vitamin D deficiency in Egyptian females

      ea0063p473
    • Hypophosphatemia in osteoporotic patients referred to a single third level centre: prevalence, clinical features and diagnostic challenges

      ea0063p474
    • McCune-Albright syndrome: report of two cases

      ea0063p475
    • Pineal chordoid meningioma in patient with familial hypocalciuric hypercalcemia, a combination of two rare conditions: Report of a clinical case

      ea0063p476
    • Hypercalcemic crisis of unknown origin: A case report

      ea0063p477
    • Trabecular bone score - a more sensible indicator in predicting negative change than bone mass density?

      ea0063p478
    • Relationship between serum levels of 25-OH vitamin D and parameters of bone mineralization (BMD) and bone quality (TBS) in clinical practice

      ea0063p479
    • Seasonal variation of osteoporotic hip fracture admitted in trauma centers in Bucharest

      ea0063p480
    • Calcitonin response to calcium infusion test in patients with primary hyperparathyroidism

      ea0063p481
    • Effect of hyperparathyroidism on coagulation: an analysis by modified rotation thromboelastogram (ROTEM)

      ea0063p482
    • Parathyroid hormone excess due to denosumab application and concomitant parathyroid adenoma with an atypical scintigraphic pattern- a case report

      ea0063p483
    • Bone mineral density and 10-year probability of fractures in type 2 diabetic patients with different vitamin D status

      ea0063p484
    • Life threatening 'hypocalcaemia' secondary to proton pump inhibitor induced 'functional hypoparathyroidism'

      ea0063p485
    • Dynamic thiol/disulfide homeostasis and oxidant status in patients with hypoparathyroidism

      ea0063p486
    • Hypercalcaemia: hypervitaminosis D or not ?

      ea0063p487
    • Primary hyperparathyroidism with ectopic mediastinal adenoma complicated with brown tumors

      ea0063p488
    • Pregnancy, pancreatitis and hypoglycemia: Difficult management options in a case with MEN-1

      ea0063p489
    • Hyperparathyroidism - jaw tumor syndrome - differential diagnostic traps

      ea0063p490
    • Rickets in a patient with melnick needles syndrome

      ea0063p491
    • Hyperparathyroidism in patients with X-linked hypophosphatemia

      ea0063p492
    • Hypocalcemic cardiomyopathy: a reversible entity?

      ea0063p493
    • Multiglandular parathyroid disease in patients with primary hyperparathyroidism and inconclusive conventional imaging

      ea0063p494
    • Acute pancreatitis, caused by parathyroid gland adenoma: A case report

      ea0063p495
    • A new and effective treatment option for challenging chronic hypoparathyroidism cases: Alternate-day dosing regimen

      ea0063p496
    • Reversible heart disease in iatrogenic hypoparathyroidism

      ea0063p497
    • Bilateral femoral fractures in a pacient with primary hyperparathyroidism: A case report

      ea0063p498
    • Uncommon cutaneous manifestation of primary hyperparathyroidism

      ea0063p499
    • Body mass index is a biomarker of resistance to active vitamin D but not to calcium supplementation, in patients with hypoparathyroidism

      ea0063p500
    • A man with maxillary swelling and tertiary hyperparathyroidism

      ea0063p501
    • Evaluation of bone metabolism in women on aromatase-inhibitors before and after antiresorptive treatment

      ea0063p502
    • Discordance in biochemistry and ultrasonography: Nonsecretory parathyroid adenoma

      ea0063p503
    • Effect of zoledronic acid on trabecular bone score and other markers of bone health in heart transplanted patients

      ea0063p504
    • Impact of three doses of vitamin D on serum 25(OH)D parathyroid hormone in overweight and obese schoolchildren: A single blind randomized clinical trial

      ea0063p505
    • The relation between circulating levels of vitamin D and parathyroid hormone in children and adolescent with overweight or obesity: quest for a threshold

      ea0063p506
    • Fahr syndrome revealing primary hypoparathyroidism: About two cases

      ea0063p507
    • Features of fractures in patients with types 2 diabetes mellitus

      ea0063p508
    • Association between 25 hydroxyvitamin D levels and insulin resistance in a cohort of obese subjects

      ea0063p509
    • Vitamin D repletion in chronic kidney disease patients with secondary hyperparathyroidism

      ea0063p510
    • Gitelman's syndrome with concomitant primary hyperparathyroidism - case report

      ea0063p511
    • Primary hyperparathyroidism: diagnosis and management

      ea0063p512
    • Clinical-biological presentation hyperparathyroidism primary function of vitamin D status

      ea0063p513
    • Vitamin D insufficiency and hyperparathyroidism, general health and quality of life - a cross sectional study

      ea0063p514
    • Denosumab, alendronate and zoledronate failure to suppress bone resorption markers in a woman affected by severe osteoporosis and subclinical hypercortisolism due to an adrenal adenoma: A case report

      ea0063p515
    • Immobilization induced hypercalcemia

      ea0063p516
    • Denosumab in clinical practice: efficacy, complications and adherence

      ea0063p517
    • Transition of denosumab to primary care is enhanced by use of a transfer pack

      ea0063p518
    • Fahr's syndrome secondary to hypoparathyroidism: about 11 cases

      ea0063p519
    • Vegan diet: a true danger in paediatrics

      ea0063p520
    • A rare case of cushing disease and hypophosphatasia

      ea0063p521
    • The effect of teriparatide on bone mineral density in a woman with severe lactation-related osteoporosis and multiple vertebral fractures

      ea0063p522
    • Relapse of primary hyperparathyroidism concurrent with a plasma cell proliferative disorder: report of a case

      ea0063p523
    • Diagnosis and treatment of an Argentine patient with severe primary hypoparathyroidism and 22q11.2 deletion syndrome

      ea0063p524
    • The association between magnesium oxide and fracture- A nationwide population-based retrospective cohort study

      ea0063p525
  • Diabetes, Obesity and Metabolism 2
  • • Hypoglycemia as a first symptom of fructosemia, complicated by gestational diabetes in III pregnancy and 26 years of delayed final diagnosis: a case report

      ea0063p526
    • Artificial intelligence for the remote evaluation of gestational diabetes using a smartphone application (Sinedie[Copy]): Study design.

      ea0063p527
    • Adolescent type 1 diabetes self-management: what about dietary regimen?

      ea0063p528
    • Epicardial fat accumulation in non-alcoholic liver disease and impaired glucose metabolism

      ea0063p529
    • Vitamin B12 and gestational diabetes mellitus

      ea0063p530
    • TRMA syndrome (thiamine-responsive megaloblastic anemia): a case report

      ea0063p531
    • Study on efficacy of long-term education for achieving compensation of type 1 diabetes mellitus in children Almaty region of Kazakhstan

      ea0063p532
    • A novel oral pyruvate dehydrogenase kinase 4 inhibitor ameliorates various spectrum of metabolic diseases in mice

      ea0063p533
    • Quality of life in patients undergoing bariatric surgery

      ea0063p534
    • Metabolic encephalopathy secondary to diabetic ketoacidosis

      ea0063p535
    • Maternal weight status and gestational diabetes

      ea0063p536
    • Diabetic retinopathy: Prevalence and risk factors

      ea0063p537
    • Efficacy of plasmapheresis in the management of severe hypertriglyceridemia

      ea0063p538
    • Insulin pump therapy in patients with type 1 diabetes in Morocco

      ea0063p539
    • Role of proinflammatory cytokines TNF-[alpha] and IL-6 in pathogenesis of type 2 diabetes mellitus in persons exposed to ionizing radiation after the Chernobyl NPP accident

      ea0063p540
    • A case of DRESS syndrome associated with autoimmune type 1 diabetes

      ea0063p541
    • Examination of the care pathways of adults with diabetes undergoing haemodialysis for end stage renal failure

      ea0063p542
    • Exploratory study into communication styles of diabetes healthcare professionals according to their patients numerical ability

      ea0063p543
    • Enterotypes of the gut microbiome in Russian population and their metabolic activity

      ea0063p544
    • Lipid profile and cardiovascular risk in ankylosing spondylitis

      ea0063p545
    • Diagnostics of carbohydrate metabolism according to the regularity of menstrual cycle

      ea0063p546
    • Clinical characteristics and foot amputations rate in patients treated in a multidisciplinary diabetic foot unit

      ea0063p547
    • Microbiota changes in type 2 diabetes patients intolerant to metformin after drug reintroduction

      ea0063p548
    • PRIMAVERA study: sibutramine therapy safety monitoring in patients with obesity

      ea0063p549
    • Does therapeutic education really prevent lipodystrophy?

      ea0063p550
    • Insulin injection techniques: what do moroccan diabetic patients do?

      ea0063p551
    • The reuse of insulin needles: a problem with consequences (about 1000 cases)

      ea0063p552
    • Polymorphisms of genes GNB3, SERT, NET, TPH2 and results of obesity treatment with sibutramine

      ea0063p553
    • Microcirculatory disorders in adolescents with tipe 1 diabetes mellitus

      ea0063p554
    • Therapeutic and nutritional compliance in diabetic patients in the Endocrinology-Diabetology-Nutrition Department of Mohammed VI University Hospital Center in Oujda

      ea0063p555
    • Diabetes increases liver fibroscan value regardless of steatosis

      ea0063p556
    • Tobacco and diabetes: a comparative study of smoking diabetic patients and non-smoking diabetic patients in the Endocrinology-Diabetology-Nutrition Department of Oujda's University Hospital in Morocco

      ea0063p557
    • Endocrinopathies and diabetes: cardiovascular risk assessment

      ea0063p558
    • Inflammation and adipocytokines in overweight and obesity

      ea0063p559
    • Free T3 correlates with iron metabolism indexes in patients with type 1 diabetes and diabetic kidney disease

      ea0063p560
    • Features of type 2 diabetes mellitus in the elderly (Minsk)

      ea0063p561
    • The role of glucagon like peptide - 1 (GLP-1) receptor agonists in the treatment of type 2 diabetes mellitus

      ea0063p562
    • Autoimmune diabetes mellitus adult patients having latent autoimmune diabetes of adulthood (LADA) form exhibit different prevalence of accompanying autoimmune diseases than patients with conventional (juvenile) autoimmune type 1 diabetes: Furthermore, anti-GAD autoantibodies are strongly associated with accompanying autoimmune diseases in patients with autoimmune diabetes mellitus

      ea0063p563
    • Erythrocytes glucose uptake increases in rats with experimental induced obesity, diabetes and hyperinsulinemia

      ea0063p564
    • Giant prolactinoma associated with alopecia universalis (AU): a case report

      ea0063p565
    • Evaluation of the improvement in vascular endothelial function from raphanus sativus via activation of PI3K/Akt pathway

      ea0063p566
    • Cardiovascular risk in obese women with polycystic ovary syndrome using Framingham scoring system

      ea0063p567
    • Association Kidney Neoplasm and recent diabetes: think about MODY 5

      ea0063p568
    • Body composition (DXA) and hormonal picture in obese children

      ea0063p569
    • Mineralocorticoid receptor and diabetes: in favour of other corticosteroids than aldosterone

      ea0063p570
    • Abstract unavailable

      ea0063p571
    • Erythrocytes membrane plasmalogens level in Diabetes Mellitus depends from Arterial Hypertension and nephropathy

      ea0063p572
    • A hyperglycemic crisis as a first appearance of newly onset diabetes mellitus in a patient using dexamethasone: Blame the usual suspect or accuse a new one?

      ea0063p573
    • Use of insulin therapy in the treatment of gestational diabetes

      ea0063p574
    • The fasting of diabetic patients during Ramadan: a dilemma of religious conviction and medical prohibition

      ea0063p575
    • Myocardial infarction in diabetic patients and cardiovascular risk factors control

      ea0063p576
    • Comparison of effects of metformin used as a monotherapy or in combination with gliclazide MR on glycemic control and lipid profile in patients with type 2 diabetes mellitus

      ea0063p577
    • Factors affecting effective gestational diabetes mellitus management: six-year experience from a single tertiary center

      ea0063p578
    • Oral glucose tolerance test is recommended for screening for new-onset glucose metabolism impairment during chronic low-dose glucocorticoid therapy

      ea0063p579
    • Incidence of diabetes and its predictive factors in cancer patients treated with phosphatidylinositol 3 kinase inhibitors

      ea0063p580
    • Flash glucose monitoring: repercussions in glycemic control

      ea0063p581
    • The role of proper insulin injection technique to achieve optimal glycemic control

      ea0063p582
    • Metabolic effects of a novel myokine, Follistatin like protein 1 (FSTL1), in human primary adipocytes

      ea0063p583
    • Discordance between body-mass index and body adiposity index in classification of adiposity status in the elderly

      ea0063p584
    • The effect of Iranian propolis on glucose metabolism, lipid profile, insulin resistance, renal function and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double blind clinical trial

      ea0063p585
    • Real-world experience of generalized and partial lipodystrophy patients enrolled in the metreleptin early access program

      ea0063p586
    • Prevalence and characteristics of Nivolumab-induced diabetes: results from a monocentric observational study

      ea0063p587
    • Genetic diagnosis of maturity-onset diabetes of the young (MODY): experience of diabetology-endocrinology department of Oujda's Mohammed VI university hospital

      ea0063p588
    • Discrete choice and SF-36 estimates of patient quality of life and benefits of leptin replacement therapy (LRT) in generalized and partial lipodystrophy (GL, PL)

      ea0063p589
    • Are all hypoglycemic drugs similar for men with type 2 diabetes and testosterone deficiency?

      ea0063p590
    • A 5-years postoperative upper digestive endoscopy in obesity surgery

      ea0063p591
    • Occupational outcomes after bariatric surgery: relation to deprivation, satisfaction score

      ea0063p592
    • Probiotic supplementation and [beta]-cell function in type 2 diabetes: evidence from randomized clinical trial

      ea0063p593
    • Relationship between lipid profile and uricemia in diabetic type 2

      ea0063p594
    • Insulin resistance, systemic and regional inflammation in subcutaneous adipose tissue during weight loss in a population with obesity

      ea0063p595
    • The effect of 3 months of daily consumption of sugar-sweetened beverages on liver, adipose tissue, and glucose metabolism in an animal study

      ea0063p596
    • A new neurocognitive phenotype in Alstrom sindrome

      ea0063p597
    • Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit

      ea0063p598
    • Testosterone restores metabolic syndrome-induced impairement in physical activity by ameliorating skeletal muscle fiber metabolism

      ea0063p599
    • Compliance with gestational weight gain in women with gestational diabetes mellitus

      ea0063p600
    • Clinical and ultrasonographic characteristics of women with co-existing gestational diabetes mellitus and thyroid disease

      ea0063p601
    • Platelet reactivity in patients with type 2 diabetes mellitus after treatment intensification with DPP-4i, SGLT-2i and GLP-1RA

      ea0063p602
    • Renoprotective effects of weekly dulaglutide in type 2 diabetes patients: A routine clinical practice study

      ea0063p603
    • The effects of testosterone treatment on fat tissue dysfunction and nonalcoholic fatty liver disease in obese men undergoing bariatric surgery

      ea0063p604
    • Parabens and their relationship to obesity

      ea0063p605
    • Complex use of noninvasive methods for estimating microcirculation of the blood and oxidative metabolism on the big sting finger in patients with diabetes, such as permeable diagnostic diagnostics diagnostics, patients with diable diagnosis

      ea0063p606
    • Liver fibrosis and steatosis severity evaluation in patients with chronic hepatitis C and type 2 diabetes mellitus

      ea0063p607
    • Determinant factors for prescription of antidiabetic drugs with beneficial effects on weight

      ea0063p608
    • Gut microbiota pattern in relation to diet, physical activity and malnutrition in patients with inflammatory bowel disease: cases-control study

      ea0063p609
    • Description of a novel AGPAT2 gene mutation (R159C) responsible for congenital generalized lipoatrophy type 1 (Berardinelli-Seip Syndrome)

      ea0063p610
    • Prenatal metformin treatment in obese rats: Evaluation of liver norepinephrine and lipogenic enzymes in offspring

      ea0063p611
    • Profile of celiac disease in diabetic children

      ea0063p612
    • A common but forgotten cause of electrolyte disturbances in patients with cachexia

      ea0063p613
    • Vitamin D status and bone metabolism in adult patients with Type 1 diabetes mellitus

      ea0063p614
    • The effect of antidiabetic drugs on serum 25-hydroxyvitamin D level: A preliminary report

      ea0063p615
    • Serum total and bioactive fibroblast growth factor 21 levels are similar in patients with gestational diabetes mellitus and healthy pregnant controls

      ea0063p616
    • Liraglutide restores the hyperglycemic oxidative imbalance and induces the expression of CRH, UCN1, UCN2 AND UCN3 neuropeptides in macroendothelial cells

      ea0063p617
    • The effects of hyperinsulinemia on cochlear functions

      ea0063p618
    • Trial-in-progress: ZEPHYR, a pivotal phase 2b/3 randomized, placebo-controlled study of livoletide, a novel unacylated ghrelin analog, for the treatment of hyperphagia and food-related behaviors in patients with Prader-Willi syndrome

      ea0063p619
    • Next generation sequencing reveals ABCC8 (MODY 12) variants in two families with diabetes mellitus (DM)

      ea0063p620
    • Nonclinical development of livoletide (AZP-531), a peptide analog of unacylated ghrelin for the treatment of hyperphagia in Prader-Willi syndrome

      ea0063p621
    • Assessment of materno-fetal complications in pregnant women with type 1 diabetes exposed to insulin degludec

      ea0063p622
    • Myeloproliferative disorder: a rare cause of insulin auto-immune syndrome leading to recurrent severe hypoglycaemia

      ea0063p623
    • Augmented Mitophagy and Inflammasome Activation with Metformin therapy in patients with T2DM

      ea0063p624
    • Features of IL-17 expression in focus of inflammation modulating in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease

      ea0063p625
  • Interdisciplinary Endocrinology 1
  • • Autoimmune thyroiditis (AIT) and diet - the patients' and medical professionals' view

      ea0063p626
    • Abstract unavailable

      ea0063p627
    • Diabetes and dementia in the geriatric population - The icing on the cake

      ea0063p628
    • Gender affirming therapy in Female to Male individuals - lipid profile alterations

      ea0063p629
    • Therapeutic education specifically dedicated to patients being followed for stunting with somatotropin

      ea0063p630
    • Mobile technologies for nutritional support and exercise for improving life of a patient with HIV: Case report

      ea0063p631
    • Alleviation of Autoimmune phenomena in Hashimoto's thyroiditis after Thyroidectomy: Is this an additional surgical indication?

      ea0063p632
    • Is Hashimoto's encephalopathy Reversible with Surgical Thyroidectomy: A South Indian experience

      ea0063p633
    • Abstract unavailable

      ea0063p634
    • Hypothyroidism and Down syndrome

      ea0063p635
    • Helicobacter pylori infection in patients with celiac disease

      ea0063p636
    • Polyphenol health effects on cardiovascular and neurodegenerative disorders: a meta-analysis

      ea0063p637
    • Causes and outcomes of hyponatraemia at Mater Dei Hospital, Malta

      ea0063p638
    • Constitutive activity of human RXFP2

      ea0063p639
    • Different regulation of erythropoietin and VEGF in clear renal cell carcinoma

      ea0063p640
    • Digital epidemiology of hypothyroidism: pilot study

      ea0063p641
    • To what extend biotin interferes with hormones immunoassays?

      ea0063p642
    • Unexpected manifestation of autoimmune thyroid disease in a lipoid proteinosis patient

      ea0063p643
    • Dominance of ovarian follicles is determined by follicle-stimulating hormone receptor (FSHR) and G protein-coupled estrogen receptor (GPER) heteromers

      ea0063p644
    • Demonstration of follicle-stimulating hormone receptor (FSHR) and G protein-coupled estrogen receptor (GPER) heterodimerization by bioluminescence resonance energy transfer (BRET)

      ea0063p645
    • Spingosine-1-phosphate induces cAMP/PKA-independent pCREB activation, but not steroidogenesis, in human granulosa cells

      ea0063p646
    • 5-Beta-reductase (AKR1D1) deletion leads to increased insulin sensitivity in mature male mice

      ea0063p647
    • Ghrelin expression in breast carcinomas

      ea0063p648
    • Polydispia can reveal underlying non-osmotic arginine-vasopressin secretion

      ea0063p649
    • Helicobacter pylori infection in patients with celiac disease

      ea0063p650
    • Biguanides exert antitumoral actions in pituitary tumor cells through AMPK-dependent and -independent mechanisms

      ea0063p651
    • Restoring the sleep disruption by blue light emitting screen use in adolescents: a randomized controlled trial

      ea0063p652
    • Dietary glycemic index and dietary glycemic load is associated with apelin gene expression from visceral and subcutaneous adipose tissues of adults

      ea0063p653
    • Habitual physical activity are associated with fat mass and obesity-associated gene (FTO) gene expression in visceral and subcutaneous adipose tissues among non-diabetic people

      ea0063p654
    • Meningiomas and hormone therapy: a multicenter, epidemiological, retrospective, uncontrolled study

      ea0063p655
    • Epidemiological characteristics of transsexual people referred to a single-center during its first fifteen years in Catania (Italy)

      ea0063p656
    • Endocrinological management of male-to-female (MtF) transgender persons: a single center experience during the last decade

      ea0063p657
    • Endocrinological management of female-to-male (FtM) transgender persons: a single center experience during the last decade

      ea0063p658
    • Long-term outcome in young women treated for central precocious puberty

      ea0063p659
    • Neurofibromatosis type 2 revealed by hypertension in a young woman: is there a link?

      ea0063p660
    • MiRNA-342-3p as a potential diagnostic biomarker in parathyroid carcinomas

      ea0063p661
    • Adaptation of hypothalamo-pituitary-adrenal axis and cardio-metabolic parameters to physical stress in professional athletes

      ea0063p662
    • Diagnotic value of Shear Wave Elastography in differentiating parathyroid adenomas from thyroid nodules

      ea0063p663
    • Differential regulation of 5[beta]-reductase (AKR1D1) expression and activity by glucocorticoids in human and rodent liver

      ea0063p664
    • CD27-IgD- memory B cells studied in polycystic ovary syndrome

      ea0063p665
    • Pan-cancer analysis of thyroid hormone signaling pathway reveals new possible targets for combinations therapy

      ea0063p666
    • CYP11A1 inhibition as a therapeutic approach for the treatment of castration resistant prostate cancer

      ea0063p667
    • Neuroendocrine effects of stereotactic hypothalamotomy in humans

      ea0063p668
    • Dyslipidaemia and altered hepatic function in males - consequences of androgen excess in fetal life

      ea0063p669
    • The impact of new technologies in the future of health somatotropin: 100% therapeutic adhesion in oncological pediatric age survivors in the Ipolfg

      ea0063p670
    • Clinical, malformative profile of turnersyndrome at mohammed VI university hospital centre oujda-morroco

      ea0063p671
  • Pituitary and Neuroendocrinology 2
  • • The management of acromegaly: experience of the endocrinology

      ea0063p672
    • Sheehan's syndrome: case report

      ea0063p673
    • First and second day cortisol levels as predictors of long-term hypocortisolism after pituitary surgery

      ea0063p674
    • Preoperative predictors of Cushing's disease remission after transsphenoidal endoscopic surgery

      ea0063p675
    • An unexpected intrasellar meningioma in a patient with anosmia

      ea0063p676
    • Erectile dysfunction in diabetic men revealing an empty sella (n=3)

      ea0063p677
    • Case report of pituitary adenoma with subclinical Cushing's disease

      ea0063p678
    • Giant empty sella and pituitary insufficiency 20 years after raditherapy for nasopharyngeal cancer

      ea0063p679
    • Acromegaly complications at the time of diagnosis

      ea0063p680
    • First case of mature teratoma and yolk sac testis tumor associated to inherited MEN-1 syndrome: a case report

      ea0063p681
    • Assessment of oro-dental manifestations in a series of acromegalic patients, the AcroDent study

      ea0063p682
    • GHD children's stature evolution after one year of treatment with growth hormone

      ea0063p683
    • Effects of growth hormone deficiency (ghd) and gh treatment on early markers of atherosclerosis in children

      ea0063p684
    • Copeptin in differential diagnosis in polyuric states

      ea0063p685
    • Delayed psychotic episod in a patient with panhipopituitarism and central diabetes insipidus after craniopharyngioma removal

      ea0063p686
    • Patient compliance, mainly due to lower socioeconomic status, is the principal predictor of effective acromegaly treatment: data from a single tertiary center

      ea0063p687
    • Case of Pituitary corticotropinoma - from PCOS to obvious Cushing's

      ea0063p688
    • Macroprolactinoma in apoplexy associated to 23 year-old Down's syndrome

      ea0063p689
    • Radiologic and laboratory predictors for the surgical outcome in acromegaly

      ea0063p690
    • Acquired bilateral cortical adrenal atrophy in a middle-aged male

      ea0063p691
    • Osteoporosis with Multiple Vertebral Fractures in a 61-year-old Male Revealing a Cushing Disease

      ea0063p692
    • Ectopic neurohypophysis: an unusual cause of growth hormone deficiency

      ea0063p693
    • New markers of systemic inflammation and oxidative macromolecular damage in partial and total Adult Growth Hormone Deficiency

      ea0063p694
    • Severe salt wasting syndrome due to spontaneous epidural haematoma

      ea0063p695
    • Endoscopic transsphenoidal surgery for Cushing's disease; a single surgeon experience

      ea0063p696
    • Therapeutic alternatives for acth secreting aggressive pituitary adenoma-case report

      ea0063p697
    • New diagnosis of Kallmann syndrome in an adult Fugitive

      ea0063p698
    • Hypogonadotropic hypogonadism in a male patient with glycogen storage disease type 1A

      ea0063p699
    • Severe hyponatremia caused by secondary adrenal insufficiency in a patient with central diabetes insipidus: A case report

      ea0063p700
    • Acromegaly in a 29-year-old woman: restored fertility after surgery and radiosurgery

      ea0063p701
    • Cardiovascular and metabolic comorbidities in patients with Cushing's disease at diagnosis and after long term remission

      ea0063p702
    • Change of the response to cabergoline after pregnancy in a patient with partially resistant microprolactinoma

      ea0063p703
    • Sex differences in presentation but not in outcome for ACTH-dependent Cushing's syndrome

      ea0063p704
    • Adrenal crisis in treated patients with Cushing's syndrome

      ea0063p705
    • Visualisation characteristic of the inactive pituitary adenoma (IPA)

      ea0063p706
    • A case of isolated adrenocorticotropic hormone deficiency diagnosed with ventricular fibrillation by prolonged QT interval

      ea0063p707
    • Hypophysitis secondary to anti-pd1/pd-l1 blockade: variations in presentation, four distinct cases

      ea0063p708
    • Protein expression of convertases involved in POMC processing in silent and functioning corticotroph tumors

      ea0063p709
    • Lymphocytic hypophysitis with disturbance of both anterior and posterior pituitary function preceded by headache, diagnosed as meningitis

      ea0063p710
    • Whole genome demethylation status of somatic DNA extracted from different pituitary adenoma types

      ea0063p711
    • Does silent pituitary neuroendocrine tumors show lower specific adenohypophyseal gene hormone expression than functioning ones?

      ea0063p712
    • Characterizing the microenvironment of pituitary neuroendocrine tumours, new approaches and tools to explore the function and contribution of folliculostellate cells

      ea0063p713
    • Low arginine vasopressin levels in patients with central diabetes insipidus is not associated with anaemia

      ea0063p714
    • Silent somatotroph tumors

      ea0063p715
    • Giant prolactinoma: a case with thirty-five years of follow-up

      ea0063p716
    • Glycogenosis and hypofisis pathology, importance of a multidisciplinary management

      ea0063p717
    • A rare case of a TSH/GH secreting pituitary macroadenoma

      ea0063p718
    • Control of hyperglycemia in a young male patient with gigantism during transition: a case report

      ea0063p719
    • Central diabetes insipidus revealing Langerhans cell histiocytosis

      ea0063p720
    • Endocrine manifestations during Langerhans cell histiocytosis

      ea0063p721
    • Growth hormone therapy in Noonan syndrome

      ea0063p722
    • Elevated Chromogranin A levels in a patient with acromegaly - who is the culprit?

      ea0063p723
    • The influence of acromegaly treatment on subclinical left ventricular dysfunction assessed by two-dimensional speckle tracking echocardiography (2D-STE)-preliminary results

      ea0063p724
    • Remission rate of acromegaly after somatostatin analogs withdrawal: an update

      ea0063p725
    • Detection of pituitary adenoma specific circulating tumour DNA using semiconductor sequencing

      ea0063p726
    • Is idiopathic mild hyperprolactinemia a cardiovascular risk factor?

      ea0063p727
    • Acromegaly in McCune-Albright Syndrome: case report

      ea0063p728
    • Muscle dysfunction is associated with poor quality of life in patients with Cushing's syndrome long-term after remission

      ea0063p729
    • Trial-in-progress: A multicenter, dose-titration, open-label phase 2b study of nevanimibe hydrochloride, A novel ACAT1 inhibitor, for the treatment of classic congenital adrenal hyperplasia

      ea0063p730
    • Therapeutic decisions in acromegaly according to disease control in patients with acromegaly with or without prior treatment: data from baseline analysis of the SAGIT® validation study

      ea0063p731
    • Assessing clinical meaningfulness of quality of life (qol) change in patients with Cushing's disease: calculation of minimal important difference estimates for the cushingqol using anchor and distribution-based approaches

      ea0063p732
    • Moderate hyponatremia at discharge is associated with increased risk of recurrence in patients with community-acquired pneumonia

      ea0063p733
    • A phase 2 study assessing osilodrostat in children and adolescent patients with Cushing's disease - Rationale and methods

      ea0063p734
    • The changing face of cushing disease in the 21st century: mood disorders and body image perception

      ea0063p735
    • Prevalence of silent acromegaly in prolactinomas (PASP): an Italian experience

      ea0063p736
    • A multicentre, randomized, open-label, Phase IV study investigating management of pasireotide-associated hyperglycaemia with incretin-based therapy or insulin in patients with acromegaly or Cushing's disease (CD)

      ea0063p737
    • Hemangiopericytoma mimicking a pituitary adenoma: a case report

      ea0063p738
    • Investigation of the role of miR-126-3p in pituitary insufficiency following traumatic brain injury

      ea0063p739
    • Secretory and proliferative activity of GH-secreting pituitary adenoma

      ea0063p740
    • Ongoing challenges in treatment of cushing's disease due to pituitary macroadenoma

      ea0063p741
  • Thyroid 2
  • • An unusual case of skull metastasis of thyroid carcinoma in an adolescent

      ea0063p742
    • The prevalence of anti-parietal cell and tissue-transglutaminase antibodies in patients with autoimmune thyroid disease: a preliminary report

      ea0063p743
    • Levothyroxine treatment of subclinical (SH) and overt (OH) hypothyroidism in children with autoimmune hashimoto thyroiditis (AHT): defining the TSH cut-off level

      ea0063p744
    • Evaluation of ultrasonographical and cytological features of thyroid nodules in patients treated with radioactive iodine for hyperthyroidism

      ea0063p745
    • External beam radiotherapy in differentiated thyroid cancer: clinical experience in a large spainish multicentre study

      ea0063p746
    • Patient with graves disease and antithyroid drugs allergy: when endocrinology becomes an art

      ea0063p747
    • Risk factors of cervical lymph node metastasis of differentiated thyroid carcinoma

      ea0063p748
    • Effectiveness of radiofrequency ablation of the large benign thyroid nodules

      ea0063p749
    • Presentation of thyrotoxicosis in hospitalized elderly patients

      ea0063p750
    • Differences between EU and ACR TI-RADS in identifying potential malignant thyroid nodules

      ea0063p751
    • Atypical hurthle cell adenoma: be aware

      ea0063p752
    • Falsely high serum calcitonin levels

      ea0063p753
    • Hyperthyroidism revealed by pulmonary embolism: a case report

      ea0063p754
    • Indicators of hormones before and after the operation of the goiter root of the tongue

      ea0063p755
    • Systematic review and meta-analysis of occurrence of other autoimmune diseases in autoimmune polyglandular syndrome type II and type III

      ea0063p756
    • Hypo-coagulated patients and ultrasound guided fine-needle aspiration of thyroid nodules: a worry?

      ea0063p757
    • Nivolumab-induced hypothyroidism in young male without prior antithyroid autoimmunity

      ea0063p758
    • Correlations between thyroperoxidase antibody titers and Levothyroxine dose in patients with primary hypothyroidism

      ea0063p759
    • NMR-measured subfractions of HDL-cholesterol through thyroid function spectrum

      ea0063p760
    • Two cases of hypothyroidism induced by tuberculosis drug

      ea0063p761
    • Thyroid ecostructural implications of antinuclear antibodies in patients with chronic autoimmune thyroiditis and hypovitaminosis D

      ea0063p762
    • Antinuclear antibodies, chronic autoimmune thyroiditis, periodontal disease - pathological correlations

      ea0063p763
    • Experience in treating patients with endocrine ophthalmopathy

      ea0063p764
    • Thyroid disfunction during treatment with Nivolumab: nuances in clinical presentation

      ea0063p765
    • Is the determination of rTSH estimulated thyroglobulin necessary for long term management in patients with differentiated thyroid carcinoma?

      ea0063p766
    • Endocrine malignancies and systemic lupus erythematosus: case report

      ea0063p767
    • Assessment of thyroid functions and thyroid volume in normal pregnant Egyptian females

      ea0063p768
    • The evaluation of peripheral vestibular system in Hashimoto's thyroiditis

      ea0063p769
    • Voluminous multinodular goiter revealing an isolated thyrotropin deficiency

      ea0063p770
    • Functional thyroid changes in the first trimester of pregnancy in a normal iodine intake area

      ea0063p771
    • Clinical features, diagnosis and management of hypothyroidism in the elderly at the Endocrinology-Diabetology-Nutrition Department of Oujda's University Hospital

      ea0063p772
    • Evaluation of oxidative stress parameters in subacute thyroiditis patients

      ea0063p773
    • Uncommon cause of dilated cardiomyopathy

      ea0063p774
    • Clinical profile and treatment modalities of patients presenting with hyperthyroidism in a tertiary endocrine center in nepal

      ea0063p775
    • Community based study of thyroid disorder prevalence in Nepal

      ea0063p776
    • Lipid profile in primary hypothyroidism: a comparative study between genders in the Endocrinology-Diabetology-Nutrition Department of Oujda's University Hospital in Morocco

      ea0063p777
    • Graves' disease: woman or man, is there a difference in clinical presentation or evolution?

      ea0063p778
    • Medical treatment of Gaves' disease in Tunisia: comparison of Methimazole and Benzylthiouracil

      ea0063p779
    • Prognostic value of the determination of interleukin-8 in development of thyrotoxic cardiomyopathy in patients with Graves' disease

      ea0063p780
    • Iodine and selenium status in adult PKU

      ea0063p781
    • Polymorphisms G691S/S904S of RET proto-oncogene in a patient with sporadic medullary microcarcinoma

      ea0063p782
    • Paradoxical first manifestation of papillary thyroid carcinoma in a young male patient

      ea0063p783
    • The association between the levels of the TSI antibodies and thyroid cancer among patients with Graves' disease who have undergone total thyroidectomy

      ea0063p784
    • Never too late for a papillary thyroid carcinoma recurrence

      ea0063p785
    • Long-term efficacy of percutaneous ethanol injection in symptomatic thyroid cysts: Results and protocol proposal

      ea0063p786
    • Cervical lymph node metastasis in thyroid microcarcinoma

      ea0063p787
    • Riedl thyroiditis associated with intense cervical pain

      ea0063p788
    • Is repeat fine needle aspiration required in thyroid nodules with initial benign cytology?

      ea0063p789
    • The prevalence of macro TSH in patients with subclinical hypothyroidism: experience of a single centre

      ea0063p790
    • Transient thyrotoxicosis in chronic thyroiditis unrelated to a pregnancy

      ea0063p791
    • Clinical staging of well differentiated thyroid cancer patients according to american thyrid association risk calculator version 7 and 8 models

      ea0063p792
    • Follicular lesion of undetermined thyroid significance: therapeutic approach to the diagnosis of bethesda 3

      ea0063p793
    • The minimal effective dose of thyroxine is increased in hypothyroid patients with ulcerative colitis

      ea0063p794
    • Effect of vitamin D supplementation on cardiovascular indices in Graves' disease. A randomized clinical trial

      ea0063p795
    • Dystrophin and titin - the new markers of muscle dysfunction in thyroid disorders?

      ea0063p796
    • Gender-specific variations of clinical outcomes after thyroidectomy

      ea0063p797
    • Value and limitation of serum MMP-9 in thyroid nodular disease

      ea0063p798
    • Cut-off values for basal and calcium stimulated calcitonin for the diagnosis of precocious medullary thyroid carcinoma

      ea0063p799
    • Pulmonary embolism: a rare complication of hyperthyroidism Report of a case

      ea0063p800
    • Autoimmune polyendocrine syndrome in patients with Graves' disease

      ea0063p801
    • Carbimazole-induced agranulocytosis: A case report

      ea0063p802
    • Genome wide linkage scan for autoimmune thyroid disease susceptibility loci in multiplex Tunisian family.

      ea0063p803
    • The manifestation of graves' disease in women with hypopituitarism as a result of radiosurgical treatment of acromegaly

      ea0063p804
    • Predisposition to autoimmune thyroid diseases within a Tunisian multiplex family

      ea0063p805
    • The relation of thyroid autoimmunity and parameters of cardiac function

      ea0063p806
    • Breast cancer mimicking metastasis on iodine-131 imaging in thyroid carcinoma

      ea0063p807
    • Clinical presentation of hypothyroidism caused by TSH-receptor antibody

      ea0063p808
    • Bone metastasis revealing thyroid micro-carcinoma

      ea0063p809
    • Outcomes of treatment for severe and active Graves' ophthalmopathy

      ea0063p810
    • Malignant lentigo melanoma in patient with agressive thyroid folicular carcinoma

      ea0063p811
  • Adrenal and Neuroendocrine Tumours 3
  • • Robotic-assisted interaortocaval dissection of an extra-adrenal paraganglioma in supine position via a trans-peritoneal approach

      ea0063p812
    • Pituitary metastasis of Neuroendocrine Carcinoma - a rare case report

      ea0063p813
    • Abnormal serotonin regulatory loop in adrenals of patients with Cushing's syndrome and 21-hydroxylase deficiency

      ea0063p814
    • Insulinoma: Diagnosis and surgical management retrospective analysis of 9 cases

      ea0063p815
    • A case of pheochromocytoma diagnosed with maternal lung edema and fetal mortality

      ea0063p816
    • A case of bilateral pheochromocytoma presenting with peritoneal metastasis after 12 years of primary diagnosis

      ea0063p817
    • Adrenal oncocytic pheochromocytoma with probable malignant potential: a case report

      ea0063p818
    • A novel pathogenic mutation in neurofibromatosis type 1

      ea0063p819
    • Clinical, hormonal and histopathological evaluation of adrenal incidentalomas: About 45 cases

      ea0063p820
    • The malignant potential of oncocytic adrenal tumours should not be underestimated

      ea0063p821
    • Melasma as a sign of Addison's disease: case report

      ea0063p822
    • Pheochromocytoma affecting Pregnancy: still searching the needle in the haystack?

      ea0063p823
    • Laparoscopic adrenalectomy for adrenocortical carcinoma is not inferior to open adrenalectomy

      ea0063p824
    • Prevalence of adrenal glands lesions and correlation with radiological findings

      ea0063p825
    • The French COMETE-Cancer network for adrenal cancer: 10 years of activity as part of a national plan for clinical care of rare cancers

      ea0063p826
    • Congenital adrenal hyperplasia: clinical and hormonal presentation about a Tunisian serie

      ea0063p827
    • Nonfunctioning adrenal incidentaloma associated with diabetes: about 40 cases

      ea0063p828
    • Multiple endocrine neoplasia type 2 family case in Belarussian population

      ea0063p829
    • An uncommon case of a large adrenal cyst

      ea0063p830
    • Catecholamine-secreting tumor and pancreatic tumor fibrosis - a coincidence?

      ea0063p831
    • Addison disease in a patient with familial mediterranean fever

      ea0063p832
    • The role of somatostatin analogs in the control of carcinoid syndrome: systematic review and meta-analysis

      ea0063p833
    • Familial multiple endocrine neoplasia type 1 revealed by a maxillary swelling

      ea0063p834
    • Bilateral adrenal masses in Addison's disease: primary tumors or tuberculosis?

      ea0063p835
    • A germline ARMC5 mutation in a patient with adrenal adenoma and multiple colonic polyps: a case report

      ea0063p836
    • Metastatic adrenal cortical carcinoma presenting with cervical mass and subclinical Cushing: a case report

      ea0063p837
    • (131) I-MIBG therapy in metastatic paraganglioma and phaeochromocytoma: a 4-year single centre experience

      ea0063p838
    • When MAX runs in the family

      ea0063p839
    • Adrenal incidentalomas - from diagnosis to follow-up

      ea0063p840
    • Malignant paraganglioma of the urinary bladder-diagnosis and management - a case report

      ea0063p841
    • Hypothalamic-pituitary-adrenal axis dysfunction in drug-naive schizophrenic patients

      ea0063p842
    • Efficacy of somatostatin analogues in managing hypercalcaemia due to PTHrP in a well differentiated metastatic pancreatic neuroendocrine tumour and discussion of modern treatment options: A clinical case

      ea0063p843
    • Association of neurofibromatosis type 1 and neuroendocrine tumor

      ea0063p844
    • Iatrogenic Cushing syndrome due to use of intranasal betamethasone - two case reports

      ea0063p845
    • Adrenal lipoma: about two cases

      ea0063p846
    • A Adrenocortical carcinoma (ACC) presenting with episodes of intermittent hypertension: Sarcomatoid type adrenocortical carcinoma

      ea0063p847
    • Synchronous tumours: Neuroendocrine Tumours and Breast cancer

      ea0063p848
    • Cervical paraganglioma: about one case

      ea0063p849
    • Measurement of androstenedione levels in adrenal veins for calculation of the selectivity index in adrenal venous sampling

      ea0063p850
    • True silent pheochromocytoma: description of a rare entity

      ea0063p851
    • Multiple paragangliomas (PGs) of head and neck and middle mediastinum: report of an apparently sporadic case

      ea0063p852
    • Your young patient has severe, resistant hypertension? Do not treat her without a workup!

      ea0063p853
    • Uncontrolledhighblood pressure in pregnancy: the pheochromocytoma is not to be ignored

      ea0063p854
    • Adrenal surgical series - radiologic-pathological correlation

      ea0063p855
    • Von hippel-lindau disease associated with bilateral pheochromocytoma and cerebellous hemangioblastoma

      ea0063p856
    • Bilateral primary adrenal lymphoma

      ea0063p857
    • Prevalence of autonomous cortisol secretion as defined in ESE guidelines in a Swedish cohort of patients diagnosed with adrenal incidentaloma: A prospective study in regional Sweden

      ea0063p858
    • Phaeochromocytoma in pregnancy

      ea0063p859
    • Clinical presentation and management of primary aldosteronism in late childhood and adolescence: Experience in an outpatient hypertension clinic

      ea0063p860
    • Neuroendocrine neoplasms: experiences of a single tertiary referral endocrine centre in Hungary

      ea0063p861
    • Asymptomatic pheochromocytomas-an unelucidated physiopathology pattern

      ea0063p862
    • A rare case of primary hyperaldosteronism associated with chronic kidney disease-difficulties in diagnosis and treatment

      ea0063p863
    • X-linked adrenoleukodystrophy phenotype evolution - is family history important?

      ea0063p864
    • Iatrogenic secondary adrenal insuficiency due to ritonavir therapyand inhaled budesonide

      ea0063p865
    • Primary adrenal lymphoma: a rare cause of adrenal insufficiency

      ea0063p866
    • Associated factors with blood pressure outcome in 75 patients after adrenalectomy for primary hyperaldosteronism

      ea0063p867
    • Uncontrolledhighblood pressure in pregnancy: the pheochromocytoma is not to be ignored

      ea0063p868
    • An unusual case of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency diagnosed in the adulthood

      ea0063p869
    • Successful percutaneous radiofrequency ablation of a secreting juxtaglomerular cell tumour

      ea0063p870
    • A misleading presentation of auto-immune diabetes associated with somatostatinoma: a case report

      ea0063p871
    • Adrenocortical cancer: our experience in a tertiary center of endocrinology

      ea0063p872
    • Immunohistochemical expression of ephrines A2 and A4 receptors in neuroendocrine neoplasms: preliminary results

      ea0063p873
    • Molecular diagnosis of multiple endocrine neoplasia type 1 (MEN 1): a single-center experience

      ea0063p874
    • Clinical spectrum of MEN1: what about other non-endocrine neoplasias?

      ea0063p875
    • An interesting case of a familial insulinoma

      ea0063p876
    • Accuracy of adrenal imaging studies in predicting histological tumor dimension following adrenalectomy

      ea0063p877
    • Metabolic profile of non-functional adrenal adenomas

      ea0063p878
    • The role of selected adipokines as predictors of excessive secretion of cortisol in patients with incidental adrenal tumors

      ea0063p879
    • Cardiovascular and metabolic risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

      ea0063p880
    • Epidemiology and evolution data on gastroenteropancretic and pulmonary neuroendocrine tumors

      ea0063p881
  • Diabetes, Obesity and Metabolism 3
  • • Vitamin D receptor gene polymorphisms and lipid profile in different vitamin D status women

      ea0063p882
    • Impact of the overweight and fatty liver in chronic hepatitis B treatment

      ea0063p883
    • Development of diabetes after pancreatic resection

      ea0063p884
    • Threatening hypertriglyceridemia during pregnancy revealing laminopathy and genetic susceptibility in a patient with type 1 diabetes

      ea0063p885
    • Perforating necrobiosis lipoidica: a new case report

      ea0063p886
    • Management of hyperglycaemia risk in patients on medium or long-term glucocorticoid treatment: a retrospective pilot study

      ea0063p887
    • Maturity onset diabetes of the young type 5 - report of one phenotype

      ea0063p888
    • Radiation-induced loss of glycemic control in a patient with refractory lymphoma

      ea0063p889
    • Auto immune hypoglycemia in individuals with type 1 diabetes, from a patient case report

      ea0063p890
    • Scleredema adultorum of buschke: a case report

      ea0063p891
    • An investigation into the relationship between plasma concentrations of cortisol, testosterone, blood pressure and blood glucose levels in diabetic hypersensitive cardiovascular patients

      ea0063p892
    • Necrosis of the nasal pyramid in a type 1 diabetic after prolonged intubation: in the light of a case

      ea0063p893
    • Revelation modalities of latent autoimmune diabetes of adults

      ea0063p894
    • Neuroendocrine neoplasia and obesity

      ea0063p895
    • NME7 gene is associated with the shape of glucose curves during oral glucose tolerance test

      ea0063p896
    • From the glucocentric model to new opportunitiesmetabolic control

      ea0063p897
    • Does diabetes expose to multidrug-resistant urinary tract infections?

      ea0063p898
    • Impact of hypomagnesemia in type 2 diabetes mellitus

      ea0063p899
    • The results of diabetic foot syndrome screening among rural patients with diabetes in Uzbekistan

      ea0063p900
    • The role of 'Diabetic Foot' rooms in the organization of specialised help to patient with diabetic foot syndrome in Uzbekistan

      ea0063p901
    • Corticoid induced diabetes: where? when?

      ea0063p902
    • Short term metabolic outcome following bariatric surgery; A single center experience from Asia

      ea0063p903
    • Case report: Bullous pemphigoid in a patient with type 2 Diabetes on treatment with linagliptin

      ea0063p904
    • Epidemiological research on diabetic rethynopatia prevalence in newly diagnosed people with type 2 diabetes in Uzbekistan

      ea0063p905
    • Gestational Diabetes in Early Pregnancy - what does fasting glucose tell us?

      ea0063p906
    • Weight change of a population of diabetic patients previously educated and having fasted the month of Ramadan

      ea0063p907
    • Association of dipeptidyl peptidase 4 inhibitor use with risk of bullous pemphighoid

      ea0063p908
    • Circulating microRNAs expression profile in individuals with obesity compared to healthy controls

      ea0063p909
    • Gestational Diabetes: what to say about body mass index and outcomes? The influence of prepregnancy body mass index on obstetric and neonatal outcomes of women with gestational diabetes

      ea0063p910
    • Assessement of magnesemic status in patients with metabolic syndrome

      ea0063p911
    • 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) and lipid accumulation in liver cells: A role for epigenetic mechanisms?

      ea0063p912
    • Blood pressure objectives in diabetic patients: about 588 cases

      ea0063p913
    • miRNAs-target genes, miRNA-lncRNA, and miRNA-small molecules interactions involved in metabolic diseases

      ea0063p914
    • Profile of patients using continuous subcutaneous insulin infusion in portugal

      ea0063p915
    • Genetic variants of TCF7L2 gene in Lithuanian women population with previously diagnosed Gestational Diabetes Mellitus compared to General Population

      ea0063p916
    • Angiotensin-converting enzyme (ACE) gene I/D polymorphism and angiotensin II type 1 receptor (AGTR1) gene A1166C polymorphism and diabetic kidney disease

      ea0063p917
    • Risk factors for diabetic retinopathy: About 454 patients

      ea0063p918
    • Diabetes Eruditus: Characteristics of type 1 diabetes of long duration

      ea0063p919
    • The Soft tissue infections in diabetic patients

      ea0063p920
    • Diabetic foot education: patient satisfaction (about 151 cases)

      ea0063p921
    • The cardio-metabolic profile of elderly patient with diabetes mellitus type 2 (about 300 case)

      ea0063p922
    • Flash glucose monitoring system in children under 18 years old with diabetes mellitus type 1 in the southern hospital area of Granada: preliminary results

      ea0063p923
    • Candidiasis infections in the diabetic About 307 cases

      ea0063p924
    • The diabetes mellitus type 2 in elderly patients: comorbidities and polymedication (about 300 cases)

      ea0063p925
    • Factors influencing the practice of physical activity in youth with type 1 diabetes mellitus

      ea0063p926
    • Reasons for consultation in diabetological emergencies

      ea0063p927
    • Assessment of therapeutic education in diabetes patients on insulin at the pharmacy

      ea0063p928
    • Idiopathic versus autoimmune type 1 diabetes - long-term differences

      ea0063p929
    • Whole body cryotherapy effect on weight gain and metabolic parameters of metabolic and type 2 diabetic patients

      ea0063p930
    • Sexual dimorphism in the mechanisms for insulin resistance

      ea0063p931
    • Glucosuric drugs + immune checkpoint inhibitors: A recipe for diabetic ketoacidosis?

      ea0063p932
    • The Oral status of elderly patient with diabetes mellitus type 2: a real factor of risk of malnutrition (about 300 cases)

      ea0063p933
    • Glycemic equilibrium of cancer patients with diabetes

      ea0063p934
    • Management of diabetic patients with cancer

      ea0063p935
    • Let use results of foot examination for guiding diabetes mellitus therapy

      ea0063p936
    • MicroRNA-26a, microRNA-33a, and microRNA-33b in patients with obesity: association with coronary artery disease

      ea0063p937
    • Transition of young adults with type 1 diabetes

      ea0063p938
    • Prevalence and predictive factors of advanced fibrosis in type 2 diabetic patient in a majoritally abstinent population of alcohol

      ea0063p939
    • The metabolic profile of diabetic patients during the month of Ramadan

      ea0063p940
    • Increased serum resistin levels in metabolically unhealthy compared to metabolically healthy obese individuals; correlation with circulating white blood cell subpopulations

      ea0063p941
    • Discharge in the diabetic foot: means, indications and observance: about 102 cases (preliminary results)

      ea0063p942
    • Drug interactions in diabetic patients

      ea0063p943
    • The impact of cigarette smoking on metabolic syndrome in diabetic patients type 2: about 322 cases

      ea0063p944
    • The association between glycemic control and hip fracture risk - a retrospective Cohort study

      ea0063p945
    • Screening of abnormal glucose metabolism in cystic fibrosis could there be a place for DPP-4 inhibitors in early stages?

      ea0063p946
    • Autoimmune diabetes mellitus versus idiopathic: differences at diagnosis

      ea0063p947
    • The relationship of vitamin D status, adherence to the Mediterranean diet and physical activity in obese children and adolescents

      ea0063p948
    • Detection of metabolic hepatic steatosis in type 2 diabetic patient: about 281 cases

      ea0063p949
    • Relative fat mass correlates better than BMI with total body fat - experience of an obesity clinic

      ea0063p950
    • Characterisation of Turner syndrome glucose homeostasis; autoimmunity, adiposity and insulin sensitivity

      ea0063p951
    • Autotaxin level in patients with type 2 diabetes mellitus or cardiovascular disease

      ea0063p952
    • Hepatic steatosis and cardiovascular risk in diabetic patient type 2

      ea0063p953
    • Doege-potter syndrome in patients with malignant extrapleural solitary fibrous tumor: a single center experience

      ea0063p954
    • Transgenic production of endogenous n-3 PUFA levels compared to fish oil intake differentially improve obesity-related metabolic disorders: role of the gut microbiota

      ea0063p955
    • Clinical particularities of acute pancreatitis in diabetic patients: about 60 cases

      ea0063p956
    • Impact of bariatric techniques in the long-term weight loss

      ea0063p957
    • Ramadan fasting effects on the clinical and metabolic parameters of a previously educated population of diabetic, hypertensive and dyslipidemic patients

      ea0063p958
    • Different pattern of clinical presentation between newly onset ketone prone diabetes and type 1 diabetes in a tertiary hospital

      ea0063p959
    • Prevalence of postprandial hyperinsulinemic hypoglycaemia in a random population after primary Roux-en-Y gastric bypass during a mixed meal tolerance test

      ea0063p960
    • The prevalence of impaired cognitive function and depression in patients with type 2 diabetes mellitus and severe insulin resistance

      ea0063p961
    • Gender differences in patients with coronary heart disease and diabetes: A multicentric retrospective study

      ea0063p962
    • Delayed menarche, oligomenorrhea and hyperandrogenism in type 1 diabetes mellitus

      ea0063p963
    • 'Development of new dietetic approach for obese and overweight adults without metabolic factors for cardiovascular disease: preliminary results'

      ea0063p964
    • Prediabetes: expectations and attitudes

      ea0063p965
    • The level of the vitamin D, osteoprotegerin and metabolic status in children with obesity

      ea0063p966
    • Assessment of the educational level of diabetics regarding their foot

      ea0063p967
    • Diabetic foot: Assessment of the diabetic patient's knowledge before and after a day of education

      ea0063p968
    • Knowledge and practices of diabetic patients during Ramadan

      ea0063p969
    • Late diarrhea in diabetic patients under metformin: An undesirable effect of the molecule appearing late?

      ea0063p970
    • Are fast insulin analogues fast enough? Switching to faster aspart may reduce glycemic variability and the risk of hypoglycemia in type 1 diabetic patients on sensor-augmented insulin pump therapy

      ea0063p971
    • The effects of metformin monotherapy on lipid profile in patients with type 2 diabetes mellitus

      ea0063p972
    • Effects of diabetes mellitus on female sexual function

      ea0063p973
    • Canagliflozin: Ankle-Brachial index (ABPI) and risk of amputations

      ea0063p974
    • Impact of diabetes on professional activity

      ea0063p975
    • Clinical characteristics of human POMC, PCSK1, and LEPR deficiencies

      ea0063p976
    • Association between physical inactivity and socioeconomic factors and lifestyle among Tunisian adolescents

      ea0063p977
    • Doctor, is it cancer? A rock-hard breast lump in an anxious type 1 diabetic male-to-female transgender patient

      ea0063p978
    • Hypoglycemia: a major problem in diabetics

      ea0063p979
    • The influence of the prediabetes phenotype on the efficacy of lifestyle interventions to improve glycemia, insulin resistance and postprandial hyperinsulinaemia

      ea0063p980
    • Effectiveness and tolerance of liraglutide and bupropion/naltrexone: clinical experience

      ea0063p981
    • The incidence of pancreatic cancer in diabetic patients

      ea0063p982
    • GLP-1 Agonist as an effective add-on basal-bolus therapy in type 2 diabetic patients

      ea0063p983
    • The relation between HbA1c, glucose management indicator and average glucose parameters

      ea0063p984
    • An overview of urinary tract infection in diabetic patients

      ea0063p985
    • Weight loss in PCOS - benefits of Metformin and Liraglutide - a single institution experience

      ea0063p986
    • Epidemiological, clinical and biochemical characteristics of metabolic syndrome in adults living in South of Tunisia

      ea0063p987
    • Effect of high protein diet over caloric expenditure and thermogenesis in individuals with obesity

      ea0063p988
    • Metformin and Vitamin B12 deficiency: evaluation of vitamin B12, homocysteine and methylmalonic acid levels in type 2 diabetics

      ea0063p989
    • What is the factor that most influences perinatal outcomes in pregnant women with Gestational Diabetes Mellitus: Country of origin or previous Gestational Diabetes?

      ea0063p990
    • Neuroimaging in the diagnosis of neuroplasticity in patients with diabetes mellitus

      ea0063p991
    • IN-FOCUS France: an epidemiological survey on severe hypertriglyceridaemiae assessing the comparative burden of illness of familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS)

      ea0063p992
    • Abstract unavailable

      ea0063p993
  • Environment, Society and Governance
  • • Effect of octyl-phenol and bisphenol A on calcium signaling in cardiomyocyte differentiation of mouse embryonic stem cells

      ea0063p994
    • Second-phase validation of developmental toxicity test using embryoid body's area

      ea0063p995
    • When do Greeks seek information on obesity and diet?

      ea0063p996
    • Influence of structure education program on glycemic control of patients with type 1 diabetes and depression

      ea0063p997
    • Evaluation of patient satisfaction in an endocrinology and metabolism diseases center

      ea0063p998
    • Low doses of persistent organic pollutants (PFOA and PCB153) increase the tumor aggressiveness of hormone-dependent cancer cells

      ea0063p999
    • In vitro effects of the endocrine disruptors DEHP, DBP and BPA on INSL3 receptor (RXFP2)

      ea0063p1000
    • Halogenous derivatives of Bisphenol A inhibit the human FSH receptor activity

      ea0063p1001
    • Observational study on the cardio-metabolic effects of a night shift on internists

      ea0063p1002
    • Anthropometric outcomes of shift work in midwives

      ea0063p1003
    • Evaluation of weight and nutritional diaries of students of public schools in a Brazilian town

      ea0063p1004
    • Genetic associations of vitamin D increase after supplementation

      ea0063p1005
    • Telemedicine in the management of acromegalic patients

      ea0063p1006
    • Seasonality of hyponatremia in hospitalized medical patients - data from a nationwide cohort study

      ea0063p1007
    • Abstract unavailable

      ea0063p1008
  • Interdisciplinary Endocrinology 2
  • • Decreased hepatic detoxification potential in males - consequences of androgen excess in fetal life

      ea0063p1009
    • Noonan syndrome: about three cases

      ea0063p1010
    • The prevalence of oral glucocorticoid use in doses associated with risk of tertiary adrenal insufficiency

      ea0063p1011
    • The association between retinol-binding protein 4 and prediabetes in obese patients with non-alcoholic fatty liver disease

      ea0063p1012
    • Burden of hyponatremia on clinical outcomes in hospitalized adult medical inpatients

      ea0063p1013
    • Characterization of type 1 angiotensin II receptor activation induced gene expression changes in rat vascular smooth muscle cells

      ea0063p1014
    • Advanced glycation end-products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation: possible role in the pathogenesis of cardiovascular late effects

      ea0063p1015
    • Differential impact of body mass index on bone and breast density in post-menopausal women and potential implications for the risk of breast cancer

      ea0063p1016
    • Diagnosis announcement procedure in rare endocrine diseases: a survey of the French National Healthcare Network for Rare Endocrine Diseases (FIRENDO)

      ea0063p1017
    • MicroRNAs regulate aldosterone signaling by post-transcriptional control of mineralocorticoid receptor expression

      ea0063p1018
    • SOAR Study: New approaches to managing social skills deficits in Turner Syndrome

      ea0063p1019
    • Circulating miRNAs expression profile in in vitro muscle cell model exposed to cortisol excess

      ea0063p1020
    • MAMLD 1 gene mutation and 46 XY sex development disorder: a case report

      ea0063p1021
    • Influence of type 2 diabetes on androgen levels in women with Alzheimer's disease

      ea0063p1022
    • The Miller-McKusick-Malvaux syndrome: a rare cause of short stature

      ea0063p1023
    • Association of the Period3 clock gene polymorphism with adrenocorticotropin-stimulated cortisol levels among patients with autoimmune thyroid disease

      ea0063p1024
    • In vitro study of Orexin alpha effects on factors involved in atherosclerosis: a dual role?

      ea0063p1025
    • Glucocorticoid receptor alpha and betaexpression, serum cortisol and cytokine levels in critical illness

      ea0063p1026
    • Immune-related endocrine toxicities in non-small cell lung cancer: predictors of outcome to checkpoint inhibitors?

      ea0063p1027
    • Impact of hormonal factors in the genesis of sarcopenia

      ea0063p1028
    • It is a link between thyroid function and our empathy in relation to animals ?

      ea0063p1029
    • The role of adenosinergic system in patients with orthostatic intolerance

      ea0063p1030
    • Acid sphingomyelinase deficiency unusually associated with severe delay of growth

      ea0063p1031
    • Efficacy of growth hormone treatment in children with turner syndrome

      ea0063p1032
    • Adipocytokines dynamics in patients operated for rectal neoplasm

      ea0063p1033
    • Harmonization status among ten European laboratories using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for steroid measurements in serum: preliminary results from the HarmoSter consortium

      ea0063p1034
    • Ultrastructural changes of neuroendocrine and endocrine responding cells associated with reproductive timing in a hibernating mammal

      ea0063p1035
    • Epilepsy induced by severe hypoglycemia: about 3 cases

      ea0063p1036
    • A case report about endocrine disorders and post transfusion hemochromatosis: a fortuitous association?

      ea0063p1037
    • Risk of type 2 diabetes (T2D) in patients with chronic hypoparathyroidism (HypoPT): A retrospective cohort study

      ea0063p1038
    • The role of the growth hormone - insulin-like growth factor 1 axis in primary osteoarthritis

      ea0063p1039
    • Diabetes and Nivolumab: 2 clinical cases compared

      ea0063p1040
    • Identification, management and outcome of endocrine toxicities related to immune checkpoint inhibitors

      ea0063p1041
    • Use of Simple Referral system to provide quality care in the management of Endocrine Toxicities with Immune checkpoint therapy: Auditing the effectiveness of a new referral system

      ea0063p1042
    • Differences in gut microbiota between patients with gestational diabetes treated with insulin in comparison to those treated with metformin: preliminary analysis

      ea0063p1043
    • Current medical care in women with Turner syndrome-retrospective data from five different specialist endocrinology centers in Germany

      ea0063p1044
    • Clinical audit of immune related adverse events of the endocrine system with checkpoint inhibitor therapies - adopting a new algorithm for routine endocrine monitoring

      ea0063p1045
  • Pituitary and Neuroendocrinology 3
  • • Recovery of the hypothalamic-pituitary-adrenal and gonadal axes following trans-sphenoidal adenomectomy, a single centre experience

      ea0063p1046
    • Cerebrovascular events, secondary intracranial tumors and other neoplasia following radiotherapy for non-acromegaly pituitary tumors and craniopharyngiomas

      ea0063p1047
    • Effectiveness of hight doses of cabergoline suppressive therapy in patients with prolactinoma

      ea0063p1048
    • Expression of programmed death ligand 1 (PD-L1) in human pituitary adenomas

      ea0063p1049
    • RNASeq of Pituitary Adenomas reveals dysfunctional metabolic, secretory and differentiation molecular pathways

      ea0063p1050
    • A comparison of glucagon stimulation and insulin tolerance test in young adults followed craniospinal irradiation

      ea0063p1051
    • Long-term treatment of chronic refractory SIADH with tolvaptan in the elderly: A report of three cases

      ea0063p1052
    • Prolactinoma and elderly subject: which caracteristics?

      ea0063p1053
    • Prolactinomas in women: clinical, neuroradiological and pathological predictive factors for efficacy of transphenoidal surgery

      ea0063p1054
    • Quality of life in patients with acromegaly assessed by AcroQoL- first application in South Poland

      ea0063p1055
    • Pituitary stalk abnormalities: etiology aspects about 28 cases

      ea0063p1056
    • Differentially expressed miRNAs in spindle cell oncocytoma of the pituitary gland

      ea0063p1057
    • Pituitary apoplexy: diagnosis, management and outcome in 44 patients

      ea0063p1058
    • The expression of somatostatin receptor subtypes in immunohistochemistry and the response to somatostatin analogue therapy in non-functioning pituitary adenomas

      ea0063p1059
    • Isolated ACTH deficiency secondary to combined immunotherapy-induced hypophysitis: predilection for corticotrophs

      ea0063p1060
    • Clinical features and endocrine evaluation of non-functioning pituitary adenomas at a secondary level hospital

      ea0063p1061
    • Osteitis fibrosa cystica of the skull in a patient with primary hyperparathyroidism

      ea0063p1062
    • Cumulative GH exposure as risk factor for mortality and morbidity in patients with acromegaly

      ea0063p1063
    • Nighttime serum cortisol level for diagnosis of hypercortisolism in hospitalized patients

      ea0063p1064
    • Graves dermopathy associating toes lesion, pretibial myxedema and acropachy, rare, but aggressive extrathyroidal manifestation of Graves' disease

      ea0063p1065
    • Reduction in serum biomarkers of acromegaly post-surgery and post-pharmacotherapy: are insulin-like growth factor (IGF)-1 and soluble (s)Klotho levels decreased to a similar extent?

      ea0063p1066
    • A closer look at pituitary deficiency in Ipilimumab-induced hypophysitis

      ea0063p1067
    • Pituitary metastases of lung cancer in an elderly men mimiking pituitary apoplexy (3 cases)

      ea0063p1068
    • Apelin, copeptin, aldosterone and renin in patients with hyponatremia after transnasal surgery for pituitary tumors

      ea0063p1069
    • Childhood-onset growth hormone deficiency: evaluation after reaching final adult height

      ea0063p1070
    • A novel mutation in CHD 7 gene: hypogonadotropic hypogonadism without charge syndrome

      ea0063p1071
    • Diabetes insipidus as first clinical manifestation of Xanthoma Disseminatum: a case report

      ea0063p1072
    • Diagnostic challenges in Ectopic Cushing's Syndome: report of 2 cases

      ea0063p1073
    • Local myofascitis: an unusual adverse reaction to lanreotide autogel injections

      ea0063p1074
    • Emotional disorders in the clinic of the thyrotropinoma

      ea0063p1075
    • Prolactinoma - is there a relationship between T2W signal intensity in MRI and response to treatment with dopamine agonists?

      ea0063p1076
    • Long term observation of patients with pituitary stalk lesions - single center experience

      ea0063p1077
    • Pituitary stalk interruption syndrome with late revelation: about 5 cases

      ea0063p1078
    • Familial hypogonadotropic hypogonadism: about a family

      ea0063p1079
    • Impairment of glucose tolerance in children and adolescentstreated for medulloblastoma

      ea0063p1080
    • ACTH-positive diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH)

      ea0063p1081
    • Nasopharyngeal carcinoma revealing acromegaly on pituitary adenoma

      ea0063p1082
    • Diabetes mellitus and metabolic syndrome in acromegaly

      ea0063p1083
    • Case report: polynodular goiter and pituitary macroadenoma co-secreting growth hormone and thyroid stimulating hormone

      ea0063p1084
    • Idiopathic Fanconi anemia and growth retardation: do not miss GH deficiency

      ea0063p1085
    • Predictive factors of surgical outcomes in acromegaly

      ea0063p1086
    • Surgical outcomes in cushing disease: Endoscopic transsphenoidal pituitary surgery

      ea0063p1087
    • Acromegaly and papillary carcinoma of the thyroid: a case report

      ea0063p1088
    • Modification of breast in hyperprolactenemic conditions

      ea0063p1089
    • Growth retardation and brain imaging

      ea0063p1090
    • Surgical outcomes in acromegaly disease: endoscopic transsphenoidal pituitary surgery

      ea0063p1091
    • Factors predicting dopamine agonist treatment withdrawal in prolactinoma patients

      ea0063p1092
    • Medical treatment of cushing's disease during pregnancy with Ketoconazole and Cabergoline - Report of 3 cases

      ea0063p1093
    • GH Deficiency in children: clinical, biological and radiological characteristics an experience of a tertiary care center

      ea0063p1094
    • Poor response to pre-surgical treatment with Somatostatin Receptor Ligands is associated with diabetes in patients with acromegaly

      ea0063p1095
    • Partial hypopituitarism and primary hypotiroidism associated with Diamond-Blackfan Anemia

      ea0063p1096
    • Predictive factor of hypopituitarism in prolactinoma

      ea0063p1097
    • The long time observation, treatment modalities and outcomes in patients with childhood/adult onset of craniopharyngioma

      ea0063p1098
    • Pituitary apoplexy (PA) - a relatively rare condition requiring early recognition, individualized treatment and longterm follow-up

      ea0063p1099
    • Outcome of prolactinoma during pregnancy

      ea0063p1100
    • Pegvisomant: daily versus non daily administration a single centre real life study

      ea0063p1101
    • The significance of low TSH value - case report

      ea0063p1102
    • Mild weakness as an only symptom for panhypopituitarism with empty sella syndrome: case report

      ea0063p1103
    • Prevalence and study of neuroendocrine deficits in a series of 75 patients following traumatic brain injury

      ea0063p1104
    • Aggressive corticotroph adenoma

      ea0063p1105
    • Analysis of gender-related differences in clinically non-functioning pituitary adenomas

      ea0063p1106
    • European observational study of ketoconazole for endogenous cushing's syndrome in collaboration with European registry on cushing's syndrome ERCUSYN: PASS ketoconazole study design and rationale

      ea0063p1107
    • Variability of momentarily measured fatigue in patients with pituitary insufficiency receiving hydrocortisone replacement therapy

      ea0063p1108
    • HPA axis function in patients with clinically non-functioning pituitary adenomas: effects of surgery and risk factors for HPA failure

      ea0063p1109
    • Isolated central hypothyroidism as a clue for empty sella syndrome

      ea0063p1110
    • Hypoglycemic coma revealing sheehan syndrome: a case reported

      ea0063p1111
    • Metabolic phenotype in acromegaly

      ea0063p1112
    • The impact of clomiphene citrate as add-on therapy in male acromegalic patients non-responsive to combined medical therapy

      ea0063p1113
    • Evolution of patients with discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly

      ea0063p1114
    • Pituitary apoplexy occurs more frequently in the morning

      ea0063p1115
    • Giant cerebral aneurysm a rare cause of hypopituitarism: a case report

      ea0063p1116
    • Epidemiology of acromegaly in Russian Federation: evaluation of National registry-based data

      ea0063p1117
    • Diagnostic evaluation of a large cohort of Brazilian patients with endogenous Cushing's syndrome

      ea0063p1118
  • Reproductive Endocrinology 2
  • • The role of omentin in inflammation and metabolic syndrome risk assessment in women with PCO-S

      ea0063p1119
    • Immunomodulatory effects of dihydrotestosterone (DHT) in rat vaginal smooth muscle cells

      ea0063p1120
    • Clinical and diagnostic criteria for patients with thyroid diseases in disturbances of the menstrual cycle

      ea0063p1121
    • Severely elevated testosterone in a woman with ovarian hyperthecosis

      ea0063p1122
    • Study of the anti-inflammatory effects of dihydrotestosterone in human vaginal smooth muscle cells

      ea0063p1123
    • Evaluation of insulin resistance and endocrine hormone parameters on etiopathogenesis of acne vulgaris, analyzing whether there is a change in insulin resistance and hormonal parameters after oral isotretinoin treatment

      ea0063p1124
    • Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction

      ea0063p1125
    • Hormonal predictors of pathologic findings at magnetic resonance imaging in secondary hypogonadal men

      ea0063p1126
    • If insulin resistance lowering therapy is effective in polycystic ovary syndrome patients with androgen excess, why to start with various symptom-oriented treatment forms?

      ea0063p1127
    • Turner's syndrome: adult life's implications

      ea0063p1128
    • Features of the clinical course of prolactinomas in women

      ea0063p1129
    • The metabolic effects of metformin, cyproterone-acetate and their combination in women with polycystic ovary syndrome

      ea0063p1130
    • Influence of kidney function on sex hormone profile in postmenopausal women

      ea0063p1131
    • Optimization of hyperproliferative syndrome treatment in woman on the background of obesity

      ea0063p1132
    • Serum anti-Mullerian hormone is significantly associated with higher luteinizing hormone level in polycystic ovary syndrome

      ea0063p1133
    • Hyperandrogenism in postmenopausal women

      ea0063p1134
    • Assessment of the feasibility and safety of a novel transvaginal ovarian drilling method in a bovine model: ovarian rebalancing

      ea0063p1135
    • Kisspeptin in regulation of menstrual function in patients with resistant hyperprolactinemia

      ea0063p1136
    • Clinical and para-clinical characteristics of Klinefelter syndrome diagnosed in adulthood

      ea0063p1137
    • Abstract unavailable

      ea0063p1138
    • Androgen steroids profile in follicular fluid of Polycystic Ovary Syndrome (PCOS) women

      ea0063p1139
    • Low levels of kisspeptin in patients with acromegaly

      ea0063p1140
    • Ovarian expression of adipokines in polycystic ovary syndrome: characterisation of the 'ECHO' condition

      ea0063p1141
    • Changes of steroid hormones in pregnant ex-smokers and their newborns

      ea0063p1142
    • AdipoRon, an adiponectin receptor agonist, reduces the proliferation and secretion of steroids by human granulosa cells

      ea0063p1143
    • The impact of vitamin D supplementation on HOMA IR and ovulation in patients with polycystic ovarian syndrome

      ea0063p1144
    • Prevalence of equol production capacity in women with polycystic ovary syndrome (PCOS) and association with reproductive, hormonal and metagenomic parameters before and 3 days after isoflavone challenge

      ea0063p1145
    • Recurrent reversal of male congenital hypogonadotropic hypogonadism and atypical fertility: A case report.

      ea0063p1146
    • Acne in girls and young women with hyperandrogenism

      ea0063p1147
    • Improvement of bone microarchitecture after 30 months of testosterone substitution therapy in young patients with Klinefelter Syndrome

      ea0063p1148
    • Predictive factors of testosterone-induced erythrocytosis on transgender males

      ea0063p1149
    • Evolution of referrals for gender dysphoria and trends in the sex ratio: Data from the Trans'Est Gender Identity Centre of the University Hospital of Nancy (2002-2018)

      ea0063p1150
    • Psychological issues in turner syndrome

      ea0063p1151
    • Effects of paroxitine on biochemical parameters and reproductive function in male rats

      ea0063p1152
    • Relationship and sexual experiences in young women with oestrogen deficiency: comparison between women with Turner syndrome and premature ovarian insufficiency

      ea0063p1153
    • A rare cause of secondary amenorrhea in a patient with non-classical CAH due to a uterine middle-line developmental defect: Case report

      ea0063p1154
    • Metabolic and hormonal improvement after ketogenic VLCD diet (VLCK): Case report

      ea0063p1155
    • Sex hormone-binding globulin (SHBG) as a marker of aggressive prostate cancer

      ea0063p1156
    • Klinefelter syndrome in adults: variability in clinical findings

      ea0063p1157
  • Thyroid 3
  • • Cosmetic complaints in patients with thyroid disease

      ea0063p1158
    • Features of depression in patients with hypothyroidism

      ea0063p1159
    • Stress induced cortisol release depresses the secretion of triiodothyronine in patients with anterior wall myocardial infarction

      ea0063p1160
    • Do patients with differentiated thyroid cancer (DTC) harboring TERT promoter mutation require a more intensive treatment and follow-up? - proposal of a prospective study

      ea0063p1161
    • Microvascular blood flow measurements of the thyroid nodules by diffuse optics

      ea0063p1162
    • Atypical hyperthyroidism in a case of neutrophilic dermatosis (Sweet's syndrome)

      ea0063p1163
    • A rare and particular form of goiter to recognize: The dyshormonogenetic goiter

      ea0063p1164
    • Thyroid carcinoma in Struma ovarii: two case reports

      ea0063p1165
    • Hyperthyroidism in children: About 3 cases

      ea0063p1166
    • Effect of maternal thyroid function on neonatal thyroid screening results

      ea0063p1167
    • The role of GLP-1, IGF-1 and leptin in thyroid cancer

      ea0063p1168
    • Surprizing diagnosis of congenital adrenal hyperplasia in a young infertile patient

      ea0063p1169
    • Carcinoma showing thymus-like differentiation (CASTLE) - a case report

      ea0063p1170
    • Obesity and differentiated thyroid cancers: What prognostic impact?

      ea0063p1171
    • Graves' disease associated with severe pancytopenia; case report

      ea0063p1172
    • Biotin thyroid interference an emerging problem with a practical solution: beyond a case report

      ea0063p1173
    • Intra-tumoral necrosis after Sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer: what's next?

      ea0063p1174
    • Familial autoimmune polyglandular syndrome: a case report

      ea0063p1175
    • Coexistence of primary mucosa-associated lymphoid tissue lymphoma of thyroid and papillary thyroid microcarcinoma in a background of hashimoto's thyroiditis

      ea0063p1176
    • Single thyroid amyloidosis: a case report

      ea0063p1177
    • Malignant melanoma and papillary thyroid carcinoma: a case report

      ea0063p1178
    • Sonographic-pathologic correlation of thyroid nodules: TI-RADS vs EU-TIRADS

      ea0063p1179
    • Long-term results in elderly patients with differentiated thyroid carcinoma

      ea0063p1180
    • Ethanol ablation of cystic thyroid nodules: an effective and not aggressive treatment

      ea0063p1181
    • Cured medullary thyroid carcinoma after surgical treatment: does initial presentation matters?

      ea0063p1182
    • Challenges of thyroid cancer management in amiodarone treated patients: a case report

      ea0063p1183
    • Screening of thyroid dysfunction in diabetic pregnant women

      ea0063p1184
    • Goiter and hashimoto's thyroiditis

      ea0063p1185
    • Graves' disease in asssociation with common neoplasms - a retrospective study

      ea0063p1186
    • Pretibial myxedema in Graves' disease: about two cases

      ea0063p1187
    • Tuberculous lymphadenitis mimicking nodal metastasis in papillary thyroid carcinoma: a diagnostic dilemma

      ea0063p1188
    • High activity range and longer follow up duration have better success rate in Radioiodine treated hyperthyroidism

      ea0063p1189
    • Clinical case: follicular thyroid carcinoma metastasis in pubic bone without primary tumor

      ea0063p1190
    • Differentiated thyroid cancer treated with lobectomy: assessment of response to therapy

      ea0063p1191
    • Amiodarone-induced thyrotoxicosis: which type?

      ea0063p1192
    • Surgical outcome of thyroid nodules with atypia of undetermined significance in fine needle aspiration biopsy

      ea0063p1193
    • Papillary thyroid carcinoma revealed by retro spinal adenopathy

      ea0063p1194
    • Amiodarone-induced thyrotoxicosis: when combined treatment is an option

      ea0063p1195
    • Stressful life events induce graves' disease: further evidence for the role of stress as an inducing factor in graves' disease

      ea0063p1196
    • Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies

      ea0063p1197
    • Radioiodine-avid bone metastases from differentiated thyroid cancer without structural abnormality, a singular entity with heterogeneous outcomes

      ea0063p1198
    • Delayed de novo onset orbitopathy after radio-iodine treatment of Graves' thyrotoxicosis

      ea0063p1199
    • Clinical, ultrasonographic, cytological and histological correlation in the diagnosis of thyroid nodules

      ea0063p1200
    • Pitutary apoplexia: a cause of spontaneous remission of cushing's disease with cyclic secretion

      ea0063p1201
    • Predictive factors of malignancy in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance

      ea0063p1202
    • Raynaud's phenomenon as a primary symptom of the thyroid carcinoma

      ea0063p1203
    • TP53 and FLT3 may become candidate markers for detecting malignancy in follicular lesions

      ea0063p1204
    • Quality of life in patients thyroidectomized for differentiated thyroid cancer

      ea0063p1205
    • Elephantiasic pretiblal myxedema with involvement of the hand

      ea0063p1206
    • Clinical, histological and evolutive characteristics of multifocal thyroid carcinomas

      ea0063p1207
    • Thyroid uptake in PET-CT: IPO-porto consecutive case series

      ea0063p1208
    • Severe hypothyroidism, a rare cause of pancytopenia: a case report

      ea0063p1209
    • Vesicular thyroid carcinomas: about 27 cases

      ea0063p1210
    • Profiling circulating microRNAs as serum biomarkers for thyroid cancer recurrence before and after recombinant human TSH stimulation

      ea0063p1211
    • Hypothyroidism and lymphoma in a patient with systemic sclerosis

      ea0063p1212
    • Hyperthyroidism and hepatic dysfunction: the impact of congestive heart failure

      ea0063p1213
    • Graves' disease and thrombocytopenia

      ea0063p1214
    • Black pigmentation seen in thyroid surgery: an indication for total thyroidectomy?

      ea0063p1215
    • Real-life experience with lenvatinib in iodine-refractory thyroid cancer in a terciary hospital

      ea0063p1216
    • Thyroid dermopathy: clinical features in patients with Graves' disease

      ea0063p1217
    • Association of polycystic ovary syndrome and graves' disease - case report

      ea0063p1218
    • Primary thyroid angiosarcoma - a case report

      ea0063p1219
    • Retrospective analysis of clinical and laboratory features of patients with Hashimoto Thyroiditis

      ea0063p1220
    • Severe hypothyroidism, a rare cause of pancytopenia: a case report

      ea0063p1221
    • Screening of transient pulmonary hypertension in patients with Graves' disease

      ea0063p1222
    • Unusual evolution of a papillary thyroid carcinoma in a hyperthyroid young woman

      ea0063p1223
    • Skin fistula after sorafenib use in differentiated thyroid cancer

      ea0063p1224
    • Clinical picture and etiology of severe hypothyroidism in a tertiary hospital setting: Implications for clinical practice

      ea0063p1225
    • Thyroglobulin in the washout fluid from lymph node fine-needle aspiration and Ultrasound features

      ea0063p1226
    • Beneficial and fast impact of intravenous levothyroxine therapy on the lipid profile in severe hypothyroid patients

      ea0063p1227
    • Radioactive Iodine (RAI) Treatment for Benign Thyroid Disease: A UK District General Hospital Perspective

      ea0063p1228
    • Influence of cigarette smoking on the efficacy of intravenous levothyroxine replacement in severe hypothyroidism: a retrospective case control study

      ea0063p1229
    • Delayed Autoimmune Thyroid Disease after Alemtuzumab Therapy: Hypothyroidism with TPO and TRAK Antibodies

      ea0063p1230
    • Spontaneous thyroid hematoma causing airway compression: a case report

      ea0063p1231
• ePoster Presentations
• • Adrenal and Neuroendocrine Tumours
  • • Pheochromocytoma in the setting of a neurofibromatous type 1

      ea0063ep1
    • Congenital adrenal hyperplasia (salt wasting form) with central precocious puberty: A combined therapeutic approach using a nighttime glucocorticoid dose, an aromatase inhibitor and a gonadotropin-releasing hormone analogue

      ea0063ep2
    • Depression and anxiety are positively correlated with higher concentrations of cortisol and blood pressure in hypertensive cardiovascular disease patients

      ea0063ep3
    • Metrorrhagia as first manifestation of adrenocortical carcinoma - case report

      ea0063ep4
    • Low blood glucose, but why?

      ea0063ep5
    • A case of Cushing syndrome due to primary bilateral macronodular adrenal hyperplasia caused by ARMC5 mutation and concomitant primary hyperparathyroidism

      ea0063ep6
    • Adrenal carcinoma presenting as suicidal depression

      ea0063ep7
    • Characteristics of factors affecting the survival of patients with adrenal cortical carcinoma treated with mitotane

      ea0063ep8
    • Singultus persistens as a presentation of addisonian crisis

      ea0063ep9
    • Acquired intermittent long QT syndrome might be challenging in substitution dosing in adult patient with Addison disease: case report after 3 years follow up

      ea0063ep10
    • Adrenal hematoma: two cases report

      ea0063ep11
    • Lost to follow-up in classic congenital adrenal hyperplasia: a case report

      ea0063ep12
    • Adrenocortical carcinoma - single center experience

      ea0063ep13
    • The diagnosis of Cushing's syndrome in pulmonary adenocarcinoma associated with an unilateral adrenal mass - case report

      ea0063ep14
    • Progress in the treatment of unresectable metastatic ileum-cecal NET - Peptide receptor radionuclide therapy (PRRT)

      ea0063ep15
    • Multiple endocrine neoplasia typu 2B - case report

      ea0063ep16
    • A rare case of ectopic ACTH syndrome due to recurrence of olfactory neuroblastoma

      ea0063ep17
    • Characteristics, management and outcome of patients with adrenocortical carcinoma in a tertiary hospital: a retrospective study

      ea0063ep18
    • ACTH-Producing neuroendocrine cancer of the thymus with pancreatic metastasis, presenting with flush

      ea0063ep19
    • Adrenocortical carcinoma: epidemiological, clinical and paraclinical profile: about 4 cases

      ea0063ep20
    • Primary hyperaldosteron detecting among the patients with essential hypertension

      ea0063ep21
    • The rare outcome of pituitary adenoma treatment

      ea0063ep22
    • Case report: patient presenting with tumor on the left adrenal gland

      ea0063ep23
  • Calcium and Bone
  • • A case of benign hypocalciuric hypercalcemia in a HLA B 27 positive ankylosing spondylitis patient

      ea0063ep24
    • Treatment sequence after teriparatide

      ea0063ep25
    • Measurement of daily calcium intake by students of 2nd year education of master degree of the tashkent pediatric medical institute

      ea0063ep26
    • Hypertension during primary hyperparathyroidism

      ea0063ep27
    • The impact of gastrointestinal diseases on bone quality: description of two cases

      ea0063ep28
    • Hypertension, diabetes, cognitive impairment, renal cancer, polymyalgia rheumatica and chronic hemodialysis treatment: so many diseases or just only one?

      ea0063ep29
    • Abnormalities of glucidic metabolism during hyperparathyroidism

      ea0063ep30
  • Diabetes, Obesity and Metabolism
  • • Interrelation between obesity, metabolic syndrome and molecular-genetic mechanisms of their formation

      ea0063ep31
    • Personality traits in the morbidly obese patients awaiting bariactric surgery and in the group of patients who have undergone surgery

      ea0063ep32
    • The effects of metabolic dysfunction (obesity diabetes type II) on the cervical epithelium cytology from Pap test survey

      ea0063ep33
    • Prevalence of high blood pressure in a group of Tunisian obese

      ea0063ep34
    • Efficacy of combination of ezetimibe and rosuvastatin in patients with dyslipidemia in type 2 diabetes mellitus

      ea0063ep35
    • Diabetic ketoacidosis

      ea0063ep36
    • Abstract unavailable

      ea0063ep37
    • Lipid profile and cardiovascular risk in psoriatic arthritis

      ea0063ep38
    • Lipid profile changes during menopausal transition

      ea0063ep39
    • Afraid that your prediabetic patients may develop type 2 diabetes with statins? Give red yeast rice + berberin a try!

      ea0063ep40
    • Characterization of essential hypertension vs secondary hypertension in late childhood and adolescence: Experience in an outpatient hypertension clinic

      ea0063ep41
    • High level hypertriglyceridemia fluctuation

      ea0063ep42
    • A diagnosis challenge: endogenous hyperinsulinism and negative localisation tests: case report

      ea0063ep43
    • Feasibility and effectiveness of a low carbohydrate diet in a traditionally high carbohydrate intake population

      ea0063ep44
    • Insulin resistance and metabolic disorders in women with morbid obesity

      ea0063ep45
    • Prevalence of non alcoholic fatty liver disease in women with morbid obesity

      ea0063ep46
    • Clinical and metabolic characteristics in a population of obese tunisian women with polykystic ovary syndrome (pkos)

      ea0063ep47
    • Assessment of body composition (service experience)

      ea0063ep48
    • Side effects of topical corticosteroids in the treatment of psoriasis: a case report

      ea0063ep49
    • Diabetes secondary to pancreatectomy an inevitable complication

      ea0063ep50
    • Effect of diabetes and high blood pressure association on degenerative complications of diabetes

      ea0063ep51
    • Penitentiary: diabetes and metabolic risk

      ea0063ep52
    • Immunological interference with hemoglobin A1c assay

      ea0063ep53
    • Diabetes mellitus revealed by hemichorea: a case report

      ea0063ep54
    • Munchhausen syndrome: in the light of 4 observations

      ea0063ep55
    • Diabetic foot in images

      ea0063ep56
    • Diabetic foot: screening and prevention

      ea0063ep57
    • Epidemiological and clinical features of the diabetic foot in the elderly

      ea0063ep58
    • Prevalence and characteristics of metabolic syndrome in diabetics

      ea0063ep59
    • Kidney failure without proteinuria in a population of diabetic women: can we incriminate diabetes?

      ea0063ep60
    • Comprehensive approach towards pediatric diabetes management: policy initiatives in developing country

      ea0063ep61
    • Impact of the month of Ramadan on the metabolic profile of non-fasting diabetic patients

      ea0063ep62
    • Correlation of body composition and glycemic profile of diabetic patients

      ea0063ep63
    • Intensive treatment for obesity at our hospital

      ea0063ep64
    • Addressing issues of diabetes patients community: evaluation in resource poor settings

      ea0063ep65
    • Whole-body insulin resistance (WBIR) evolving in four stages and its evolutionary effect on the body weight

      ea0063ep66
    • Vitamin D as a predictor of insulin resistance in PCOS

      ea0063ep67
    • Lack of definite association of vitamin D deficiency with diabetic neuropathy: Investigation in Greek and in Bangladeshi patients

      ea0063ep68
    • Multiple causes of hyponatremia, which one is the most severe? - case report

      ea0063ep69
    • Influence of obesity on glycemic balance in type 2 diabetics

      ea0063ep70
    • Multidisciplinary approach for diabetes management: developing nations healthcare model

      ea0063ep71
    • Nutritional support in diabetic gastroparesis

      ea0063ep72
  • Interdisciplinary endocrinology
  • • Steatosis in chronic hepatitis C: prevalence and therapeutic impact

      ea0063ep73
    • Cardiovascular manifestations and risk in acromegaly: experience of diabetology-endocrinology department of Oujda's Mohammed VI university hospital

      ea0063ep74
    • Short stature revealing Thomsen's disease: a case report

      ea0063ep75
    • Rare variant of benign premature pubarche in a 6 months old boy

      ea0063ep76
    • Effect of diets rich in n-3 or n-6 polyunsaturated fatty acids on fibrinogen and haptoglobin on the acute phase response

      ea0063ep77
    • Assessment of cardiovascular diseases awareness and knowledge among people living with diabetes

      ea0063ep78
    • Hidradenitis suppurativa and endocrine disturbance: a case report

      ea0063ep79
    • Hypercortisolemia in Rothmund Thomson syndrome with RECQL4 mutation

      ea0063ep80
    • Epilepsy induced by severe hypoglycemia: about three cases

      ea0063ep81
    • Effectiveness and safety of candesartan cilexetil/hydrochlorothiazide combination in jordanian hypertensive patients at risk of cardiovascular disease

      ea0063ep82
    • Hyperprolactinemia

      ea0063ep83
    • Osteoporosis issues [and] complementary Indian medicine: three years experiences in Asian population

      ea0063ep84
  • Pituitary and Neuroendocrinology
  • • The frequency of subclinical cushing's syndrome in women with polycystic ovaries syndrome

      ea0063ep85
    • Prognostic interpretation of four different dynamic biochemical tests of growth hormonal status for acromegaly

      ea0063ep86
    • Studying of a condition of reproductive function of patients with the inactive pituitary adenomas (IPA)

      ea0063ep87
    • Secondary amenorrhea as unique manifestation of acromegaly due to giant pituitary adenoma

      ea0063ep88
    • Pituitary neuroendocrine tumor/pit 1 with gh producting cells

      ea0063ep89
    • A metastasis of large B-cell lymphoma mimicking a pituitary adenoma: a case report

      ea0063ep90
    • Thyroid diseases during acromegaly: about 43 cases

      ea0063ep91
    • Cardiovascular manifestations of acromegaly: about 43 cases

      ea0063ep92
    • Etiology of syndrome of inappropriate antidiuretic in patients on parenteral nutrition: prospective multicenter study

      ea0063ep93
    • TSH secreting pituitary tumor

      ea0063ep94
    • Acute pituitary apoplexy-one year case series

      ea0063ep95
    • Combination of cushing's syndrome and acromegaly: a rare case report

      ea0063ep96
    • Restoration of fertility in a woman with giant prolactinoma in response to cabergoline treatment (case report)

      ea0063ep97
    • Effectiveness of somatostatin analogues in the treatment of acromegaly

      ea0063ep98
    • Challenges in management of diabetes insipidus with impaired thirst perception

      ea0063ep99
    • Follistatin is negatively associated with growth hormone and insulin-like growth factor 1 in patients with acromegaly

      ea0063ep100
    • Pituitary apoplexy and transient hypopituitarism

      ea0063ep101
    • Thyrotropin-producing pituitary adenoma: 3 case reports

      ea0063ep102
    • Non-functional pituitary adenoma

      ea0063ep103
    • Corticotroph adenoma associated with a rare infection - case report

      ea0063ep104
    • Therapeutic challenges in a case of TSH/GH co-secreting pituitary macroadenoma

      ea0063ep105
    • Central resistance to thyroid hormone coexisting with autoimmune thyroid disease - case report

      ea0063ep106
    • Pituitary stalk interruption syndrome: about 9 case report

      ea0063ep107
    • Central diabetes insipidus in children: difficulties of etiological diagnosis

      ea0063ep108
    • Idiopathic short stature in a female patient

      ea0063ep109
    • A rare pituitary adenoma: silent corticotroph adenoma

      ea0063ep110
    • A case of primary autoimmune hypophysitis associated with hashimoto's disease, alopecia areata and chronic hepatitis

      ea0063ep111
    • Short stature and undescended testis in pituitary stalk interruption syndrome

      ea0063ep112
    • The case of recurrence of the growth non-functional pituitary macroadenoma with hypopituitarism

      ea0063ep113
    • sLiving with acromegaly: depicting acromegaly treatment evolution in 18 years period

      ea0063ep114
    • Pseudo-tumoral hypophysis: what can it be?

      ea0063ep115
    • Association of accelerated coronary atherosclerosis and steroid induced hyperglycemia in craniopharyngeoma operated patient: 15 years follow up patient

      ea0063ep116
    • Primary amenorrhea at age 37 - case report

      ea0063ep117
    • Familial hypogonadotropic hypogonadism: about a family

      ea0063ep118
    • Pitutary apoplexia: a cause of spontaneous remission of Cushing's disease with cyclic secretion

      ea0063ep119
    • Management challenge of child hood Cushing disease

      ea0063ep120
    • Delayed diagnosis of acromegaly: a two-year journey

      ea0063ep121
  • Reproductive Endocrinology
  • • Severe pulmonary tromboembolism and klinefelter syndrome

      ea0063ep122
    • Klinefelter syndrome and hypogonadotropic hypogonadism: an unusual presentation

      ea0063ep123
    • Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus

      ea0063ep124
    • A rare case of hypergonadotrophic hypogonadism by 47,XXY/46,XX mosaic

      ea0063ep125
    • Analysis of quality of life in women of reproductive age with polycystic ovarian syndrome

      ea0063ep126
    • The role of transcription factors in control of ovarian functions

      ea0063ep127
    • Reproductive disorders in women with morbid obesity

      ea0063ep128
    • A case of post-menopausal hirsutism

      ea0063ep129
    • Ovarian ultrasound features in women with morbid obesity

      ea0063ep130
    • Secondary amenorrhea: epidemiological, clinical and etiology profile at the university hospital center Mohammed VI Oujda

      ea0063ep131
    • Major getational hypertriglyceridemia

      ea0063ep132
    • Hirsutism in women of reproductive age from the oriental region of eastern Morocco: what features?

      ea0063ep133
    • Primary amenorrhea: clinical, biological, etiological and therapeutic features

      ea0063ep134
    • Clinical, malformative and cytogenetic profile of mosaicturnersyndrome at Mohammed VI University Hospital Centre Oujda

      ea0063ep135
  • Thyroid
  • • Evaluation of thyroid function in obese adults with non-alcoholic fatty liver disease attending at Tanta university hospitals

      ea0063ep136
    • Differential diagnosis of thyrotoxicosis syndrome in postpartum period

      ea0063ep137
    • Severe primary hypothyroidism as a cause of reversible renal failure

      ea0063ep138
    • Case report: Myxedema coma after radiotheraphy for Laryngeal cancer

      ea0063ep139
    • Significance of testing anti-thyroid peroxidase in euthyroid patients

      ea0063ep140
    • Association of a toxic thyroid nodule and papillary microcarcinoma: case report

      ea0063ep141
    • Primary thyroid lymphoma: a differential diagnosis to be considered

      ea0063ep142
    • Clinical case of giant goiter with chronic lymphoid leukemia

      ea0063ep143
    • The rare association of graves disease with chronic spontaneous urticaria

      ea0063ep144
    • Correction of androgen deficiency in men with hypothyroidism

      ea0063ep145
    • Investigation of blood groups in benign thyroid diseases in Turkey

      ea0063ep146
    • A rare variant of Hashimoto's thyroiditis

      ea0063ep147
    • Rhabdomyolysis as clinical presentation of hypothyroidism

      ea0063ep148
    • Primary thyroid lymphoma: about two cases

      ea0063ep149
    • Mixed histiocytosis with BRAF (V600E) mutation and papillary thyroid carcinoma

      ea0063ep150
    • Multicentric papillary thyroid carcinoma with concomitant rare dedifferentiation in the lymph node metastasis

      ea0063ep151
    • Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies

      ea0063ep152
    • Surgical treatment for graves' disease: about 39 cases

      ea0063ep153
    • A case of probable thyroid hormone resistance syndrome

      ea0063ep154
    • Transient elevation of CA 19-9 due to cessation of levothyroxine in a patient with Hashimoto's thyroiditis

      ea0063ep155
    • An uncommon debut of graves disease with bilateral gynecomastia: case report

      ea0063ep156
    • Thyroid storm, a rare but life-threatening appearance of hyperthyroidism

      ea0063ep157
    • Indian endocrine surgery websites-comparable or not?

      ea0063ep158